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end of the Csy3 crescent. The stable association between Csy1
and Csy2 (established by coexpression and mass spectrometry) is
consistent with the additional density on one end being composed
of the Csy1-2 heterodimer and tandem mass spectrometry experi-
ments suggest that these two subunits are localized at the periph-
ery of this complex.
To complement the two-dimensional structural analysis by
TEM, we used small-angle X-ray scattering for three-dimensional
shape determination of the Csy complex (Fig. 4B). Scattering
curves generated from thirty exposures were superimposable and
linear in the Guinier region, suggesting that there was no radia-
tion-induced change in the X-ray scattering properties (Fig. S6A).
These data were radially integrated, averaged, and background
subtracted, resulting in a final scatter plot that includes scattering
vectors (q) ranging from 0.0141 to 0.1369 Å−1 (Fig. S6B). The
paired-set of distances (Pr) between scattering electrons indicates
that the most frequently sampled interatomic distance in the Csy
complex is 52.0 Å (Fig. S6C). This real-space distribution of
scattering pairs indicates a monodispersed sample with real-space
dimensions consistent with reciprocal-space Guinier approxima-
tions and agrees with the dimensions observed by TEM. Twenty
independent bead models were generated by simulated annealing
and these models were aligned, filtered, and averaged based on
occupancy. Nineteen of the original bead models are included
in the final volumetric reconstruction, suggesting that this is a
reliable and stable three-dimensional model of the Csy complex
(Fig. S6D). The overall crescent-shaped morphology of the
complex is similar to that observed by TEM and the additional
asymmetric density is clearly evident in the small-angle X-ray
scattering (SAXS) model. The arch of the Csy complex spans
approximately 200 Å when measured from tip to tail. Although
we do not directly observe the crRNA in either structure, the
dimensions and the dependence of complex formation on the
crRNA are consistent with an RNA that extends along the arch
of the structure.
Discussion
Constant selective pressure from invasive genetic elements has
driven the diversification of both RNA and protein components
of CRISPR-mediated adaptive immune systems. Despite this se-
quence diversity, we find that the Csy proteins of P. aeruginosa
assemble into a 350 kDa complex with some structural and func-
tional similarities to the Cascade complex formed by E. coli Cas
proteins (Fig. S7). The Csy complex includes a crRNA, produced
by the CRISPR-specific endoribonuclease (Csy4) that is required
for complex assembly (10). Unlike CRISPR RNA processing in
E. coli (by CasE or Cse3) and P. furiosus (by Cas6), which produce
crRNAs with a 2′,3′-cyclic phosphate, the crRNAs generated
by Csy4 have a terminal 3′ phosphate (Fig. S2 E and F). These
differences in the chemical nature of mature crRNAs between
CRISPR subfamilies highlight possible mechanistic differences
in both CRISPR RNA biogenesis and RNA–protein complex
assembly.
The mature crRNA isolated from the Csy complex can be
divided into three discrete segments (8-nt 5′ handle/32-nt spacer/
20-nt 3′ hairpin) that have distinct functions (Fig. 3A). The 3′
hairpin provides a recognition site for endonuclease binding
and cleavage. The 5′-handle, whose length is conserved between
distinct immune system types, may play a role in target discrimi-
nation similar to that observed for crRNAs in S. epidermidis (21).
Spacer sequences are thought to have a universal function in tar-
get recognition. Phage challenge experiments in S. thermophilus
and in natural microbial communities have shown that spacers
A
B
Fig. 3. The Csy complex enhances target recognition through seed-sequence interactions. (A) Schematic representation of the mature crRNA showing the
5′ hydroxyl and the 3′ phosphate. Eight-nucleotide oligos complementary to discrete regions of the crRNAwere titrated into a 200 ul sample cell containing the
Csy complex. The raw ITC data for each titration is shown for each oligo. Titrations performed using oligos outside the seed were originally done using
0.5 mM Csy complex and 0.5 mM oligo. These titrations were repeated at higher concentrations (4–10×) with similar results. Titrations preformed using oligos
complementary to the seed were done using 0.01 mM Csy complex and 0.1 mM oligo. (B) Average parameters from triplicate experiments.
A
B
Fig. 4. EM and SAXS reconstructions of the Csy complex reveal a crescent-
shaped particle. (A) Averaged two-dimensional EM projections of the
Csy complex reveal a 120 × 150 Å crescent-shaped particle. (B) Ab initio SAXS
reconstruction of the Csy complex reveals a crescent-shaped particle reminis-
cent of the Cascade complex from E. coli (13).








which may prevent heteroassembly of Csd1 in E. coli Cascade.
The B. halodurans Cascade appears to contain two copies
of the Cas5d protein, and we speculate that they play the
equivalent functions of CasE and CasD in E. coli Cascade
by assembling at the opposite ends of the B. halodurans
Cascade complex, where one binds to the crRNA 50 handle
and the other to the 30 handle (Figure 7). Further mechanistic
and structural details of the subtype I-C B. halodurans Cascade
complex await more detailed examination. Assuming that this
model stands (Figure 7), our work supports the notion that a
common molecular pathway is utilized by all type I CRISPR-
Cas systems to target double-stranded (ds)-DNA for degrada-
tion. In subtype I-C/Dvulg, CRISPR interference involves three
molecular events, formation of the crRNA-presenting Cascade
complex, scanning the ds-DNA substrate and R-loop forma-
tion by Cascade, and Cas3-assisted degradation of ss-DNA
around the R-loop region (Jore et al., 2011; Wiedenheft et al.,
2011).
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
Csd1 (UniProt accession number: Q9KFY2), Csd2 (Q9KFY1), and Cas5d
(Q9KFY3) from B. halodurans were cloned into a modified pSUMO vector
and expressed in E. coli BL21 star cells. Protein expression was induced by
the addition of 0.5 mM isopropyl b-D-1-thiogalactopyranoside (IPTG) for
12 hr at 18!C. The cells were harvested by centrifugation and lysed by sonica-
tion in buffer A (50 mM Tris-HCl [pH 7.5], 200 mM NaCl, and 0.2 mM phenyl-
methylsulfonyl fluoride [PMSF]). In the case of Csd1 and Csd2, soluble
proteins were first purified using Ni-NTA resin as an N-terminal SUMO-fusion
(Qiagen, Venlo, the Netherlands), followed by the incubation with SUMO
protease to remove the SUMO tag overnight during dialysis to a low salt
buffer. After a second pass through the Ni-NTA resin to remove the cleaved
SUMO tag, the flow-through was further purified by Mono Q column (GE
Healthcare, Waukesha, WI, USA), followed by Superdex 200 10/300 (GE
Figure 5. Reconstruction of Subtype I-C/
Dvulg Cascade Complex
(A–C) Superose 6 SEC elution profile of the
B. halodurans Cascade complex reconstituted
from coexpressing Csd1, Csd2, Cas5d, and
crRNA in E. coli. Themolecular weight is"400 kDa
as compared to the MW standards. Analysis of the
fractions in (A) was done using (B) Coomassie
blu -stai ed SDS-PAGE g l r (C) SYBR-GOLD-
tain d denaturing gel. Fraction numbers are
consistent with those shown i (A).
(D) Negative staining electr n micrograph of the
B. halodurans Cascade.
(E) Two major species were i entified from the
two-dimensional classification (odd rows, corre-
sponding raw images were shown underneath in
even rows). The smaller complex (bottom two
rows) likely lacked the Csd1 sub nit (in icated by
the arrows on the top two rows). Scale bars
correspond to 10 nm. See also Figure S4.
Healthcare) into a buffer containing 10 mM Tris-
HCl (pH 8.0), 500 mM NaCl, 10% glycerol, and
2 mM DTT. Cas5d precipitated heavily after
removing the SUMO tag; therefore, the tag was
not removed until crystallization using the in situ
proteolysis method. Purification of the Se-methio-
nine derivatized -Cas5d and Cas5d mutants were
essentially the same as for the wild-type Cas5d. The purified proteins were
concentrated to 20–30 mg/ml and stored at #80!C.
Preparation of the CRISPR RNAs
Pre-crRNAs containing the repeat sequence, with or without residue substitu-
tions and deletions, were chemically synthesized with a HEX or fluorescein
label at either the 50- or 30-end (from Sigma-Aldrich, St. Louis, MO, USA).
They were dissolved in 10 mM HEPES (pH 7.5) and 50 mM NaCl, refolded
by heating to 75!C for 5 min, and flash-cooled on ice. The pre-crRNA contain-
ing multiple repeat-spacer units were transcribed from a pUC19 vector con-
taining a T7 transcription cassette encoding the B. halodurans CRISPR3
locus. The run-off transcription and RNA purification were carried out as
described (Ke and Doudna, 2004). Secondary structures of pre-crRNA were
calculated using the MFOLD program (Zuker, 2003).
Pre-crRNA Cleavage of Cas5d
All pre-crRNA processing reactions were performed at 25!C for 20 min. The
50-HEX-labeled or 30-fluorescein-labeled pre-crRNA repeats at 0.2–1.0 mM
were incubated with Cas5d (0.2–10 mM) in 20 mM HEPES (pH 7.5), 100 mM
KCl, 0.02% (v/v) Triton X-100, 10% (v/v) glycerol, and 2 mM DTT. Metal-
dependent nuclease activity wasmeasured in the presence of 2.5 mM divalent
cations (Mg2+, Mn2+, Ca2+, Zn2+, or Cu2+) or EDTA. Cleavage products were
analyzed on 15% (w/v) sequencing gels after phenol extraction. The fluores-
cent signals were recorded and analyzed using a Typhoon 9400 scanner
(GE Healthcare).
Crystallization, Data Collection, and Structure Determination
Both native and Se-methionine derivatized Cas5d proteins were crystallized
using the in situ proteolysis method, by mixing the SUMO-Cas5d fusion
protein with the SUMO protease at a 100:1 ratio, in a buffer containing 0.1 M
MES (pH 6.0) and 0.8 M ammonium sulfate. The crystals were equilibrated in
a cryoprotectant buffer containing reservoir buffer plus 30% (v/v) ethylene
glycol. The Se-Single Anomalous Dispersion (SAD) data sets were collected
at the A1 beamline in MacCHESS (Cornell High Energy Synchrotron Source)
and 24ID beamlines at Advanced Photon Source. The data sets were indexed
and processed using the program HKL2000 (Otwinowski and Minor, 1997).
Phasing of Cas5d was carried out using the programs SOLVE (Terwilliger
and Berendzen, 1999) and PHENIX AutoBuild (Terwilliger et al., 2008). The
Structure
Pre-crRNA Endoribonuclease Cas5d
Structure 20, 1574–1584, September 5, 2012 ª2012 Elsevier Ltd All rights reserved 1581
crimination between foreign DNA and the chromosomal
CRISPR loci, which lack PAM sequences and are the fore
not targeted by the CRISPR system (10). The target oligonu-
cleotide A1 used for gel shifting included a PAM sequence,
however, binding to an alternative oligonucleotide lacking a
PAM sequence gave similar results (data not shown). This
suggests that there is no discrimination based on PAM pres-
ence or absence in the minimal recombinant system tested
here.
Structural Studies of aCASCADE—To investigate the overall
structure of the aCASCADE complex purified from S. solfatari-
cus, the purified material was visualized using negative stain
transmission electron microscopy (TEM). Following elution
from the streptactin column, and at all subsequent stages of the
purification including the peak fraction from the size exclusion
column, we observed protein filaments with a width of!6 nm.
Interestingly, the filaments are present as extended right-
handed helices of variable length, with an average helical width
of 11.5 nm and a pitch of 14 nm (Fig. 3D). These particles are
clearly larger than that suggested by size exclusion chromatog-
raphy, probably due to their non-spherical nature.
Importantly, the observed right-handed helical assemblies
indicate that Csa2, the major protein in aCASCADE, is capable
of forming oligomers with open, as opposed to closed symme-
try. Although these assemblies are significantly larger than
those seen in E. coliCASCADE, we note that this unusual open
oligomeric assembly is consistent with the relative abundance
of the Cas7 protein in both S. solfataricus (Csa2) and E. coli
(C sC) CASCADE. In addition, the observation that recomb -
nant Csa2 expressed in E. coli is predominantly monomeric in
the bsence of Cas5a and crRNA suggests that Cas5a nd
crRNA m y be responsible for nucleation and/or stabi ization
f this helical ssembly. For these, and other reasons discussed
in more detail below, we believe that many features of this
extended complex ar likely to be r levant to endogenous
aCASCADE.
The Structure of Csa2—To better understand the role of the
Cas7 family of proteins in CASCADE in general, and the role
of Cs 2 in aCASCADE in particular, the structure of recombi-
nant Csa2 was solv d u ing x-ray c ystall graphy. Csa2 crystal-
lized in space group P212121 with four copies per asymmetric
unit (chainsA-D).However, the protein-protein contacts in the
Csa2 crystal appear unlikely to recapitulate protein-protein
interactions in aCASCADE. Although there ar sub ta tial
contacts at the A/B and C/D interfaces, the surfaces are discon-
tinuous and exhibit improper, closed symmetry that is incon-
sistent with the apparent open symmetry of aCASCADE.
The structure of the Csa2 protomer reveals a 3-domain, cres-
cent-shaped structure that is 65 Å in length, tip to tip (Fig. 4A).
The central domain is comprised of a fiv -stranded anti-
parallel !-sheet (!6, !7, !1, !8, and !9), flanked by four
"-helices. The first four strands of the central !-sheet along
with helices "2 and "8 unexpectedly display the !"!!"!
topology of the RNA-binding domain or RNA recognition
motif (RRM), a ferredoxin-like fold that frequently serves in
RNA recognition. We thus refer to these structural elements
as the RRM-like subdomain (purple, Fig. 4A). In Csa2, the
RRM is elaborated upon by a C-terminal addition comprised
of residues 256–320 that begins with an ext nded 13-residue
connection leading into helix "9. This is followed by a short
FIGURE 3. crRNA and target-DNA binding by a Csa2-Cas5a complex.
A, recombinant Csa2 and Cas5a form a complex when co-expressed in E. coli.
Coomassie-stained SDS-PAGE gel showing material purified using Ni-NTA
affinity chromatography andgel-filtration chromatography (second lane) and
further purified using a heparin column (third to 10th lanes). B, EMSA showing
the binding of Csa2 alone (second to eighth lanes) and the Csa2-Cas5a com-
plex (ninth to 15th lanes). The first lane shows crRNA alone. Protein concentra-
tions for both Csa2 andCsa2-Cas5a complexwere 0.25, 0.5, 1, 2, 3, 5, and 7#M
and the crRNA concentration was 100 nM. C, target-DNA binding by the
recombinant complex. Increasing amounts of the Csa2-Cas5a complex were
incubated with radiolabeled target single-stranded DNA in the absence of
crRNA (lanes 1–5), in the presence of crRNA (lanes 6–10), and in the presence
of crRNA and non-target DNA (lanes 11–15). D, TEM images of the helical
filaments formedbyaCASCADEpurified fromS. solfataricus. Theblackbarsare
20 nm.
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a scaffold for the assembly of the other Cmr subunits around the
periphery (black arrows in Figure 4C).
Ribonuclease Activity of SsoCMR
We tested the ability of SsoCMR to recognize and cleave RNA
targets corresponding to spacers A1 and D63 in vitro. Both RNA
targets were cleaved efficiently when a cognate crRNA (guide
RNA) with an 8 nt 50 tag was present (Figure 5). Manganese ions
were essential for this activity, and magnesium could not substi-
tute. ATP was not essential, but clearly stimulated the cleavage
reaction (Figure S5). No crRNA-directed cleavage of DNA targets
was observed (data not shown). To rule out the possibility of
activity from a contaminating ribonuclease, the CMR complex
was immunodepleted using antibodies raised against the Cmr7
subunit. Immunodepletion abolished the nuclease activity, sug-
gesting strongly that the activity was associated with the CMR
complex (Figure S5A). As a further control, native untagged
SsoCMR purified from S. solfataricus cell extract by immunopre-
cipitation using the anti-Cmr7 antibody had the same activity as
the column-purified, tagged protein complex (Figure S5B).
Features of Guide and Target RNAs Important
for Cleavage by CMR
The sequence and structural requirements of RNA cleavage by
CMR were investigated by constructing a range of target and
guide RNA molecules based on the spacer A1 and D63
sequences. To test for a molecular ruler mechanism as observed
for PfuCMR, we reduced the length of the guide RNA (Figure 5A,
panel ii). The cleavage sites did not move in register with the 30
end of the guide RNA, suggesting that Sulfolobus and
Pyrococcus CMR differ fundamentally in this respect. Deletion
of the repeat-derived 50 tag from the guide RNA abolished
cleavage activity (Figure 5A, panel iii) and could not be rescued
by substitution with a 50 8A sequence (panel iv), showing that
this 50 tag sequence is essential for cleavage, ruling out the
possibility of a contaminating nuclease. The presence of an
unpaired flap at the 30 end of the target RNA was also required
for activity (panel vi). This corresponds to the position of the
PAM that is essential for cleavage of viral DNA targets by
CASCADE (Gudbergsdottir et al., 2011; Lintner et al., 2011).
However, for target RNA cleavage by CMR, the PAM sequence
at this position was not essential, as a 6A sequence could substi-
tute (Figure 5B, panel vii).
In addition to the target RNA, the guide RNA strand could also
be cleaved by SsoCMR (Figure 5C, panel viii). Cleavage of the
guide RNA was dependent on the presence of a 30 overhang
on the target RNA (Figure 5C, panel ix, xi). Guide and target
were cleaved at approximately equal rates when present at an
equimolar ratio, but at ratios of 20:1 or 5:1 excess of target
over guide, the guide RNAwas cleaved significantly more slowly.
Under these conditions, multiple turnover cleavage of the target
RNA was observed, suggesting that cleavage of the guide RNA
was not essential for catalysis (Figure S5D).
Sequence-Specific Cleavage by SsoCMR
The cleavage patterns observed for SsoCMR suggested a
sequence- or structure-specific component to the activity.
Sequence mapping suggested that strong cleavage always
occurred at a UA dinucleotide in both the A1 and D63 target
RNAs and the A1 guide RNA (Figure 5). Weaker cleavage was
observed at UU dinucleotides. RNA cleavage by SsoCMR re-
sulted in products with 30-hydroxyl termini that could be
extended by PolyA polymerase (Figure S6A). This is similar to
the metal-dependent RNaseH-type activity observed for Piwi
and Argonaute (Hutvagner and Simard, 2008). In contrast, the
(metal-independent) Cas6 endonuclease yields 30-cyclic phos-
phate products that are not extended by PolyA polymerase
(Figure S6B). PfuCMR is also reported to generate 30-cyclic
phosphate products (Hale et al., 2009), another distinction
between the two enzymes. To map the cleavage site of SsoCMR
precisely, the cleavage at site 2 in the D63 target RNA was
compared to a synthetic oligonucleotide terminating after the
relevant UA dinucleotide (Figure S6C). The cleavage product
generated by SsoCMRwas 1 nt shorter than the oligonucleotide,
consistent with cleavage at this position (and by extension at the
other sites) as occurring at the center of the UA sequence.
To examine the importance of sequence for CMR-mediated
cleavage of RNA, a D63-derived target RNA with only one
UA site, corresponding to position 2, was synthesized. In the
Figure 4. 3D EM Visualization of CMR Complex
(A) Surface representation of the Cmr2/Cmr3/Cmr7 subcomplex devoid of
crRNA.
(B) Surface representation of the full CMR complex with bound crRNA.
(C) Superposition of Cmr2/Cmr3/Cmr7 (blue surface) on CMR/RNA (black
mesh). Black arrowheads point to regions of additional density on the full CMR
complex with bound crRNA compared to Cmr2/Cmr3/Cmr7. Gray arrows
indicate dimensions in angstroms.
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We tested the ability of SsoCMR to recognize and cleave RNA
targets corresponding to spacers A1 and D63 in vitro. Both RNA
targets were cleaved efficiently when a cognate crRNA (guide
RNA) with an 8 nt 50 tag was present (Figure 5). Manganese ions
were essential for this activity, and magnesium could not substi-
tute. ATP was not essential, but clearly stimulated the cleavage
reaction (Figure S5). No crRNA-directed cleavage of DNA targets
was observed (data not shown). To rule out the possibility of
activity from a contaminating ribonuclease, the CMR complex
was immunodepleted using antibodies raised against the Cmr7
subunit. Immunodepletion abolished the nuclease activity, sug-
gesting strongly that the activity was associated with the CMR
complex (Figure S5A). As a further control, native untagged
SsoCMR purified from S. solfataricus cell extract by immunopre-
cipitation using the anti-Cmr7 antibody had the same activity as
the column-purified, tagged protein complex (Figure S5B).
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end of the guide RNA, suggesting that Sulfolobus and
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on the target RNA (Figure 5C, panel ix, xi). Guide and target
were cleaved at approximately equal rates when present at an
equimolar ratio, but at ratios of 20:1 or 5:1 excess of target
over guide, the guide RNAwas cleaved significantly more slowly.
Under these conditions, multiple turnover cleavage of the target
RNA was observed, suggesting that cleavage of the guide RNA
was not essential for catalysis (Figure S5D).
Sequence-Specific Cleavage by SsoCMR
The cleavage patterns observed for SsoCMR suggested a
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occurred at a UA dinucleotide in both the A1 and D63 target
RNAs and the A1 guide RNA (Figure 5). Weaker cleavage was
observed at UU dinucleotides. RNA cleavage by SsoCMR re-
sulted in products with 30-hydroxyl termini that could be
extended by PolyA polymerase (Figure S6A). This is similar to
the metal-dependent RNaseH-type activity observed for Piwi
and Argonaute (Hutvagner and Simard, 2008). In contrast, the
(metal-independent) Cas6 endonuclease yields 30-cyclic phos-
phate products that are not extended by PolyA polymerase
(Figure S6B). PfuCMR is also reported to generate 30-cyclic
phosphate products (Hale et al., 2009), another distinction
between the two enzymes. To map the cleavage site of SsoCMR
precisely, the cleavage at site 2 in the D63 target RNA was
compared to a synthetic oligonucleotide terminating after the
relevant UA dinucleotide (Figure S6C). The cleavage product
generated by SsoCMRwas 1 nt shorter than the oligonucleotide,
consistent with cleavage at this position (and by extension at the
other sites) as occurring at the center of the UA sequence.
To examine the importance of sequence for CMR-mediated
cleavage of RNA, a D63-derived target RNA with only one
UA site, corresponding to position 2, was synthesized. In the
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(B) Surface representation of the full CMR complex with bound crRNA.
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periphery (black arrows in Figure 4C).
Ribonuclease Activity of SsoCMR
We tested the ability of SsoCMR to recognize and cleave RNA
targets corresponding to spacers A1 and D63 in vitro. Both RNA
targets were cleaved efficiently when a cognate crRNA (guide
RNA) with an 8 nt 50 tag was present (Figure 5). Manganese ions
were essential for this activity, and magnesium could not substi-
tute. ATP was not essential, but clearly stimulated the cleavage
reaction (Figure S5). No crRNA-directed cleavage of DNA targets
was observed (data not shown). To rule out the possibility of
activity from a contaminating ribonuclease, the CMR complex
was immunodepleted using antibodies raised against the Cmr7
subunit. Immunodepletion abolished the nuclease activity, sug-
gesting strongly that the activity was associated with the CMR
complex (Figure S5A). As a further control, native untagged
SsoCMR purified from S. solfataricus cell extract by immunopre-
cipitation using the anti-Cmr7 antibody had the same activity as
the column-purified, tagged protein co plex (Figure S5B).
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end of the guide RNA, suggesting that Sulfolobus and
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of the repeat-derived 50 tag from the guide RNA abolis d
cleavage activity (Figure 5A, panel iii) and could not be rescued
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this 50 tag sequence i essential for cleavage, ruling out the
possibility of a contaminating nuclease. The presence of an
unpaired flap at the 30 end of the target RNA was also required
for activity (panel vi). This corresponds to the position of the
PAM that is essential for cleavage of viral DNA targets by
CASCADE (Gudbergsdottir et al., 2011; Lintner et al., 2011).
However, for target RNA cleavage by CMR, the PAM sequence
at this position was not essential, as a 6A sequence could substi-
tute (Figure 5B, panel vii).
In addition to the target RNA, the guide RNA strand could also
be cleaved by SsoCMR (Figure 5C, panel viii). Cleavage of the
guide RNA was dependent on the presence of a 30 overhang
on the target RNA (Figure 5C, panel ix, xi). Guide and target
were cleaved at approximately equal rates when present at an
equimolar ratio, but at ratios of 20:1 or 5:1 excess of target
over guide, the guide RNAwas cleaved signifi antly more slowly.
Under these conditions, multiple turnover cleavage of he target
RNA was observed, suggesting that cleavage of the guide RNA
was not essential for catalysis (Figure S5D).
Sequence-Specific Cleavage by SsoCMR
The cleavage patterns observed for Sso MR suggested a
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Sequence mapping suggest d that strong cleavage always
occurred at a UA dinucleotid in both the A1 and D63 target
RNAs and the A1 guide RNA (Figure 5). Weak r cleavage was
observed at UU dinucleotides. RNA cleavage by SsoCMR re-
sulted in products with 30-hydroxyl termini that could be
extended by PolyA polymerase (Figure S6A). This is similar to
the metal-dependent RNaseH-type activity observed for Piwi
and Argonaute (Hutvagner and Simard, 2008). In contrast, the
(metal-independent) Cas6 endonuclease yields 30-cyclic phos-
phate products that are not extended by PolyA polymerase
(Figure S6B). PfuCMR is also reported to generate 30-cyclic
phosphate products (Hale et al., 2009), another distinction
between the two enzymes. To map the cleavage site of SsoCMR
precisely, the cleavage at site 2 in the D63 target RNA was
compared to a synthetic oligonucleotide terminating after the
relevant UA dinucleotide (Figure S6C). The cleavage product
generated by SsoCMRwas 1 nt shorter than the oligonucleotide,
consistent with cleavage at this position (and by extension at the
other sites) as occurring at the center of the UA sequence.
To examine the importance of sequence for CMR-mediated
cleavage of RNA, a D63-derived target RNA with only one
UA site, corresponding to position 2, was synthesized. In the
Figure 4. 3D EM Visualization of CMR Complex
(A) Surface representation of the Cmr2/Cmr3/Cmr7 subcomplex devoid of
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Ribonuclease Activity of SsoCMR
We tested the ability of SsoCMR to recognize and cleav RNA
targets corresponding to spacers A1 and D63 in vitro. B th RNA
targets were cleaved efficiently when a cognate crRNA (guide
RNA) with an 8 nt 50 tag was present (Figur 5). Man anes ions
were ess ntial for this activity, nd magn sium could not substi-
tute. ATP was not essential, but clearly stimulated the cleavage
reaction (Figure S5). No crRNA-directed cleavage of DNA targets
was observed (data not shown). To rule out he possibility of
activity from a contaminating ribonuclease, the CMR co plex
was im unodepleted using antibodies raised a ainst the Cmr7
subunit. Immunodepletion ab lished the nuclease a tivity, sug-
gesting strongly that the activity was associated with the CMR
complex (Figure S5A). A a furthe control, native untagged
SsoCMR purified from S. solfataricus cell extract by immunopre-
cipitation using the anti-Cmr7 antibody had the same activity as
the column-purified, tagged protein complex (Figure S5B).
Features of Guide and Target RNAs Important
for Cleavage by CMR
The sequence and structural requirements of RNA cleavage by
CMR were investigated by constructing a range of target and
guide RNA molecules based on the spacer A1 and D63
sequences. To test for a molecular ruler mechanism as observed
for PfuCMR, we reduced the length of the guide RNA (Figure 5A,
panel ii). The cleavage sites did not move in register with the 30
end of the guide RNA, suggesting that Sulfolobus and
Pyrococcus CMR differ fundamentally in this respect. Deletion
of the repeat-derived 50 tag from the guide RNA abolished
cleavage activity (Figure 5A, panel iii) and could not be rescued
by substitution with a 50 8A sequence (panel iv), showing that
this 50 tag sequence is essential for cleavage, ruling out the
possibility of a contaminating nuclease. The presence of an
unpaired flap at the 30 end of the target RNA was also required
for activity (panel vi). This corresponds to the position of the
PAM that is essential for cleavage of viral DNA targets by
CASCADE (Gudbergsdottir et al., 2011; Lintner et al., 2011).
However, f r t r t RNA cleavage by CMR, the PAM sequence
at this position was not essential, as a 6A sequence could substi-
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uide RNA was dependent on the presence of a 30 overhang
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were cleaved at approximately equal rates when present at an
equimolar ratio, but at ratios of 20:1 or 5:1 excess of target
over guide, the guide RNAwas cleaved significantly more slowly.
Under these conditions, multiple turnover cleavage of the target
RNA was observed, suggesting that cleavage of the guide RNA
was not essential for catalysis (Figure S5D).
Sequence-Specific Cleavage by SsoCMR
The cleavage patterns observed for SsoCMR suggested a
sequence- or structure-specific component to the activity.
Sequence mapping suggested that strong cleavage always
occurred at a UA dinucleotide in both the A1 and D63 target
RNAs and the A1 guide (Figure 5). Weaker cleavage was
observed at UU dinucleotides. RNA cleavage by SsoCMR re-
sulted in products with 30-hydroxyl termini that could be
extended by PolyA polymerase (Figure S6A). This is similar to
the metal-dependent RNaseH-ty e activity observed for Piwi
and Argonaute (Hutvagner and Simard, 2008). In contrast, the
(m tal-independent) Cas6 endonuclease yields 30-cyclic phos-
phate products that are not extended by PolyA polymerase
(Figure S6B). PfuCMR is als reporte to generate 30-cyclic
phosph te products (Hale et al., 2009), another distinction
between the two enzymes. To map the cleavage site of SsoCMR
precisely, the cleavage at site 2 in the D63 target RNA was
compared to a synthetic oligonucleotide terminating after the
relevant UA dinucleotide (Figure S6C). The cleavage product
gen rated by SsoCMRwas 1 nt shorter than the oligonucleotide,
consistent with cleavage at this position (and by extension at the
other sites) as occurring at the center of the UA sequence.
To examine the importanc of sequence for CMR-mediated
leavage of RNA, a D63-derived target RNA with only one
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,:('@)%,:E# )%# !X# W;# %7&/'E7/'%"# C++,%,/:)**PD# %7-# -*'-:%# 0&/?# %7-# I,>(/*'?:# 8).#
+&/<<-+# +,&-(%*P# ,:%/# .)?<*-# @'00-&# %/# ,??-+,)%-*P# &-+'(-# %7-# <&/%-,:# ):+#







/:-#(/:+,%,/:#<&/+'(-+# .?)**# (&P.%)*.# %7)%#+,00&)(%-+# %/#!11#Z# &-./*'%,/:# ,:>7/'.-#
LQ,E'&-# !"5# CO"# 67-# <&-(,<,%):%# (/:.,.%-+# /0# S"1#T# $/+,'?# )(-%)%-# <J# K"=D# S"51#T#
A,%7,'?# (7*/&,+-# ):+# K1# [# UNV=SS"# 67-# (&P.%)*.# 8-&-# /<%,?,.-+# @P# G)&P,:E# %7-#
<&-(,<,%):%\#S"1#T#$/+,'?#)(-%)%-#<J#K"S>="4D#S"S=>S"KS#T#A,%7,'?#(7*/&,+-#):+#5=>
K=# [# UNV=SS"# A,%7,'?# (7*/&,+-# 8).# )*./# &-<*)(-+# 8,%7# )??/:,'?D# ?)E:-.,'?D#
</%)..,'?#):+# ./+,'?#(7*/&,+-.D#87,*-#UNV=SS#8).# &-<*)(-+#8,%7#UNV.#/0# G)&P,:E#
T].# L!=S>X=SO"# R:# )++,%,/:# %7-# <&/%-,:# (/:(-:%&)%,/:#8).# G)&,-+# 0&/?# S"=# %/# 4"S###
?E#?A>1#):+#%7-#+&/<#.,B-.#0&/?#1=S^1=S#:A#%/#5^5#_AD#8,%7#&)%,/.#/0#1\5D#1\1#):+#5\1#
<&/%-,:>%/><&-(,<,%):%"#67-#(&P.%)*#%&,)*.#8-&-#,:('@)%-+#)%#K#):+#5S#W;`#%7-#(&P.%)*.#





%@-.-# ;&/:,.,75# &-.'*%.># %@-# &-./*'%,/7# (/'*+# 7/%# P-# 0'&%@-&# ,:;&/Q-+# ';/7# PL#




!"#$%&' ()*+' ,$%"-"./0"12' 1-' 341*(56)' FTJ# $O$NCTED# )7)*L.,.# /0# %@-# 0,&.%# U,N)00,7,%L# (@&/:)%/5&);@L#
.%-;"# R@-# 6).@,75# FVJ# )7+# -*'%,/7# FDJ# ;@).-.# )&-# ,**'.%&)%-+"# FIJ# WQ-&7,5@%# ,7('P)%,/7#




































































7++,%,A-# .(&--:.# (/:%),:# ?-%)*# ,/:.B# .)*%.B# .?)**# /&C):,(# ?/*-('*-.B# +-%-&C-:%.B#
>/*;?-&.#):+#@,/)(%,A-#?/*-('*-.#:/%#%;>,()**;#0/':+#,:#.>)&.-#?)%&,D#.(&--:."1EFB1E1#
GH-.-# ?/*-('*-.# ():# ,?>&/A-# (&;.%)**,.)%,/:# @;# >&/?/%,:C# 0)A/'&)@*-# >&/%-,:#
(/:0/&?)%,/:.B# )*%-&,:C# %H-# ./*'@,*,%;# /0# %H-# >&/%-,:# /&# .%)@,*,.,:C# >&/%-,:I>&/%-,:#
(/:%)(%."#$./1!23#J).#.(&--:-+#)C),:.%#%J/#(/??-&(,)**;#)A),*)@*-#)++,%,A-#.(&--:.#
'.,:C#)#@).-#>&-(,>,%):%#0&/?#%H-#/>%,?,.)%,/:#/0#%H-#:)%,A-#(&;.%)*."#K/J-A-&B#%H-.-#
(&;.%)*# %&,)*.# 0),*-+# %/#>&/+'(-#):;#+,00&)(%,/:IL')*,%;# (&;.%)*.B# ,:.%-)+#;,-*+,:C#/:*;#
















0/&6)%,/7"189:18;# <&/%-,7# -7=,7--&,7=# ()7#>-#'.-+# %/#?&/+'(-# .%)>*-# (/7.%&'(%.# >'%#
@,%A/'%#?&,/&#B7/@*-+=-#/0#%A-#.%&'(%'&-#=-7-&)%,/7#/0#%A-#(/&&-(%#(/7.%&'(%#()7#>-#
+,00,('*%"# C,6,%-+# ?&/%-/*D.,.# ,.# )#6-%A/+# /0%-7# '.-+# %/# &-6/E-# 0*-F,>*-# &-=,/7."# G#
()%)*D%,(#)6/'7%#/0#)#7/7:.?-(,0,(#?&/%-).-#,.#)++-+#%/#%A-#%)&=-%#?&/%-,7#*-)+,7=#%/#
%A-#(*-)E)=-#/0# 0*-F,>*-# &-=,/7."#HA-# &-.'*%,7=#@-**:/&+-&-+# 0&)=6-7%#A).#)#=&-)%-&#
(A)7(-#/0#(&D.%)**,.,7=#%A)7#%A-#0'**:*-7=%A#?&/%-,7"#H@/#6-%A/+.#/0#?&/%-/*D.,.#)&-#
%D?,()**D# '.-+I# !"# $!%&# ?&/%-/*D.,.J18!J18;#@A-&-# %A-# %)&=-%# ?&/%-,7# ,.# ,7('>)%-+#@,%A#





!"#$%&' ()(*' +,-&./0",' %&1%&2&30/0"43' 45' 6"."0&7' 1%40&4682"2)' KGM# '"# $!%&# ?&/%-/*D.,."# HA-# ?&/%-,7J#
(/7.,.%,7=#/0#)#(/6?)(%#(/&-#K?'&?*-M#)7+#0*-F,>*-#&-=,/7.#K>*)(BM# ,.#6,F-+#@,%A#?&/%-).-#





6/*)&# &)%,/.# /0# 1I1OO# )7+# 1I!OO# ?&/%-).-:%/:?&/%-,7"# HA-# .)6?*-.# @-&-# .(&--7-+#
)=),7.%# .?)&.-# 6)%&,F# .(&--7.# %/# =-7-&)%-# 7-@# (&D.%)*# A,%."# HA-.-# (&D.%)*# %&,)*.#
?&/+'(-+# .-E-&)*# .-%.# /0# 0,7-# 7--+*-.# >'%# 7/# +,00&)(%,/7:P')*,%D# (&D.%)*."#















5,6-+# 7,%8# )# .-&,-.# /0# 9&/%-).-.# ):+# %8-:# ):)*;.-+# <;# $=$>?@AB# CD,E'&-# !"FG"#
$./1!23# 9&/H-+# %/# <-# &-5)&I)<*;# &-.,.%):%# %/# 9&/%-/*;%,(# )(%,H,%;# ):+# :/# .%)<*-#
0&)E5-:%#7).#/<.-&H-+"#J8,.#.'EE-.%-+#%8)%#%8-#9&/%-,:#7).#7-**#/&+-&-+#):+#%8)%#












,59&/H-# /&# (&-)%-# :-7# (&;.%)*# (/:%)(%.R# %8'.# 9&/+'(,:E# )# <-%%-&>/&+-&-+# (&;.%)*#
*)%%,(-# ):+# +-(&-).,:E# %8-# -:%&/9;# /0# %8-# .,+-# (8),:."1SO>1SS# $./1!23# (/:%),:.# 11#
*;.,:-# &-.,+'-.# CS#P#/0# %8-#9&/%-,:G# ./# ,%#7).#8;9/%8-.,.-+# %8)%# *;.,:-#5-%8;*)%,/:#
5,E8%#*-)+#%/#+,00&)(%,/:>T')*,%;#(&;.%)*."#$./1!23#7).#,:('<)%-+#7,%8#0/&5)*+-8;+-#



















































































$./1!2356.7-%#8).#9'&,0,-+#8,%:#)# 0,;)*# 6,-*+#/0#1<#="#>:-# *)&?-# */..#/0#9&/%-,;#8).#
+'-# %/# 9&-(,9,%)%,/;# +'&,;?# %:-# &-)(%,/;"# 7$# );)*6.,.# .:/8-+# %:)%# )# @,A%'&-# /0#
@-%:6*)%-+# .%)%-.# 8-&-# 9&-.-;%# 8,%:# %:-# :,?:-.%# @)..# 9-)B# (/&&-.9/;+,;?# %/# CD#
@-%:6*#?&/'9.E#(/;.,.%-;%#8,%:#11# *6.,;-#&-.,+'-.#);+#%:-#FG%-&@,;'.#HI,?'&-#!"J#K#






9&/%-(%);%.# (/;%),;,;?# 1<E# 1JE# C<# );+# CJ# =# ULVD<<# ,;# );# )%%-@9%# %/# &-+'(-# %:-#






);+# +,00&)(%-+# 9//&*6# HS:)9%-&# !"J"1M"# $--+,;?# :).# O--;# '.-+# ,;# @);6# ().-.# %/#
,@9&/N-#%:-#.,[-#);+#X')*,%6#/0#(&6.%)*.#);+#8/&B.#O6#)**/8,;?#(&6.%)*#?&/8%:#,;#%:-#
@-%).%)O*-#[/;-"1\3#])9/'&#+,00'.,/;#(&6.%)**,.)%,/;#@-%:/+.#,;N/*N-#%:-#@/N-@-;%#
/0# 8)%-&# 0&/@# %:-# 9&/%-,;G9&-(,9,%);%# +&/9# %/# %:-# &-.-&N/,&# ./*'%,/;E# &-.'*%,;?# ,;#
.'9-&.)%'&)%,/;# /0# %:-# 0/&@-&"# >:-# .'9-&.)%'&)%-+# [/;-# ();# O-# +,N,+-+# ,;%/# %:-#
*)O,*-# [/;-E# 8:,(:# ();# .'99/&%# O/%:# ;'(*-)%,/;# );+# (&6.%)*# ?&/8%:E# );+# %:-#
@-%).%)O*-#[/;-E#8:,(:#();#/;*6#.'99/&%#?&/8%:# HI,?'&-#!"4M"# ^;#@/.%#(&6.%)*# %&,)*.#
(&6.%)*.#)&-#0/&@-+#);+#?&/8#,;#%:-#*)O,*-#[/;-"#Q/8-N-&E#(&6.%)*#?&/8%:#();#O-#%//#
0).%# );+# &-.'*%# ,;# 9//&# X')*,%6# (&6.%)*."# S&6.%)*# ?&/8%:# ,;# %:-#@-%).%)O*-# &-?,/;# ,.#
.*/8-&#);+#();#&-.'*%#,;#*)&?-&#);+#O-%%-&#X')*,%6#(&6.%)*."#Q/8-N-&E#.,;(-#;'(*-)%,/;#
,.#;/%#9/..,O*-# ,;# %:-#@-%).%)O*-# [/;-# ,%# ,.# ;-(-..)&6# %/# ,;%&/+'(-#;'(*-)%,/;# .,%-.#
.'(:# ).# @,(&/(&6.%)*."# >:-.-# .'OG@,(&/.(/9,(# (&6.%)*.# /0# %:-# %)&?-%# 9&/%-,;# )&-#








B# .%/(C# ./*'%,/8#/0# $./1!23#A,(&/(&6.%)*.#;).# (&-)%-+#=6# D/&%-E,8:# 8)%,D-# (&6.%)*.#
;,%<#)#.A)**#7/*6.%6&-8-#.7<-&-#?F.--+#=-)+G@"#H/:#+,*'%,/8.#/0#%<-#.%/(C#;-&-#'.-+#
).# %<-# 7&-(,7,%)8%# ,8# 8-;# (&6.%)*# %&,)*."# 5<,.# .--+,8:#A-%</+# 6,-*+-+# )# (&6.%)*# %<)%#
+,00&)(%-+# %/#I"2J#K#'.,8:# .68(<&/%&/8# &)+,)%,/8# ?L,:'&-#!"M@"# 5<-# (&6.%)*# :&-;# ,8# )#
(/8+,%,/8# /0# 1# NH# 7&/%-,8O# 1# NH# 1PJ# +,*'%,/8# A,(&/(&6.%)*# .%/(C# ,8# )# 7&-(,7,%)8%# /0#######
P"1# Q# $/+,'A# )(-%)%-O# P"I# Q# H,%<,'A# (<*/&,+-O# R1# S# TUVRPP"# W)%)# (/**-(%,/8#
.%)%,.%,(.#)&-#7&-.-8%-+#,8#5)=*-#!"!"##
#
!"#$%&' ()9+' :;6"1"/&0' </3=(>?' 4%5/6.7/)' ?B@# XA):-# /0# %<-# =-.%# (&6.%)*# :&/;8# '.,8:# .--+,8:"# ?Y@# ?,@#













































Q:/'9:# :/H/*/9K# O-%M--8# $./1!23# )8+# %:-# /%:-&# .H)**# .'O'8,%.# :).# O--8#
>&-+,(%-+A@3#%:-&-#,.#H,8,H)*#.-S'-8(-#(/8.-&7)%,/8#O-%M--8#%:-.-#>&/%-,8.#)8+#./#
,%# M).# 8/%# >/..,O*-# %/# '.-# %:-# )7),*)O*-# G.-?# /&# GH&B# .%&'(%'&-.# ).# H/+-*.# 0/&#
H/*-('*)&# &->*)(-H-8%"# T/# /%:-&# .%&'(%'&-.# /0# :/H/*/9/'.# >&/%-,8.# :)+# O--8#
>'O*,.:-+# )8+# ./# ,%# M).# 8-(-..)&K# %/# ./*7-# %:-# >:).-.# -R>-&,H-8%)**K"# U#
.-*-8/H-%:,/8K*# +-&,7)%,7-# /0# $./1!23# ;$./1!23$-J-%=# M).# -R>&-..-+# '.,89# %:-#
H-%:/+# />%,H,.-+# 0/&# $./14?B# ;.--# G:)>%-&# ?"B"?=A# M:,(:# )*./# M/&V-+# M-**# 0/&#
$./1!23"#$./1!23$-J-%#M).#>'&,0,-+#).#M,%:#%:-#8)%,7-#>&/%-,8#-R(->%#%:-#>&/%-,8#M).#
,8('O)%-+#M,%:#QWX#>&/%-).-#0/&#@5#:#+'-#%/#>//&#(*-)7)9-#-00,(,-8(K"#Q:-#.-(/8+#T,F
)00,8,%K# (/*'H8# +,+# 8/%# .,98,0,()8%*K# ,8(&-).-# %:-# >'&,%K# /0# %:-# .)H>*-# O'%# ,%# M).#
>/..,O*-#%/#.->)&)%-#$./1!23$-J-%# 0&/H#%:-# ,H>'&,%,-.#OK#9-*# 0,*%&)%,/8#;Y,9'&-#!"3#U#











$./1!23$-;-%# =).# '.-+# ,9# (&G.%)*# %&,)*.# ?).-+# /9# %<-# @/.%# .'((-..0'*# :&-(,:,%)9%.#
0/'9+#0/&#9)%,I-#$./1!23"#H9-#(&G.%)*K#>&/=9#,9#)#(/9+,%,/9#/0#L"1#;#$/+,'@#)(-%)%-#
:M#N"LK#L"O!#;#D/%)..,'@#(<*/&,+-K#)9+#!2#P#DE8QQLK#+,00&)(%-+#%/#O"4#R#&-./*'%,/9#
'.,9># .G9(<&/%&/9# &)+,)%,/9# 5S,>'&-# !"2# 6# )9+# A7"# T<-# .@)**# .,U-# /0# %<-# (&G.%)*########
5!NL#J#4L#V@7#&-W',&-+#%<-#'.-#/0#)#@,(&/0/('.#?-)@"#6#+)%).-%#=).#(/**-(%-+#)%#%<-#
$-CX#)?./&:%,/9#-+>-#5S,>'&-#!"2#F7Y#+)%)#(/**-(%,/9#.%)%,.%,(.#)&-#:&-.-9%-+#,9#T)?*-#
















































!"#$%&' ()*+' ,%-./011".0/"23'24' 5.26(*75&8&/)' 678#9:-#/;%,<,.-+#$./1!23$-=-%# (&>.%)*"# 6?8# 6,8#@,00&)(%,/A#
;)%%-&A#/0#%:-#/;%,<,.-+#(&>.%)*#'.,AB#.>A(:&/%&/A#&)+,)%,/A#6C-)<*,A-#D5EF#@,)</A+8"#6,,8#





%:-# */I# &-./*'%,/A# /0# %:-# +)%)# )A+# %:)%# %:-&-# I).# *,J-*># /A*># /A-# /&+-&-+#
.-*-A/<-%:,/A,A-#&-.,+'-#;-&#</A/<-&#6%:-#/%:-&#C-,AB#%:-#,A,%,)%,AB#<-%:,/A,A-F#
I:,(:# I).# *,J-*># %/# C-# +,./&+-&-+8"# N/I-H-&F# $NOPK@# 0/'A+# %:-# (/&&-(%# ./*'%,/A#
C-()'.-#)*%:/'B:#%:-#./*'%,/A#:)+#)#*/I#GG)**#H)*'-F#%:-#0,&.%#A,A-#:-)H>#)%/<#.,%-.#
:)+# /((';)A(,-.# /0# WV"R# 0/**/I-+# )# .,BA,0,()A%# +&/;# %/# /((';)A(,-.# /0# XV"!# 0/&# )**#
0'&%:-&# .,%-.F# ,A+,()%,H-# /0# )# (/&&-(%# ./*'%,/A# 6U,B'&-# !"1V#?# )A+#G8"# 9:,.# .'BB-.%-+#
%:)%# A,A-#</A/<-&.#I-&-# ;&-.-A%# ,A# %:-# 7$Y"# U'&%:-&</&-F# %:-&-#I).# .,BA,0,()A%#





























O,%9# %9-# (/&&-(%# ./*'%,/7# )%# ?4# )7+# 7/,.-# )%# 6)*'-.# W?="# :G<# X(('>)7(,-.# /0# %9-# 9-)6K#










67-# .%&'(%'&-#8).# %7-9# ./*:-+# '.,9;# <7-9,=# >'%/$/*:-?# 87,(7# .'((-..0'**@# */()%-+#
9,9-# .-*-9,'A.#8,%7# 7,;7# /(('B)9(,-.# )9+# C',*%# )#A/+-*# 8,%7# )# 0,9)*# D8/&EFD0&--# /0#
G"!2FG"5!"#67/';7#%7-#-*-(%&/9#+-9.,%@#8).#(*-)&#)9+#,9%-&B&-%)C*-?#%7-#(7),9#%&)(,9;#
8).#B//&"#67-&-0/&-#%7-#-*-(%&/9#+-9.,%@#A)B#8).#0'&%7-&#,AB&/:-+#'.,9;#<)&&/%1H3#
0/&# +-9.,%@# A/+,0,()%,/9# )9+# %7-# (7),9.# 8-&-# %&)(-+# '.,9;# I'(()9--&"1H2?142# >.#
-=B-(%-+?# 9,9-#A/9/A-&.#8-&-# B&-.-9%# ,9# %7-# >$J"# 67-#A/+-*#8).# &-0,9-+# '.,9;#
D-0A)(15K# )9+# %7-9# :)*,+)%-+# '.,9;# %7-# L/*<&/C,%@# .-&:-&"153# D-0,9-A-9%# )9+#
:)*,+)%,/9#.%)%,.%,(.#)&-#B&-.-9%-+#,9#6)C*-#!"K"##
#
#># !"#$%"&"%'# ()*+,-./ I# 0*123*4$'5/2636&"'"3/ 7618"/
# !"#$%F!&$''# G"MGFG"MM# # N*).7.(/&-?#)**#)%/A.# 1G"1K#
# L-)9#IO:)*'-#PQMR# # # <//&#&/%)A-&.#PSR# M"53#
# #####>**#)%/A.# 5!# # D)A)(7)9+&)9#/'%*,-&.#PSR# G"33#
# #####<&/%-,9# 5!# # D)A)(7)9+&)9#0):/'&-+#PSR# 2H"M3#
# #####T)%-&# MH# # U/"#/0#NV#+-:,)%,/9.#PW#G"MK#QR# !#
# #####<XY# KH# # L/*<&/C,%@#$(/&-# M"G3#
# U/"#)%/A.# # # D-.,+'-.#8,%7#C)+#C/9+.#PSR# G"GG#
# #####<&/%-,9# 11!M2# # D-.,+'-.#8,%7#C)+#)9;*-.#PSR# G"M1#
# #####T)%-&# 1HG# # # #
# #####<XY# H!# # # #
# DA.+# # # # #
# #####I/9+#*-9;%7.#PQR# G"G1# # # #













6&-+/7,8)8%*9# :;.<--%# +/7),8# =:;+/7),8># &-.,+'-.# ?5;1@2A# =B,C'&-# !"11# DA"# E<-#
<-*,()*#+/7),8#(/8.,.%-+#/0#.,F#<-*,(-.#G<,*.%#%<-#:;.<--%#+/7),8#(/8%),8-+#/8-#%'&8#
/0# )# <-*,F# )8+# .,F# :;.%&)8+.# )&&)8C-+# ,8# %<&--# )8%,6)&)**-*# :;.<--%."# E<-#H;# )8+# I;
%-&7,8,# G-&-# J/%<# */()%-+# ,8# %<-# <-*,()*# +/7),8"# E<-# .,8C*-# /&+-&-+#







"#$%&'! ()**+! ! ,-'! .&/0123! 01&%.1%&'! 45! 604*(78)! =DA#S,-G#/0# %<-#7/8/7-&#G,%<#.-(/8+)&9#.%&'(%'&-#
-*-7-8%.# *)J-**-+"#E<-#.-*-8/7-%<,/8,8-#&-.,+'-#)8+#%<-#+,.'*0,+-#J/8+#)&-#.</G8#).#





IA"# D8)*9.,.# /0# .977-%&9# 7/*-('*-.# .</G-+# %<)%# %<-# <-*,(-.# G-&-# (/8%,8'/'.#
%<&/'C</'%#%<-#(&9.%)*#)8+#-F<,J,%-+#)#G,+%<#/0#3#87#)8+#)#6,%(<#/0#13#87"#I&9.%)*#



































L;-# H-*# 0,*%&)%,/9# -*'%,/9# 6&/0,*-# /0# $./1!23# .'HH-.%-+# %;)%# %;-# 6&/%-,9# 0/&7-+# )#
&)9H-#/0#/*,H/7-&.#(-9%&-+#/9#)#;-O)7-&#IT,H'&-#!"1#>K"#L;-&-0/&-#%;-#=P$8#.-&@-&#
6&-+,(%,/9# %;)%# %;-# (&:.%)**/H&)6;,(# /*,H/7-&.# <-&-# 9/%# E,/*/H,()**:# &-*-@)9%# <).#
'9-O6-(%-+"#J*/.-&#,9.6-(%,/9#/0#%;-#,9%-&0)(-#&-@-)*-+#)#.)*%#E&,+H-#E-%<--9#8.6!A#
)9+#8&HAA# IT,H'&-#!"1D#8KN#E/%;#/0# %;-.-#&-.,+'-.#)&-#@-&:#;,H;*:#(/9.-&@-+#)(&/..#
%;-# J.)A# 0)7,*:"# >,.&'6%,/9# /0# %;,.# .)*%# E&,+H-# ,9# %;-# 6)&)*/H'-# $./1UU!# I>!D8K#
6&/+'(-+#)#7/9/7-&,(#6&/%-,9#).# V'+H-+#E:#()*,E&)%-+#H-*# 0,*%&)%,/9#)9+# ,9(&-).-+#
%;-# ./*'E,*,%:# /0# %;-# 6&/%-,9# E:# /@-&# 1B# 0/*+"13B# L;-# (/&&-.6/9+,9H# 7'%)%,/9# 0/&#
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P=-.-# 8/+,0,()%,/;.# .,<;,0,();%*:# ,89&/7-+# %=-# .%)?,*,%:# /0# %=-# 9&/%-,;# +'&,;<#
9'&,0,()%,/;#);+#%=-#:,-*+#,;(&-).-+#0&/8#RR#1#8<#%/#S#8<#9&/%-,;#KD1#('*%'&-#@T,<'&-#
!"3C"# $./1!23#-*'%-+# 0&/8#<-*# 0,*%&)%,/;#).#)#>-**D+-0,;-+#+,8-&# @T,<'&-#!"3#UC"#P=-#
9&/%-,;#,+-;%,%:#>).#(/;0,&8-+#?:#F$#@+)%)#;/%#.=/>;C#);+#%=-#.)89*-#>).#.=/>;#







!"#$%&' ()*+' ',$%"-"./0"12' 1-' 3415(6*)' 678# $9$:;7<=# )>)*?.,.# /0# %@-# 0,&.%# A,:)00,>,%?# (@&/B)%/C&)D@?#
.%-D"#E*/F:%@&/'C@#6EG8H#F).@#6I8#)>+#-*'%,/>#6=8#0&)(%,/>.#)&-#,>+,()%-+"#6J8#7#.)BD*-#/0#
D&/%-,>#)0%-&#(*-)K)C-#/0# %@-#L,.M:%)C#'.,>C#G=N#D&/%-).-"# 6O8#7>)*?.,.#/0# %@-#.-(/>+#A,:

































































.(&--5-+# ,567/'.-#)5+# %7-#8-.%# (&9.%)*#+,00&)(%-+#:-&9#;-)<*9# %/#!!"=#># &-./*'%,/5#
?@,A'&-#!"B#CD"#EF%,G,.)%,/5#/0#%7-#8-.%#(&9.%)*.#89#G/+,09,5A#%7-#F&-(,F,%)5%#?FH#)5+#
(7-G,()*# (/5(-5%&)%,/5.D# )5+#F&/%-,5# (/5(-5%&)%,/5# ?I6B#GA#GJ61D# &-.'*%-+# ,5# :-&9#




"#$%&'! ()*+! ,&-./01.! 23! 4.25(67)! ?KD6?LD# M7-#G)N/&#G/&F7/*/A9# /0# $./1!23# (&9.%)*.# ;).# 7-O)A/5)*#
8,F9&)G,+)*#;,%7#(&9.%)*#.,P-#:)&9,5A#0&/G#?KD#Q=#RG#%/#?SD#!=4#RG#%/#?LD#!I44#RG"#?TD#




$./1!23# ;).# .%,**# %-GF-&)%'&-# .-5.,%,:-# )0%-&# F'&,0,()%,/5# )5+# )FF-)&-+# %/#
F&-(,F,%)%-#)%#%-GF-&)%'&-.#WI4#XLV#;7,(7#G-)5%#%7)%#F&/%-,5#.%/&-+#)%#6B4#XL#7)+#%/#
8-# %7);-+# )%# 23# XL# %/# F&-:-5%# F&-(,F,%)%,/5"# H/;-:-&V# %7-# F&-(,F,%)%,/5# (/'*+# 8-#
&-:-&.-+#89#7-)%,5A#)%#23#XL#)5+#(&9.%)*#%&,)*.#.-%#'F#)%#I=#XL#)5+#%7-5#.%/&-+#)%#!#XL#
F&/+'(-+#.G)**#(&9.%)*.V#.'AA-.%,5A#%7)%#%7-#YF&-(,F,%)%,/5Z#;).#,5#0)(%#G,(&/(&9.%)*#






6,%</'%# %<-# 5--+# 0/&# )# 7&-(,7,%)5%"# =,%<,5# 4,5'%-.# .4)**# <->):/5)*# 8,79&)4,+)*#
(&9.%)*.# 0/&4-+#8'%#/?-&# %<-# (/'&.-#/0# .-?-&)*#6--@.# %<-# (&9.%)*.# &-A+,../*?-+#)5+#






$%/&,5:# (&9.%)*# %&,)*.# )%# 23# SN# &-.'*%-+# ,5# 7&-(,7,%)%,/5# ,5# )**# (/5+,%,/5.;# 6<,(<#
.'::-.%-+#%<)%#%<-#&)%-#/0#?)7/'&#+,00'.,/5#6).#%//#.6,0%#%/#.'77/&%#(&9.%)*#:&/6%<"#
T%#6).#<97/%<-.,.-+# %<)%# .-%%,5:#'7# %<-# (&9.%)*# %&,)*.# )%#23# SN#)5+# *-%%,5:# %<-#7*)%-#
(//*# .*/6*9# %/# &//4# %-47-&)%'&-# 6/'*+# 7&/+'(-# *)&:-&# (&9.%)*.# .,5(-# %<-# 7&/%-,5#
6/'*+# )77&/)(<# .'7-&.)%'&)%,/5# 4/&-# .*/6*9"# K/6-?-&;# %<,.# )(%')**9# *-+# %/#
7&-(,7,%)%,/5# ,5#)**# (/5+,%,/5."#G<-&-0/&-# %<-#<,:<-&# &)%-#/0#-?)7/&)%,/5#+'-# %/# %<-#
,5(&-).-+# %-47-&)%'&-# /?-&6<-*4-+# %<-# .*/6# +-(&-).-# ,5# ./*'8,*,%9# +'-# %/# %<-#
%-47-&)%'&-#:&)+,-5%"#G<-#/7%,4'4#%-47-&)%'&-#0/&#7*)%-#7&-7)&)%,/5#)5+#.%/&):-#






7/..,8*-# %<)%# *9.,5-# 4-%<9*)%,/5# 6/'*+# 7&/+'(-# 8-%%-&# H')*,%9# (&9.%)*."# U'&,0,-+#











)%# %@-# .)A-# B/*'A-# ).# %@-# 9)%,B-# :&/%-,9"# 5C7# $D$EF68G# )9)*<.,.# /0# %@-# 0,9)*# .)A:*-#
.@/?,9H#:'&,%<#/0#%@-#.)A:*-"#5I7#)9+#5D7#=$#)9)*<.,.#/0#5I7#$./1!23#)9+#5D7#$./1!23;<.=-%#




)9+# 0)&# 0-?-&# (&<.%)*# @,%.# ?-&-# /K.-&B-+"# M@-&-0/&-# %@-# A-%@<*)%,/9# .,H9,0,()9%*<#
(@)9H-+#%@-#(&<.%)*#(/9%)(%.#0/&A-+#K<#%@-#:&/%-,9"#J9-#(/9+,%,/9#5N"1#=#C,(,9-#:O#
P"Q># 4N# R# FG8SNNN7# :&/+'(-+# /K*/9H# (&<.%)*.# %@)%# +,00&)(%-+# %/# 4"PQ# T# '.,9H#
.<9(@&/%&/9# &)+,)%,/9# 5U,H'&-#!"1N#67"#D'-# %/# ,9.'00,(,-9%# (&</E:&/%-(%,/9># ,(-# &,9H.#
?-&-# B,.,K*-# 5U,H'&-# !"1N# C7"# D-.:,%-# /:%,A,.)%,/9# /0# %@-# :&-(,:,%)9%# )9+# :&/%-,9#




































































!"#$%&' ()*+,' -%./0122"/10"34' 35' 6/3*(789./:&0)' 456# 78,%,)*# (&9.%)*.# /0# $./1!23:9.;-%"# 4<6# 4,6# =,00&)(%,/8#
>)%%-&8#/0# %?-# ,8,%,)*# (&9.%)*.#'.,8@#.98(?&/%&/8# &)+,)%,/8# 4A-)B*,8-# 7CDE#=,)B/8+6"# 4,,6#
F*/.-&#G,-H#/0#%?-#+,00&)(%,/8#.>/%.#,8#%?-#A*)(I#&-(%)8@*-#/0#4,6"#4F6#J>%,B,.-+#(&9.%)*.#/0#





























7/+-*.# ,9(*'+-+# %5-# ?).@# .%&'(%'&-.# );),*)<*-# )%# %5-# %,7-# AB0?).@C# 4%?).@-# )9+#
B)?).@0D#).#-,%5-&#0'**E*-9=%5#8&/%-,9#/&#FE#/&#?E%-&7,9)*#+/7),9.#).#6-**#).#)#7/+-*#
/0# $./1!23# (&-)%-+#'.,9=# %5-# B:GHIJ#8&/%-,9# &-(/=9,%,/9# .-&;-&"1KL#M/+-*.# /0# %5-#
?).@#5/7/*/='-.#6-&-#)*./#7/+,0,-+#'.,9=#?5),9.)61NJ#%/#&-7/;-#.,+-E(5),9.#%/#%5-#
?O#8/.,%,/9#%/#*-..-9#%5-#+,00-&-9(-#<-%6--9#%5-#.-)&(5#7/+-*#)9+#%5-#.%&'(%'&-#/0#
$./1!23"# 45-# 0),*'&-# 6).# *,P-*># %/# <-# +'-# %/# 8//&# .-Q'-9(-# )*,=97-9%.# <-%6--9#
$./1!23#)9+# %5-#/%5-&#?).@#5/7/*/='-.# *-)+,9=# %/#8//&#7/+-*."# R%#6).# %5-&-0/&-#
9-(-..)&>#%/#-S8-&,7-9%)**>#./*;-#%5-#85).-."#
#
!"#$%&'()*"+' ,-.' /"01*2"0' 340%)$"' 556'
B0?).@# 2R!:# 2EJ!N# 2"N# 1T#
B0?).@# 2R!:# 2E1J@# 2"2# J1#
B0?).@# 2R!:# 12NEJ!N# 2"2# JT#
4%?).@-# 1UVK# 1EJ11# S# S#
4%?).@-# 1UVK# 1EL!# !"K# JJ#
4%?).@-# 1UVK# KJEJ11# !"N# 1K#
B)?).@0# JWXY# TEK1# !"2# JJ#
B:GHIJ#7/+-*# # KEJLN# 2"N# N#
B:GHIJ#7/+-*# # KE1JK# !"1# JJ#
B:GHIJ#7/+-*# # 11!EJL!# !"K# 1K#
#
7#8+"' 9:;<' ' -"=#1+0' )>' =&"'?)+"%2+#$' $"@+#%"?"A=' #=="?@=0' 201AB' C#$1)20' 0"#$%&'?)*"+0:'MH#6).#
8-&0/&7-+# '.,9=# B5).-&ZMH# ,9# ??B!"# [%%-78%.# %5)%# 0),*-+# (/78*-%-*># )&-# &-8&-.-9%-+#
6,%5#\S]"#45-#^E.(/&-.#)9+#X/=#X,P-*,5//+#_),9#AXX_D#.(/&-.#,9+,()%-#0),*-+#./*'%,/9."##
#
9:D:; E$F0=#++10#=1)A' )>' !"+"A)?"=&1)A1A"4+#8"++"*G' ("=&F+#="*'
!0)H9;I'
#
$./1!23$-M-%# 6).# -S8&-..-+# ,9# )# 7,9,7)*# 7-+,)# .'88*-7-9%-+# 6,%5# AXDE
.-*-9/7-%5,/9,9-#)9+#8'&,0,-+#).#6,%5#%5-#9)%,;-#8&/%-,9C#-S(-8%#0/&#%5-#)++,%,/9#/0#
1# 7M# `MI# %/# )**# <'00-&.# %/# 8&-;-9%# /S,+)%,/9# /0# %5-# .-*-9,'7# Aa,='&-# !"11D"# M$#
!"#$%&'(%'&)*#$%'+,-.#/0#$./1!23#
# 114#
)5)*6.,.# (/50,&7-+# %8-# 9&-.-5(-# /0# %:/# .-*-5/7-%8,/5,5-# &-.,+'-.;# ).# -<9-(%-+#







.8/:,5?# %8)%# %8-# 9&/%-,5# -*'%-+# ,5# )# .,7,*)&# 7)55-&# %/# $./1!23F6.D-%"# =OB# $A$KPMNL#
)5)*6.,.#/0#%8-#0,5)*#9&/%-,5#.8/:,5?#%8-#9'&,%6#/0#%8-#.)79*-"#=@BK=LB#D$#)5)*6.,.#/0#=@B#
$./1!23;# =AB# $./1!23$-D-%# )5+# =LB# $./1!23$-D-%EF6.D-%"# QG.-&J-+# )5+# -<9-(%-+# 7)..-.#
)&-# ,5+,()%-+#:,%8#%8-#*)%%-&#.8/:5#,5#9)&-5%8-.-."#=>B#=,B#C8-#+,00&)(%,/5#9)%%-&5#0&/7#


















































$./1!23$-5-%678.5-%# 9).# .(&--:-+# );),:.%# (/:+,%,/:.# %<)%# =&/+'(-+# $./1!2378.5-%#
(&8.%)*."# >'&%<-&# /=%,?,.)%,/:# .(&--:.#9-&-#=&/+'(-+#9,%<# */9-&#5@#ABC.# D22EFG
4FFF#H)I#%/#,?=&/J-#%<-#(&8.%)*#K')*,%8"#L<-#M-.%#(&8.%)*#;&-9#,:#)#(/:+,%,/:#/0#F"FE#
5# N,(,:-# =O# P"1Q# RS# T# ABC22EF# ):+# 9).# (&8/G=&/%-(%-+# ,:# RF# T# C*8(-&/*"# U:#
):/?)*/'.# +)%).-%# 9).# (/**-(%-+# %/# R"S# V# &-./*'%,/:# )%# %<-# $-GW# )M./&=%,/:# -+;-#



















1FF# W# '.,:;# M-)?*,:-# \H1!G!Q# B$Y>"# L<-# +)%)# 9-&-# =&/(-..-+# '.,:;# ],)R"# $%)%,.%,(.# )&-#




L)M*-# !"R# 0/&# (/?=)&,./:I# /:*8# %<-# $./1!23$-5-%678.5-%# +)%)# 9-&-# '.-+# +'&,:;#













(/&&-(%# ./*'%,/9"# BJF# >,A4%# .-*-9,'<.# 7-&-# */()%-+# 7,%4# /(('8)9(,-.# /0# KL"M"# BEF# H4-#




















%-(56,A'-# )B-&)9-.# %5-# -*-(%&/6# +-6.,%,-.# /0# %5-# 0/'&# :&/%/;-&.# ,6# &-)*# .:)(-C#
,;:&/B,69#%5-#.,96)*7%/76/,.-#&)%,/"#D).E.#F-&-#9-6-&)%-+#)&/'6+#-)(5#/0#%5-#0/'&#









D-%58*#9&/':.#F-&-#6/%#;/+-**-+#/6%/# %5-# *8.,6-# &-.,+'-.#R-()'.-# %5-8#F-&-#6/%#
/R.-&B-+# ,6# %5-# -*-(%&/6# +-6.,%8"# P,6)*# &-0,6-;-6%# )6+# B)*,+)%,/6# .%)%,.%,(.# )&-#
:&-.-6%-+#,6#@)R*-#!"I"#>5),6#G#(/6.,.%-+#/0#&-.,+'-.#172HC#IQ74HC#HI7QQQC#)6+#QQH7
Q4QC#(5),6#S#/0#Q724C#IQ7L!C#3274HC#)6+#HI7Q42C#(5),6#>#/0#!7!TC#I!7LTC#32743C#)6+#HI7














D# !"#$%"&"%'# ()*+,-./ E# 0*123*4$'5/2636&"'"3/ 7618"/
# !"#$%F!&$''# >"B>F>"B!# # <*).8.(/&-G#)**#)%/6.# 1C"B!#
# H-)7#EI:)*'-#J@BK# # # L//&#&/%)6-&.# B"CB#M#
# #####D**#)%/6.# 22# # N)6)(8)7+&)7#/'%*,-&.# >"2>#M#
# #####L&/%-,7# 22# # N)6)(8)7+&)7#0):/'&-+# 43"44#M#
# #####O)%-&# !2# # P/"#/0#<Q#+-:,)%,/7.#JR#>"BC#@K# 2#
# #####S*T(-&/*# !3# # H/*L&/U,%T#$(/&-# 1"44#
# P/"#)%/6.# # # N-.,+'-.#9,%8#U)+#U/7+.# >">>#
# #####L&/%-,7# V11B# # N-.,+'-.#9,%8#U)+#)7;*-.# >">>#
# #####$/*:-7%# 4# # # #
# #####S*T(-&/*# ?# # # #
# N6.+# # # # #
# #####E/7+#*-7;%8.#J@K# >">1# # # #























!"#$%&' ()*(+' ,-&' .%/0123' 01%$.1$%&' 45' 604*(78)' >?@# A7-#$./1!23#B/8/B-&# >(/*/'&-+# 0&/B#=*'-# >CD




)# +,00-&-8%# (/*/'&"# >E@# A7-# .%&'(%'&-# /0# $./1!23# 7,97*,97%,89# %7-# F?GH# -*-B-8%.#
(/*/'&-+# ).# ,8# O,9'&-# !"4"# A7-# .%)8+)&+# F?GH# 8'B=-&,89# /0# .-(/8+)&:# .%&'(%'&-#
-*-B-8%.# ,.# .7/68# 0/&#-)(7#+/B),8"#A7-#-P<-(%-+#</.,%,/8#/0# %7-#F?GH#Q4#/0# %7-#CD
%-&B,8)*#+/B),8#,.#,8+,()%-+"#
#
A7-# .,B,*)&,%:# /0# $./1!23# %/# I8/68# .%&'(%'&-.# 6).# )8)*:.-+# '.,89# %7-# HLM-O/*+#
.-&K-&"1RS#H0E).T8(# >HLM#2NOE@#)8+#H0E).T# >HLM#2;!U@#-P7,=,%# %7-#(*/.-.%#.,B,*)&,%:#















































































































E/#:&/C,+-# 0'&%B-&#-C,+-9(-# 0/&#+,>-&,(# $./1!23?# %A/#:/,9%#>'%)%,/9.# 5F13GH#)9+#
J4G4H7#A-&-#,9%&/+'(-+#)%#%B-#,9%-&0)(-"#EB-#.,+-#(B),9.#/0#%B-#%A/#F-'13G#&-.,+'-.#
/0#%B-#+,>-&#:/,9%#%/A)&+.#-)(B#/%B-&?#).#+/#%B-#J)*4G4#.,+-#(B),9.#5P,K'&-#!"1Q#R7?#
./# %B-# ,9%&/+'(%,/9# /0# >'*%,:*-# 9-K)%,C-# (B)&K-.# .B/'*+# &-9+-&# %B-# :&/%-,9#
>/9/>-&,("#EB-#K-*#0,*%&)%,/9#-*'%,/9#:&/0,*-.#/0#$./1!23#)9+#$./1!23F13GHIJ4G4H#
A-&-# (/9.,.%-9%# A,%B# )# +,>-&# )9+# )# >/9/>-&# &-.:-(%,C-*L# 5P,K'&-# !"1Q# 67"# HF$#







)9+#%B-#K*L(,9-U&,(B# *//:?#).# ,9#/%B-&#B/>/*/K'-."#EB-#()%)*L%,(#B,.%,+,9-#/0# %L:,()*#
6).S# :&/%-,9.# ,.# 9/%# (/9.-&C-+# ,9# $./1!23?# ).# /9*L# /9-# B,.%,+,9-# &-.,+'-# 5=,.11G?#
*/()%-+#)%#%B-#TU%-&>,9'.#/0#YQ7#,.#*/()%-+#9-)&#%B-#:'%)%,C-#)(%,C-#.,%-#@'%#.,9(-#,%#,.#
9/%# ./*C-9%# )((-..,@*-# ,%# ()99/%#:*)L# )# &/*-# ,9# ()%)*L.,."# N++,%,/9)**L?# 9/# (/9.-&C-+#
%L&/.,9-#&-.,+'-.#A-&-#0/'9+#,9#:&/Z,>,%L#%/#%B-#:'%)%,C-#)(%,C-#.,%-"#EB-&-0/&-#%B-#
&-.,+'-.# ,9C/*C-+# ,9# K-9-&)*# )(,+I@).-# ()%)*L.,.# ,9# /%B-&# 6).S# B/>/*/K'-.# )&-# 9/%#
(/9.-&C-+#,9#$./1!23"##
#
E/# ,9C-.%,K)%-# /%B-&# &-.,+'-.# %B)%#>,KB%# B)C-# )# :/..,@*-# &/*-# ,9# ()%)*L.,.?# &-.,+'-.#
%B)%#)&-#B,KB*L#(/9.-&C-+#,9#(&-9)&(B)-)*#6).S#:&/%-,9.#)9+#)&-#(*/.-#%/#%B-#:'%)%,C-#
)(%,C-# .,%-# A-&-# %)&K-%-+# @L# .,%-U+,&-(%-+# >'%)K-9-.,.# 5P,K'&-# !"1S# N7"# N# .,9K*-U
%'&9/C-&# )..)L#A).# '.-+# %/# +-%-&>,9-# %B-# -00-(%.# /0# %B-.-#>'%)%,/9.# /9# ()%)*L.,.#




/0# %;-# &-)(%,/:# ):)*@.-+# )%# F)&,/'.# %,>-# E/,:%.# 5@# +-:)%'&,:G# G-*# -*-(%&/E;/&-.,.#
HI,G'&-# !"1A# JK"# L'-# %/# %;-# *,>,%)%,/:.# /0# %;-# -ME-&,>-:%N# %;-# (;):G-.# ,:# )(%,F,%@#
(/'*+# /:*@# 5-# .%'+,-+# O')*,%)%,F-*@"# 8(('&)%-*@# >-).'&,:G# 0*'/&-.(-:(-# 0&/>#
+-:)%'&,:G# G-*.# ,.# +,00,('*%# ):+# ./# ,%# ,.# 5-%%-&# %/# ):)*@.-# %;-# &-.'*%.# O')*,%)%,F-*@"#
P'):%,%)%,F-#:'(*-).-#)..)@.#)&-#/0%-:#E-&0/&>-+#'.,:G# &)+,/)(%,F-*@# *)5-**-+# H24QK#




























!"#$%&' ()*+,' -%./"0#' 12&' 341"5&' 6"1&' .7' 86.*(9:' ;"12' 6"1&<="%&41&=' >$13#&0&6"6)' 567# 8,-9# /0# %:-#
$./1!23# ;/</;-&# .:/9,<=# %:-# >/.,%,/<.# /0# %:-# &-.,+'-.# %)&=-%-+# ?@# ;'%)=-<-.,.#




%/# ,<.'00,(,-<%# +-<.,%@# )<+# ./#9-&-# >*)(-+# ,<# .%)<+)&+# (/<0/&;)%,/<."# 5H7# I-<)%'&,<=#




B:-# B416G# $!J6G# S13TUG# V1T46# )<+# $44J6#;'%)%,/<.# :)+# </# .,=<,0,()<%# ,;>)(%# /<#
)(%,E,%@#9:,*.%#N4JT6G#*/()%-+#,<#%:-#=*@(,<-C&,(:#*//>G#+,+#.,=<,0,()<%*@#+-(&-).-#%:-#
)(%,E,%@"#W/9-E-&#%:-#;'%)%,/<#/0#0/'&#?).,(#&-.,+'-.#5K4L6G#K4M6G#KL16#)<+#N42167#






(&@.%)**,.)%,/<# /0# $./1!23#9,%:# &->-)%# NO6#9).# )%%-;>%-+"# X<)(%,E-# >&/%-,<.#9-&-#
'.-+#+'&,<=#(/C(&@.%)**,.)%,/<#%/#>&-E-<%#(*-)E)=-#/0#%:-#.'?.%&)%-"#$./1!23K4M6#,.#
;,<,;)**@#)(%,E-#5Y"2#Z#/0#%:-#PB#&)%-71T2#9:,*.%# *@.,<-#;-%:@*)%,/<#)*;/.%#-<%,&-*@#
)?/*,.:-.# )(%,E,%@G# %:/'=:# <-,%:-&#;/+,0,()%,/<# .,=<,0,()<%*@# &-+'(-.# %:-# )00,<,%@# /0#




-*-(%&/.%)%,(# ,<%-&)(%,/<.# ?-%9--<# %:-# >:/.>:)%-# ?)(A?/<-# )<+# %:-# >&/%-,<# )&-#
9-)A-<-+"# B:-&-0/&-# %:-# .)*%# (/<(-<%&)%,/<# /0# %:-# ?'00-&# 9).# */9-&-+# 0/&# -)(:#






E-B-)%# .-F'-<(-.# +-&,C-+# 0&/># %D-# !"# $%&'()(*+,-$# GEH$IE# */(,# 8JK# )<+# GJL# =-&-#
.-*-(%-+#0/&#(/M(&:.%)**,.)%,/<"#8**#%D&--#B&/%-,<.#=-&-#>,N-+#=,%D#%D-#&-B-)%.#8K#)<+#
GL#)%#)#&)%,/#/0#1O1"1#)<+#%D-<#.(&--<-+#)P),<.%#.B)&.-#>)%&,N#.(&--<."#QD-#>)R/&,%:#
/0# %D-# (&:.%)*.# %D)%# P&-=# 0/&>-+# %D-# D-N)P/<)*# ?,B:&)>,+)*#>/&BD/*/P:# /?.-&C-+#
-N%-<.,C-*:#=,%D#<)%,C-#$./1!23"#QD,.#.'PP-.%-+#%D)%#%D-#(&:.%)*.#+,+#</%#(/<%),<#ES8#
?'%#-C-<#)0%-&#/B%,>,.)%,/<#%D-#(&:.%)*.#+,+#</%#+,00&)(%#=-**#-</'PD#%/#(/<0,&>#%D,."#
T/=-C-&A# /<-# (/<+,%,/<# (/<%),<,<P# $./1!236478# )<+# &-B-)%# GL# B&/+'(-+# /?*/<P#




(D*/&,+-A# 43"5# Y# Z-00)>,<-# ;MX@@# )<+# +,00&)(%-+# %/# 2"@# [# &-./*'%,/<# '.,<P#
.:<(D&/%&/<# &)+,)%,/<# U^,P'&-# !"13# K# )<+# GV"# QD-# >/%D-&# *,F'/&# =).# )# .',%)?*-#




/0# $./1!239:.;-%# ).# %D-# .-)&(D#>/+-*"# QD-# ./*'%,/<#(/<%),<-+#/<-#>/</>-&# ,<# %D-#










/0# $./1!23<4=7#A/':%-+# ,:# )# *//@"# 6B8# 6,8# C,00&)(%,/:# @)%%-&:# 0&/A# %D-# (&;.%)*# ,:# 6>8#
'.,:E#.;:(D&/%&/:#&)+,)%,/:#6F-)A*,:-#94!G#C,)A/:+8"#6,,8#B*/.-#H,-I#/0#+,00&)(%,/:#.@/%.#
0&/A#%D-#D,ED*,ED%-+#)&-)#/0#6,8"#6C8#J)(K,:E#/0#%D-#@&/%-,:#,:#%D-#(&;.%)*#D,ED*,ED%,:E#%D-#



























E)P,E'E# /(('5)B(H# /0# M,B+,B6# M'%# /B(-# )6),B# /B*H# B/BC/5%,E,.)M*-# L-P)6/B)*#
M,5H&)E,+)*# (&H.%)*.# 0/&E-+"# V-)%,B6# $./1!23K4<RSH.G-%# )B+# &-5-)%# DI# 81T1"4@#
%/6-%L-&# )%# !4# ?D# 0/&# 2:# E,B# 5&,/&# %/# (&H.%)**,.)%,/B# *-+# %/# (&H.%)*.# %L)%# (/'*+# M-#
/5%,E,.-+"#OL-#/&,6,B)*#(&H.%)*.#6&-J#,B#:"1#G#O&,.#5V#<">7#:"4#G#G)6B-.,'E#(L*/&,+-7#
2:#F#WXY!:::#JL,*.%#%L-#/5%,E,.-+#(&H.%)*.#6&-J#,B#)#(/B+,%,/B#/0#:"1#G#O&,.#5V#<"<7#
:"4#G#G)6B-.,'E# (L*/&,+-7# 22# F# WXY!:::# J,%L# %L-# 5&/%-,B# +&/5.# .'55*-E-B%-+#
J,%L#1:#F#Y*H(-&/*# 8Z,6'&-#!"1<@"#OL-#Y*H(-&/*#J).# &-[',&-+# %/#5&/%-(%# %L-#(&H.%)*.#
+'&,B6#(&H/5&/%-(%,/B#J,%L#W-&0*'/&/5/*H-%L-&"#
#
OL-# +,00&)(%,/B# 0&/E# %L-.-# (&H.%)*.# J).# L,6L*H# )B,./%&/5,(7# -Q-B# M-0/&-# (&H/C
5&/%-(%,/B# )B+# 0*).L# (//*,B67# )B+# 'B+-&# L/E-# ./'&(-# &)+,)%,/B# %L-&-# J-&-# ,..'-.#
J,%L#/Q-&*)55,B6#.5/%.#+'-#%/#)#*/B6#(-**#-+6-#8!24:#9@#8Z,6'&-#!"1<#D@"#XP5/.'&-#/0#
%L-.-#(&H.%)*.# %/#.HB(L&/%&/B#&)+,)%,/B#&-.'*%-+# ,B#+,00&)(%,/B#%/#2"<#9#&-./*'%,/B# ,B#
/B-# +,&-(%,/B# )B+# <":# 9# ,B# %L-# /%L-&# )B+# %L-# '.-# /0# )# *)&6-&# +-%-(%/&# )**/J-+# 0/&#
.-5)&)%,/B#/0#%L-#+,00&)(%,/B#.5/%.#8Z,6'&-#!"1<#I@"#\Q-&)**#%L-#+)%)#5&/(-..-+#%/#=":#
9# &-./*'%,/B# ,B# .5)(-# 6&/'5# 1!2414# )B+# ,%# J).# 5/..,M*-# %/# ./*Q-# %L-# .%&'(%'&-# MH#
E/*-('*)&#&-5*)(-E-B%#'.,B6#)#E/B/E-&#/0#$./1!23SH.G-%#8]C.(/&-#3"3@"#OL/'6L#%L-#
-*-(%&/B#+-B.,%H#J).#5//&#+'-# %/# %L-# &-./*'%,/B7# %L-#./*'%,/B#J).#5&-.'E-+# %/#M-#
!"#$%&'(%'&)*#$%'+,-.#/0#$./1!23#
# 145#
(/&&-(%# 6-()'.-# )*%7/'87# /9*:# /9-#;/*-('*-#<).# =&-.-9%# ,9# %7-# >$?@# ,%# 0/&;-+# )#
+,;-&#<,%7#)#.:;;-%&:#;)%-@#).#<).#/6.-&A-+#<,%7#$./1!23B:.C-%#DE,8'&-#!"15#FG"#H/#
+-9.,%:# <).# =&-.-9%# 0/&# IH>@# %7/'87# %7-# =//&# &-./*'%,/9# )9+# 6,).# %/<)&+.# %7-#
.-)&(7#;/+-*#(/'*+#7)A-#/6.('&-+#%7-#+-9.,%:#DE,8'&-#!"15#EG"#J7-#(&:.%)*.#(/'*+#9/%#




!"#$%&' ()*+,' -%./0122"/10"34' 35' 6/3*(789:+;<./=&0)' D>G# K9,%,)*# (&:.%)*.# /0# $./1!23L45>B:.C-%"# DMG#
N=%,;,.-+#(&:.%)*#/0#$./1!23L45>B:.C-%#;/'9%-+#,9#)#*//="#DOG#D,G#P,00&)(%,/9#,;)8-#/0#)9#
/=%,;,.-+# (&:.%)*# %)Q-9# )%# &//;# %-;=-&)%'&-# '.,98# 7/;-# ./'&(-# &)+,)%,/9"# D,,G# O*/.-#
A,-<# /0# %7-# /A-&*)==,98# .=/%.# ()'.-+# 6:# %7-# */98# (-**# -+8-"# DPG# D,G# P,00&)(%,/9# ,;)8-#






































56-# .%&'(%'&-# /0# $./1!23# &-7-)*.# )# %89,()*# :).;# 9&/%-,<# =,%6# -)(6# >/</>-&#
(/<.,.%,<?#/0#%=/#@ABC#+/>),<.#.-9)&)%-+#D8#)<#EF6-*,G"#H'&,<?#%6-#9&-9)&)%,/<#/0#
%6,.# %6-.,.I# %6-#.%&'(%'&-#/0# %6-#9)&)*/?'-#$./J44!#=).#9'D*,.6-+# ,<#)9/#)<+#@KAF
D/'<+#0/&>."J44#56-#%=/#9&/%-,<.#.6)&-#LM#N#.-O'-<(-#,+-<%,%8#)<+#.'9-&,>9/.-#/<#
-)(6# /%6-&# =,%6# )# :E# &>.+# /0# 1"1# P# /7-&# JQJ# &-.,+'-.# RCHS# !TU@V"# 56-&-# )&-# </#
.,?<,0,()<%#+,00-&-<(-.#D-%=--<#%6-#%=/#.%&'(%'&-.#-G(-9%#0/&#%=/#)++,%,/<)*#6-*,(-.#
,<#$./J44!# */()%-+# ,<#+,./&+-&-+#&-?,/<.#/0#$./1!23#RW,?'&-#!"1MV"#56-#0,&.%#6-*,G# ,.#
*/()%-+# ,>>-+,)%-*8# )0%-&# %6-# @ABC#E1# 6-*,G# /0# %6-#KF%-&>,<)*# +/>),<# R6-&-)0%-&#
+-</%-+#E1XV#=6,*.%#%6-#.-(/<+#,.#%6-#@ABC#EJ#6-*,G#/0#%6-#KF%-&>,<)*#+/>),<"#56-#






6%7(2/+ !",89+ :);<=2%&)*+ )3+ 1./+ &12('1(2/&+ )3+ 0&),!45>+ 0&)?@@!+ =*A+ B3:=&#"+ $./1!23# R/&)<?-V# ,.#













&-.,+'-.#)4+#2"2#G#/H-&#1J3# &-.,+'-.<# &-.>-(%,H-*K# @L,;'&-#!"1IE"# C4#)++,%,/4# %/# %8-#
%K>,()*#MNO?#-*-7-4%.<#%8-#>&/%-,4.#.8)&-#F1P#).#=-**#).#)#.8/&%#QR8),&>,4#0/&7-+#SK#
)4# TR%-&7,4)*# -U%-4.,/4# /0# Q!# =,%8# %8-# >&-(-+,4;# 4/4RMNO?# QR.%&)4+"# V8,.# ,.#
/S.-&H-+#,4#./7-#%&)+,%,/4)*#MMO#0/*+.<#=8-&-#,.#,%#W4/=4#).#%8-#Q2XRQ2X#.8--%"1JY#V8-#
('$#>)&)*/;'-.#)&-#)*./#.,7,*)&#%/#%8-#/%8-&#9).:#>&/%-,4.#=,%8#$./1!23#-U8,S,%,4;#9F#
&7.+.# /0# 2":# G# /H-&# 1Y!# &-.,+'-.# =,%8# V%9).:-# @?AB# 1Z[IE# )4+# !"I# G# /H-&# IY#
&-.,+'-.#=,%8#?)9).:0#@?AB#5\]^E"#V8-#/4*K#4/4RMNO?#-*-7-4%#.8)&-+#S-%=--4#%8-#










)#Y#4%# *//>"#V8,.# ,.#.'&>&,.,4;#S-()'.-#%8-#&->-)%# ,.#>&-+,(%-+#%/#S-#'4.%&'(%'&-+<25#
7-)4,4;# %8)%# %8-# -4`K7-# .%)S,*,.-.# %8-# MTN# ,4# )# (/40/&7)%,/4# %8)%# ,.# '4.%)S*-# ,4#





(/4%)(%# %8-# >8/.>8)%-# ;&/'>.# /0# N1:<# N1!# )4+# c1Y<# &-.>-(%,H-*K"# V8-.-# %8&--#










0&/D#"#! $%&'()(*+,-$#95-7#A/'7+#AB# $./4==!"# >E@# 85-# .%&'(%'&-#/0# %5-# $./4==!#+,D-&#
>A*'-#)7+#(B)7@#,7#(/D6*-F#9,%5#.'A.%&)%-#GH?#>/&)7<-@#>IJE#!KLL@"#>M@#85-#.%&'(%'&-#/0#
%5-# $./4==!N6&/+'(%# (/D6*-F# >IJE# !KLO@"# P7*B# %5-#D/7/D-&# ,.# .5/97"# >J@# $./4==!#
>IJE#!KLL@#,7#(/D6*-F#9,%5#.'A.%&)%-#5,<5*,<5%,7<#%5-#A).,(#&-.,+'-.#>B-**/9#.%,(Q.@#%5)%#

















































%5)%# ,6%-&)(%# :,%5# %5-# E5/.E5)%-# ;)(F;/6-# )&-# 5,=5*,=5%-+# :,%5# >)=-6%)# (,&(*-.G#
&-.,+'-.# %5)%# 0/&># 57+&/=-6# ;/6+.# %/# %5-# .';.%&)%-# )&-# 5,=5*,=5%-+# :,%5# =&--6#
+,)>/6+."# 45-# &-.,+'-.# %)&=-%-+# ;7# .,%-H+,&-(%-+# >'%)=-6-.,.# )&-# ,6+,()%-+# :,%5#
)&&/:."#I6,B&/%#(/+-.#)&-#E&/<,+-+#0/&#-)(5#E&/%-,6"#
#
J*-)<)=-# /(('&.# )%# %5-# 2K# ;).-# /0# %5-# ?L@# 5),&E,6M# ).# .--6# ,6# /%5-&# (5)&)(%-&,.-+#
J?N$B?OJ).#.7.%->."P9MP1M32#45-#Q8KHQ2K#5),&E,6#/0#$./899!#,.#,6.-&%-+#,6%/#%5-#;).-#/0#


















































. . . . . . . . . . . . . . . . M P L I F K I G Y N V I P L Q D V I L P T P S S K V L K Y L I Q S G K L I P S L K D 42
L I T S R D K Y K P I F I S H L G F . . N Q . R R I F Q T . . N G N L K T . . I T K G S R L S S I I A F S T . . Q A 91
N V L S . . . E V A D E G I . F E T V Y G K F H I M I E S I E I V E . V E K L K E E V E K H M N D N I R V R F V S P 144
T L L S S K V L L P P S L S E R . . Y K K I H A G Y S T L P S V G L I V A Y A Y N V Y C N L I G K K . . . . . . E V 194
E V R A F K F G I L S N A L S R I I G Y D L H P V T V A I G E D S K G N L R K A R G V M GW I E F D . . . . I P . . 246
. D E R L K R R A L N Y L L T S S Y L G I G R S R G I G F G E I R L E F R K I E E K E G . . . . . . . . . 289
. . . . . . . . . . . . . . . . M P L I F K I G Y N V I P L Q D V I L P T P S S K V L K Y L I Q S G K L L P S L N N 42
L I T S R D K Y K P I F I S H L G L . . N Q . R R I F Q T . . N G N L K T . . I S R G S K L S S T I A F S T . . Q V 91
N V L P . . . E L . D E G V . F E T I Y G K F H I T I E S V E I V E . V E K L K E E V E K H M N D N I R V R F I S P 143
T L L S S K V L L P P S L S E R . . Y K R V N A G Y S T L P S V G L I V A Y A Y N V Y C N L I G K K . . . . . . E V 193
E V R A F K F G V I S N A L S R I I G Y D L H P V T I V I G E D S K G N L R K A R G V M GW I E F D . . . . I P . . 245
. D E K L K R R A L R Y L L A S S Y L G I G R S R G I G F G E I K L E F I K R E E N H . . . . . . . . . . 287
M L I T D I I G S R L L Y S A S P R T Y Y K A H I V L E V K G E A V L P P Y T G K V V K T L L I N A E . . P G L E D 56
V F S S N Y N P K P I A I S T L A K R V N N . K Y L Y L W K K S G S D I V L K V D P G D T V E F W V G F T E D I A S 113
K M I E A L T S L D G L K . L F N T K W S L L E Y N I E S Y K L P A K P E E I P L D Y R L D D A I A V K V E F R T P 170
A L L L . . . . . D P Y K K T R . . Y K R F . . . . . . L P T P G N V F S Y N I G D L L R L T R D K E Y . . . . . I 210
E V V I . L V N A L L N E T . Y T V L E T V K P V K Y V Y G N . . . . . . K S L P G I I G Y A K Y M I D W D L L A . 259
. E T K A K H L L E N I L L H A S I M G I G T S R A N G F G H V T I K V I Q S N E . . . . . . . . . . . . 299
. . . . . . . . . . . . . . . . . M Q L M K M T F N V T P L H D V V L P P L S S K V L K Y L V L S Q Q V L P F L E E 41
L V R S K D K Q K P L F I S N L A L . . D G . K R L Y S R . . . G E P I T . . V K A K T R L T G S V T F P F . . S K 89
E A F . . . . N V . G G G R . V K T V Y G E Y E I S L K . . . . . E . V S V L D E T P S T S T R G N L R V S F L T P 135
A L L C S K I Y L P P F L R E K . . Y R R K K I G F S L I P T P G L V V A Y G Y R Q Y L A L L G K T D S . . . Y E N 188
D I K T F K L L V M A N A L S R V V G Y R L Y P E T V V I G E D E K G R L R L T R G V K GW I E F D . . . . I V G . 241
. . . K L K E S A A K Y L E V A S F L G I G R S R G I G L G E V H F K M V E R G E N S H . . . . . . . . . 282
. . . . . . . . . . . . . . . . M P L I F K I G Y N V I P L Q D V I L P T P S S K V L K Y L I Q S G K L I P S L K D 42
L I T S R D K Y K P I F I S H L G F . . N Q . R R I F Q T . . N G N L K T . . I T K G S R L S S I I A F S T . . Q A 91
N V L S . . . E V A D E G I . F E T V Y G K F H I M I E S I E I V E . V E K L K E E V E K H M N D N I R V R F V S P 144
T L L S S K V L L P P S L S E R . . Y K K I D A G Y S T L P S V G L L V A Y A Y N V Y C N L I G K K . . . . . . E V 194
K V R A F K F G I L S N A L S R I I G Y D L H P V T V A I G E D S K G N L R K S R G V M GW I E F D . . . . I P . . 246
. D E R L K R R A L K Y L L T S S Y L G I G R S R G I G F G E I R L E F R K I E E K E D K Y T S S D F K G 298
. . . . . . . . . . . L V F C V S G F V F G V R F C V V P F D R V C I N I Y T P R F V K A L L F L S R G F S W V R G 47
L Y E D R R S V K P F S L S P L Y G . . G N G Y V L D E G . V . . . C I D . . S S . . S R Y F F D L S I A S R . D T 94
S L L D S I S S V Y E D V V E V S S WG A R F R V S I D S I E I V S . I D N L S I G F N D S G K Q V V K L V F H T P 151
T L L S S K L M A P P L D S F K K R I E S M P N L Y I L Y P S T G H I C S Y L A R L W Y S A T G R S . I C S G P T E 208
E W A A Y F M G R L C E A T L V P I D Y R I S L K T V R Y D E N . . . . . R R I R G F V GW T I L R . . . . L G I R 257
S . R K V I D R I D K I F A L A S K L G I G K S R T I G F G I T R A F V K E L R D . . . . . . . . . . . . 297
. . . . . . . . . . . . . . . . . . M I F W I R F S L K F K D E V I V Q P F T S K V S R I V M N N . . . Y P S Y V K 37
I S E S S E P L K P V R V T V I K D . . E E G R S I F K G . M D K N V L R . . L K . . P Q I N Y F F D L T S L . D I 87
N L F E E I . . . V S N P Y . F N T . . . K V Y S T E A S V E V G E . T K . V F E E V E I E D S K A Y K I E F K T P 136
T L I Q . . . . . P P R P N F K R K . . . . K N R Y L L F P F S P Y F L V S I Q R H W N K Y Q E K K . I I I S . . . 181
. . . . . . Y S R . A L Y Y F K E V D Y N L K P V T V I Y D K . . . . . . S K V R G F V GW T L F T . . . . L E A R 222
K N S S L R E G I R K L L A Y S N Y I G V G K S R A I G F G E V M V K G V R K . . . . . . . . . . . . . . 261
. . . . . . . . . . . . . . . . M T L I V S A E I D V I P K H D V I L P L L T S K V A K F I L S K N Q . . . Q I G E 39
L I G S K K K Y K E L S I S P L S S . . N G . R F L Y A E . N D G K L L R . . A M R G E K L H F T F S V A T S . E V 90
N E . . K T F D . . L D G D . V S T S Y G E F Y V L L K T I Y I N Q . L K D I R H E I K . . . E R N V N L R F E S P 139
T L L S N K Y M V P P V F K K K K V . . . . R S M N R L I P Q P S L I F S F L A N L W N S I A D E R E R I V K G D L 193
E W T P Y Y I G R I A D V A F A E I G Y S L R P V T V I I G K D N N Q R I R Q A R G F V GW V K Y E . . . . V I N V 247
. N P R Y L E T F E R L L G L A K I F G I G R S R G I G L G R V K V E . . . . . . . . . . . . . . . . . . 281
                                                          
                                                          
                                                          
                                                          
                                                          
                                                     
                                                          
                                                          
                                                          
                                                          
                                                          
                                                     
                                                          
                                                          
                                                          
                                                          
                                                          
                                                     
                                                          
                                                          
                                                          
                                                          
                                                          





):+# 7&?D2D# /0# %4-# HDIJH2I# 4),&;,:K# %4)%# )&-# *,9-*A# &-L',&-+# %/# .%)8,*,.-# %4,.#
(/:0/&=)%,/:"#
#
6'(*-/%,+-.# 1MJD2# )&-# ;/.,%,/:-+# 8-%N--:# G1# ):+# G1O# N,%4# CA.!1P# N4,(4# ,.# ;//&*A#
(/:.-&>-+# ,:# (&-:)&(4)-)*# Q).R# 4/=/*/?'-.P# (//&+,:)%,:?# %4-# ;4/.;4)%-# /0# 7D1"#




%4-# )(%,>-# .,%-# )0%-&# (*-)>)?-"# 6'(*-/%,+-.# 1JE# 0/**/N# )# (*-0%# */()%-+# 8-%N--:# %4-####
HDIJH2I#4),&;,:# ):+# %4-# *//;# */()%-+# )0%-&# G1I"# @4-# ;&/%-,:# +/-.# :/%# 8,:+# U1# N4,*-#
:'(*-/%,+-.# DJ!# );;-)&# %/# 8-# N-)9*A# 8/':+"# @4-&-0/&-# %4-# =),:# ,:%-&)(%,/:.# /0#






@%Q).R-"# W/%4# -:XA=-.# (//&+,:)%-# %4-# .(,..,*-# ;4/.;4)%-# ):+# %4-# ;4/.;4)%-#
8)(98/:-#/0# %4-#2I# .,+-#/0# %4-#4),&;,:#'.,:?#(/:.-&>-+#8).,(# &-.,+'-.# ,:# %4-#G1OJHD#
*//;P# %4-# HDIJH2I#4),&;,:# ):+# %4-# ?*A(,:-# &,(4# *//;"# @4-# '.-# /0# %4-# HDIJH2I#4),&;,:# %/#
(*)=;#%4-#.(,..,*-#;4/.;4)%-#)?),:.%#G1#,.#.--:#,:#$./DSS!P#@%Q).R-#):+#Y)Q).R0Z#,%#,.#
*,9-*A#%/#8-#)#(/:.-&>-+#0-)%'&-#/0#%4-#Q).R#0)=,*A"#@4-#?*A(,:-J&,(4#*//;#,.#(/:.-&>-+#
,:#Q).R#;&/%-,:.P# -<(-;%# 0/&#=-=8-&.#/0# %4-#Q).R0# .'80)=,*AP# ):+# ,.# ,=;/&%):%# 0/&#
8,:+,:?# %4-# ;4/.;4)%-# 8)(98/:-# ,:# $./DSS!# ):+# @%Q).R-"# @4-# 4,?4# +-?&--# /0#













&,(I#I-*,U# %/# (//&+,F)%-# %I-#QI/.QI)%-#M)(PM/F-#/0# %I-#4V# .,+-#/0# %I-#WX6#I),&Q,F#
5Y,N'&-#!"88#A7"#@I,.#I-*,U#,.#F/%#(/F.-&L-+#,F#%I-#/%I-&#A).B#.%&'(%'&-.#).#,%#,.#0/'F+#
,F# %I-# )%OQ,()*# A).B0# AT%-&K,F)*# +/K),F"# @I-# N*O(,F-T&,(I# *//Q?# JI,(I# +/-.# F/%#




./K-JI)%# .'&Q&,.,FN# %I)%# %I-O# )QQ-)&# %/# M,F+# WX6# ,F# .'(I# +,00-&-F%# J)O."# $,F(-#
F'(*-/%,+-.# 11T29# )&-# +,./&+-&-+# ,F# %I-# :0A).B\WX6# .%&'(%'&-?# $I)/# )F+# >,# I)L-#
Q&/Q/.-+#%I)%#%I-.-#F'(*-/%,+-.#K,NI%#0/&K#)#I),&Q,F#.%&'(%'&-#.,K,*)&#%/#%I)%#.--F#
J,%I# $./899!"899# X'(*-/%,+-.# 12T81# J/'*+# %I-/&-%,()**O# M-# ()Q)M*-# /0# 0/&K,FN# )#
I),&Q,F#.%&'(%'&-#J,%I#)#8#MQ#*/FN#.%-K#J,%I#)#4#F%#*//Q?#JI,(I#,.#.,K,*)&#%/#)#K'%)F%#
WX6# .'M.%&)%-# %I)%# $./899!# ,.# ()Q)M*-# /0# Q&/(-..,FN?# )*M-,%# .*/J*O# 5Y,N'&-# !"827"#
]/J-L-&?#E)FN#$%&'()#-U%-F.,L-*O#K'%)%-+#%I-#.'M.%&)%-#WX6#/0#:0A).B#%/#+-%-&K,F-#

























!"#$%&' ()*+,' -./01%"2.3' .4' 56&' 789' :"3;"3#' /.;&2' .4' <2.*==(' 13;' >4-12?)' ;:=# L6-# &-7-)%#
.-M'-5(-.#7&/(-..-+#JH#$./B<<!#;*-0%=#)5+#?0@).4#;&,G6%="#L6-#5'(*-/%,+-.#/J.-&>-+#,5#
%6-# (&H.%)*# .%&'(%'&-.# )&-# .6/D5# ,5#/&)5G-"# L6-#!"#$%$%%&'# &-7-)%# (/'*+# %6-/&-%,()**H#



































%>-# *//4# 79@# )5+# 89="# A>-.-# 5'(*-/%,+-.# +/# 5/%# 0/&B# .%&/5C# ,5%-&)(%,/5.# ?,%>#
$./6DD!# )5+# ./# %>-# +,00-&-5(-.# E-%?--5# %>-.-# %?/# &-4-)%.# >)F-# *,%%*-# ,B4)(%# /5#
-5GHB-#-00,(,-5(H"# A>-#+,00-&-5(-.#E-%?--5# &-4-)%.#8I#)5+#<#)&-#B/&-# .,C5,0,()5%#
?,%>#%>-# *//4#(>)5C-+#0&/B#89@8@#7&-4-)%#<=# %/#98888#7&-4-)%#8I=#)5+#%>-#%>,&+#
E).-# 4),&# /0# %>-# .%-B# (>)5C-+# 0&/B# @J8# %/# 9JK;# )*%/C-%>-&# -5(/B4)..,5C#
5'(*-/%,+-.# LJ1M# /0# &-4-)%# <"# N>,*-# 5'(*-/%,+-.# LJ1D# ,5%-&)(%# ?-)O*H# ?,%># %>-#
4&/%-,5;# 5'(*-/%,+-.# 16J1M# 7888K=# 0/&B# B/&-# -P%-5.,F-# ,5%-&)(%,/5.# )5+# ./# %>-#
+,00-&-5(-# ,5# 4&/(-..,5C# -00,(,-5(,-.# ,.# *,O-*H# +'-# %/# .-Q'-5(-J.4-(,0,(# ,5%-&)(%,/5.#
?,%>#%>-.-#5'(*-/%,+-."#A>-#%?/#&-4-)%.#)*./#+,00-&#)%#%>-#MR#-5+#/0#%>-#ST8#?>-&-#



























































%5-# /%5-&# (5)&)(%-&,.-+# 6).7# 5/8/*/9'-.:# 5,.%,+,;-:# %<&/.,;-# );+# .-&,;-# &-.,+'-.#
5)=-# >--;# .5/?;# %/# @*)<#8)A/&# &/*-.# ,;# ()%)*<.,."# B5-&-# )&-# ;/# 5,.%,+,;-# &-.,+'-.#
.'&&/';+,;9#%5-#.(,..,*-#@5/.@5)%-#,;#$./CDD!"#B5,.#,.#,;#+,&-(%#(/;%&).%#%/#%5-#/%5-&#
6).7# 5/8/*/9'-.# ?5-&-# )# 5,.%,+,;-# &-.,+'-# ,.# ()%)*<%,()**<# (&,%,()*# );+# ,.# -,%5-&# )#







(/;.-&=-+# ,;# (&-;)&(5)-)*# 6).7#;'(*-).-.# ER,9'&-#!"C1G"# B5-#/;*<# %<&/.,;-# (*/.-# %/#
%5-# .(,..,*-# @5/.@5)%-# ,.# B<&CH:# ?5-&-# %5-# 5<+&/P<*# 9&/'@# ,.# 12# S# )?)<# 0&/8# %5-#
.(,..,*-# @5/.@5)%-:# %5/'95# &/%)%,/;# )&/';+# %5-# 6TU6V# >/;+# ?/'*+# @/.,%,/;# %5-#
5<+&/P<*#9&/'@#!C#S#)?)<"#K/?-=-&:#,;#%5-#.'>.%&)%-U>/';+#.%&'(%'&-#%5-&-#,.#?-**U
+-0,;-+# +-;.,%<# 0/&# %5-# .,+-# (5),;# @/,;%,;9# )?)<# 0&/8# %5-# .(,..,*-# @5/.@5)%-# );+#
.,;(-#%5,.#.%&'(%'&-#&-@&-.-;%.#)#@&-U(*-)=)9-#(/8@*-P#,%#,.#';*,M-*<#%5)%#B<&CH#@*)<.#)#









/0# %5-.-# &-.,+'-.# +/-.# ;/%# .,9;,0,();%*<# +-(&-).-# %5-# )00,;,%<# /0# %5-# $./1!23# 0/&#
.'>.%&)%-# NYL# E@-&./;)*# (/&&-.@/;+-;(-:# N,(5)&+# $/M/*/?.M,# );+#O)*(/*8#Z5,%-:#
[;,=-&.,%<# /0# $%# L;+&-?.G# %5-<# 8'.%# >-# ,;=/*=-+# ,;# ()%)*<.,."# L;)*<.,.# /0# %5-#
.'>.%&)%-U>/';+#(/8@*-P# .5/?.# %5)%# \<.C4#);+#\<.I1# ,;%-&)(%#?,%5# %5-#@5/.@5)%-#




5-)6"# 78# %9-# :&/+'(%;</'8+# (/=:*->?# %9-# ,8%-&)(%,/8# <-%5--8# @A.B1# )8+# C1D# ,.#










































&-.,+'-.# )&-# &-.</7.,8*-# 0/&#=),7%),7,7># %6-#<6/.<6)%-# 8)(;8/7-# ,7# %6-# -?%-7+-+#
(/70/&=)%,/7#&-@',&-+#0/&#,7%&)=/*-('*)&#)%%)(;#/7#%6-#.(,..,*-#<6/.<6)%-"#A7/%6-&#
</..,8*-# &/*-# ,.# %6-# .%)8,*,.)%,/7# /0# %6-# <-7%)(//&+,7)%-# %&)7.,%,/7# .%)%-# +'&,7>#
(*-)B)>-"# $6)/# )7+# C,# .'>>-.%-+# %6)%# A&>D2D# (/'*+# )(%# ).# )# >-7-&)*# 8).-# %/#
+-<&/%/7)%-#%6-#DEF69+&/?9*#0/&#)%%)(;#/7#%6-#.(,..,*-#<6/.<6)%-#G.--#H,>'&-#!"2I"D44#





56-# -00-(%.# /0# %6-# /%6-&#='%)%,/7.# <-&0/&=-+# /7# $./1!23# ()7# 8-# &)%,/7)*,.-+# 89#




S13OH# ='%)%,/7# +/-.# 7/%# .,>7,0,()7%*9# ,=<),&# %6-# 7'(*-).-# )(%,B,%9L# <&-.'=)8*9#
8-()'.-# %6-# *)(;#/0# %6,.# 69+&/>-7#8/7+# ,.# '7*,;-*9# %/# )00-(%# %6-#/&,-7%)%,/7#/0# %6-#
.(,..,*-#<6/.<6)%-#%6)%#,.#!1M#T#)K)9"#56-#)=,+-#8)(;8/7-#/0#$-&DD3#G-@',B)*-7%#%/#
$-&DDM# /0# $./1!23I# ,7%-&)(%.# K,%6# %6-# DEF69+&/?9*# /0# U3L# K6,(6# -?<*),7.# K69# %6-#
$DDMA# ='%)%,/7# +,+# 7/%# .,>7,0,()7%*9# (6)7>-# %6-# &)%-# /0# ()%)*9.,.# )7+# K69# %6,.#
&-.,+'-# ,.#7/%#B-&9#(/7.-&B-+"#$-&!M# ,.#<)&%,)**9#8'&,-+#'</7#PQA#8,7+,7>#8'%#+/-.#
7/%# 0/&=# )79# 69+&/>-7# 8/7+.# %/# %6-# .'8.%&)%-L# K6,(6# &-.'*%.# ,7# )# B-&9# K-);#
,7%-&)(%,/7#K,%6# %6-# PQA# )7+# -?<*),7.# %6-# *)(;# /0# )# .,>7,0,()7%# -00-(%# /7# ()%)*9.,."#
A&>D34#GA&>DMR#,7#$./1!23I#,7%-&)(%.#K,%6#%6-#<6/.<6)%-#>&/'<#/0#N1V#)7+#K6,*-#%6-#
()%)*9%,(# &)%-# ,.# .,>7,0,()7%*9# ,=<),&-+# G14# W# /0# X5# $./1!23# )(%,B,%9IL1O2# %6-#







08%#&0&>' 7?' 9$08#&=&/"/)' 45-# &-.,+'-.# -6',7)*-8%# %/# %5/.-# /0# $./1!23# %5)%# +,+# 8/%#
.,98,0,()8%*:#)00-(%#)(%,7,%:#;5-8#<'%)%-+#%/#)*)8,8-#)&-#.5/;8#).#:-**/;#.%,(=.#)8+#%5-#




7)&:,89# 0&/<# B"G# %/# G"B# <,8F1"G1H1BBH1I2HABB# 45-# &)%-.# /0# %5-# C).D# ?&/%-,8.# )&-# </&-#
(/<?)&)>*-# %/# &,>/E:<-.# %5)8# %/# /%5-&# <-%)*F,8+-?-8+-8%# &,>/8'(*-).-.H# ;5,(5#
-J5,>,%#&)%-#(/8.%)8%.#/&+-&.#/0#<)98,%'+-#9&-)%-&#%5)8#%5)%#/0#%5-#C).D."1BBHAB1#45-#
!"##5/</*/9'-.#)&-#%5-#.*/;-.%#&-?/&%-+#C).D#?&/%-,8.H#*,=-*:#+'-#%/#%5-#)>.-8(-#/0#
>/%5# )# 9-8-&)*# )(,+# )8+# )# 9-8-&)*# >).-"#K-.?,%-# %5-.-# */;# &)%-.H# %5-# 7)&,/'.#C).D#






































5/%# /6.-&7-+# ,5# 8/&-# +,.%)5%*9# &-*)%-+# :/8/*/;'-."# </5.,.%-5%# =,%:# %:,.># %:-#
.%&'(%'&-.# /0# /%:-&# <).?# :/8/*/;'-.# &-7-)*# 8/5/8-&,(# @&/%-,5.# =,%:# %:-# /5*9#
-A(-@%,/5# 6-,5;# B:<).?5(># =:,(:# ,.# ()@)6*-# /0# CDEF+-@-5+-5%#
+,8-&,.)%,/5"GH>G1>1I?>1I3>1IJ>1J4# K/=-7-&># .,5(-# %:,.# -5L98-# ,.# 5/5F()%)*9%,(# )5+#
+,8-&,.)%,/5#:).#/5*9#6--5#/6.-&7-+#=,%:#)#5/5F@:9.,/*/;,()*#&-@-)%>#,%#,.#'5*,M-*9#%/#








)%# %:-#)..)9# %-8@-&)%'&->1J2# .';;-.%,5;# %:)%# %:-#/6.-&7-+# */..#/0#)(%,7,%9# ,.#+'-# %/#
%:-#0/&(-+#8/5/8-&,(#.%)%-"#K/=-7-&>#,%#,.#/0#(/'&.-#@/..,6*-#%:)%#%:-#8'%)%,/5.#+/#
+,.&'@%#%:-#)(%,7-#.,%-#,5#./8-#8)55-&#%:)%#=).#5/%#&-0*-(%-+#,5#%:-#%:-&8)*#.%)6,*,%9#
/0# %:-#@&/%-,5"#E..'8,5;# %:)%# %:-#+,8-&# ,.# ,8@/&%)5%# 0/&# ()%)*9.,.># ,%# (/'*+#6-# %:)%#
%:-&-# ,.# )5# )**/.%-&,(# ,5%-&)(%,/5# 6-%=--5# %:-# %=/# )(%,7-# .,%-."# W:-# .%&'(%'&-# /0#
.'6.%&)%-F6/'5+# $./4HH!# .:/=.# %:)%# %:-# 6/%:#8/5/8-&.# ()5# )((/88/+)%-# CDE#
.,8'*%)5-/'.*9># =:,(:# .';;-.%.# %:)%# (&-5)&(:)-)*# <).?# +,8-&.# (/'*+# @&/(-..#
)+Z)(-5%# &-@-)%#.-['-5(-.# ,5#)#.,5;*-#8/*-('*-#/0#@&-F(&CDE"#W:-#!2H#5%#.@)(-&# ,.#
*/5;#-5/';:#%/#*//@#6-%=--5#%:-#%=/#.'6'5,%.>#%:/';:#,%#,.#'5*,M-*9#%/#6-#6/'5+#69#
%:-#-5L98-#+'-#%/#.@)(-#(/5.%&),5%."#W:-#)**/.%-&,(#-00-(%#/5#()%)*9.,.#(/'*+#@&/8/%-#




%:-# (/8@*-A># +,8-&,.)%,/5# /0# <).?# =/'*+# *,M-*9# 6-# )# (/8@*,()%,/5# .,5(-# (/8@*-A#








45-# (&6.%)*# .%&'(%'&-# /0# $./1!23# &-7-)*.# %5)%# %5-# 8&/%-,9# (/9%),9.# %:/# ;<=>#
+/?),9.#)&&)9@-+# ,9#%5-#.)?-#?)99-&#).#?)96#/%5-&#A).B#5/?/*/@'-."#C/:-7-&D#
%5-# 8&/%-,9# )+/8%.# )9# '9'.')*# 5/?/+,?-&,(# )&&)9@-?-9%# %5)%# ,.# ,?8/&%)9%# 0/&#
()%)*6.,.# )9+# )88-)&.# %/# E-# (/9.-&7-+# ,9# /%5-&# (&-9)&(5)-)*# 5/?/*/@'-."# 45/'@5#
/%5-&# A).B# 5/?/*/@'-.# ()%)*6.-# 8&-F(&;G<# (*-)7)@-# %5&/'@5# )# @-9-&)*# )(,+HE).-#
?-(5)9,.?D#(&-9)&(5)-)*#A).B.#8&,/&,%,.-#%5-#'.-#/0#(/9.-&7-+#E).,(#&-.,+'-.#%/#E,9+#






































)..,>6-+# %/# %;-# 4).?)@# 0)7,*="# 4).?)@# ,.# %;-# *)&>-# .'<'6,%# /0# %;-# %=5-# 89:#
,6%-&0-&-6(-# (/75*-A"# $./1231# (&=.%)**,.-+# -).,*=# <'%# /6*=# 5&/+'(-+# 5*)%-9*,B-#
(&=.%)*."# C/D-E-&F# %;-.-# (&=.%)*.# +,00&)(%-+# D-**# )6+# )# .-*-6/7-%;,/6=*# +-&,E)%,E-#
D).#'.-+#%/#./*E-#%;-#.%&'(%'&-#%/#)#&-./*'%,/6#/0#@#G"#C/D-E-&F#-*-(%&/6#+-6.,%=#D).#
/6*=#E,.,<*-#0/&#%;-#49%-&7,6)*#+/7),6#/0#%;-#5&/%-,6F#*-)E,6>#)#E/,+#,6#%;-#+-6.,%=#0/&#
%;-# H9%-&7,6)*# +/7),6"# I;,.# ,.# (/6.,.%-6%#D,%;# %;-# 0/&7)%,/6# /0# 5*)%-9*,B-# (&=.%)*.#
&-.'*%,6>#0&/7#)#+-0-(%#,6#/6-#+,7-6.,/6#/0#%;-#(&=.%)*"#J-0,6-7-6%#/0#%;-#.%&'(%'&-#
)6+#+-6.,%=#7/+,0,()%,/6#/0#%;-#-*-(%&/6#+-6.,%=#7)5.#+,+#6/%#*-)+#%/#,6%-&5&-%)<*-#
+-6.,%=# 0/&# %;-# H9%-&7,6)*# +/7),6F# .'>>-.%,6># %;)%# %;-# H9%-&7,6)*# +/7),6# D).#





O;,*.%#)# 0'&%;-&#2P# &-.,+'-.#(/'*+#<-# %&)(-+# ,6# %;-#H9%-&7,6)*#+/7),6# Q)((/'6%,6>#




I;-# .%&'(%'&-# /0# %;-# 49%-&7,6)*# +/7),6# /0# $./1231# D).# 6/E-*# )6+# .;/D-+# 6/#
.,>6,0,()6%# ;/7/*/>=# %/# /%;-&# 5&/%-,6.F# ,6(*'+,6># %;-# *)&>-# .'<'6,%.# /0# /%;-&#
,6%-&0-&-6(-# (/75*-A-.# Q4).13<# )6+# 4.-1S"# I;-# *)(B# /0# ;/7/*/>=# 7-)6%# %;)%# )#






$./1231# 0&/5# %6-# %78-# 9:;# 1# */('.# /0# !"# $%&'()(*+,-$# <).# ,=,%,)**7# ,+-=%,0,-+# ).# )#
!-&'%&%.(&/$:.8-(,0,(# 8&/%-,="# >/5/*/?'-.# <-&-# /=*7# ,+-=%,0,-+# ,=# %</# .8-(,-.@# !"#
+$&(01+,-$#)=+#!"#)%2%1(++A#-B6,C,%,=?#DE#F#)=+#G!#F#.-H'-=(-#,+-=%,%7A#&-.8-(%,I-*7"#
J-(-=%*7# $./1231# <).# )..,?=-+# %/# %6-# K).L)E# 0)5,*7A# )# =-<# 0)5,*7# (&-)%-+# C7#
5-&?,=?# %6-#K.)2#)=+#K.BD# 0)5,*,-.A#C).-+#/=#.-(/=+)&7# .%&'(%'&-#8&-+,(%,/=.#)=+#
*/()%,/=#/0# %6-#$$%3453# ?-=-#<,%6,=# %6-# */('."2E#>/<-I-&A# .-H'-=(-#)*,?=5-=%.#/0#
$./1231# <,%6# /%6-&# 5-5C-&.# /0# %6-# 0)5,*7# )&-# I-&7# %-='/'.# )=+# ,%# ,.# )=# /8-=#
H'-.%,/=#).#%/#<6-%6-&#$./1231#,.#)(%')**7#)#5-5C-&#/0#%6-#K).L)E#0)5,*7"##
#
M'**:+/<=# -B8-&,5-=%.# 0&/5# !"# $%&'()(*+,-$# (-**# *7.)%-.# 6)I-# .6/<=# %6)%# $./1231#
<-)N*7#,=%-&)(%.#<,%6#%6-#(K).()+-:E#.'C(/58*-B#/0#K).!OK).P"2G#>/<-I-&A#$./1231#
)=+# %6-# .'C'=,%.# /0# (K).()+-:E# )&-# */()%-+# ,=# +,00-&-=%# ,($# */(,# )=+# %/# +)%-# =/#
,=%-&0-&-=(-# (/58*-B-.# 6)I-# C--=# 0/'=+# %6)%# (/=%),=# .'C'=,%.# 0&/5#5'*%,8*-# */(,"#




R-&7# *,%%*-# ,.# N=/<=# )C/'%# %6-# &/*-# 8*)7-+# C7# K).L)E"# 9=# 6"# )/0(7# K).L)E# ,.#
,=(/&8/&)%-+#,=%/#(K).()+-#)=+#8*)7.#)=#'=N=/<=#&/*-#,=#,=%-&0-&-=(-"DL#Q6-#*)&?-&#
K).L#0)5,*7#(/=.,.%.#/0#0/'&#.'C0)5,*,-.@#K).L)1#)=+#K).LE#S%78-#9:;#.7.%-5.TA#K).LC#
S%78-# 9:UT# )=+# K).L(# S%78-# 9:KT"2E# Q6-.-# 8&/%-,=.# )&-# %6-# *)&?-# .'C'=,%.# /0# %6-,&#
&-.8-(%,I-#,=%-&0-&-=(-#(/58*-B-."#;#&-(-=%#C,/,=0/&5)%,(.#.%'+7#/0#%6-#K).L#0)5,*7#
.'??-.%-+#%6)%#%6-.-#8&/%-,=.#<-&-#6/5/*/?/'.#%/#K).13A#%6-#*)&?-#.'C'=,%#/0#%78-#
999# .7.%-5."2L# 9=# 0)(%A# )**#/0# %6-# *)&?-# .'C'=,%.# 0&/5# %6-# %78-# 9# )=+# 999# .7.%-5.#<-&-#
8&/8/.-+#%/#C-*/=?#%/#)#.,=?*-A#*)&?-#K).13:*,N-#.'8-&0)5,*7"#K).13#(/=.,.%.#/0#)=#V:
%-&5,=)*#>W#='(*-).-#+/5),=#)=+#)#K:%-&5,=)*# &-?,/=# SK).13+>WT#(/=.,.%,=?#/0# 0/'&#









@'-# %/# %9-# 0).%# -A/*'%,/8# 5BC$DBE5).# .F.%-:.G# .%&'(%'&)**F# 9/:/*/;/'.# H&/%-,8.#
/0%-8# (/8%),8# A-&F# :,8,:)*# .-I'-8(-# 9/:/*/;F"# J9,.# 9):H-&.# /'&# )<,*,%F# %/#
'8+-&.%)8+# %9-# (/88-(%,/8.# </%9# ?,%9,8# )8+# <-%?--8# 5BC$DBE5).# .F.%-:."#
$%&'(%'&)*#<,/*/;F#,.#H)&%,('*)&*F#.',%)<*-#0/&#,+-8%,0F,8;#9/:/*/;FG#.'(9#).#<-%?--8#
%9-#8/?#'8,0,-+#5).K#9/:/*/;'-.#659)H%-&#27"#$%&'(%'&)*# ,80/&:)%,/8#H-&%),8,8;#%/#



















1!C#BQ#7-+,)# 1Q# 7B# 1!CO2;*# R$,>7)SD# ==# 7B# TO=@U2D# ==# 7B# C)=O@U2D########################
Q#7B#C);*# #





56-# !!"#$%## >-8-# :).# (*/8-+# ,8%/# %6-# <ML$5V12# <*).7,+1KP# :,%6# )# 5LX# <&/%-).-#
(*-)N)9*-#CV%-&7,8)*#O,.YV%)>#)8+#:).#<&/N,+-+#9I#B)*(/*7#J6,%-#RZ8,N-&.,%I#/0#$%#










<).# >-&0/&=-+# '.,:G# JKL# >/*@=-&).-# 8E/M)G-:9# ).# >-&# %C-# =):'0)(%'&-&D.#
,:.%&'(%,/:.# 8H)?*-#!"1#N9"#HC-#AB5#>&/+'(%.#<-&-#):)*@.-+#/:#1#O#<-,GC%PM/*'=-#
8<PM9#)G)&/.-#G-*.#(/:%),:,:G#3"!#=G#=Q61#-%C,+,'=#?&/=,+-#):+#%C-#LEN#0&)G=-:%.#
(/**-(%-+# ?@# G-*# -R%&)(%,/:# 8S,)G-:9# )((/&+,:G# %/# %C-# =):'0)(%'&-&D.# ,:.%&'(%,/:."#
HC-# 0&)G=-:%.# <-&-# +,G-.%-+# /M-&:,GC%# )%# 7T# UB# '.,:G# E(/F# ):+# $)*F# 8A&/=-G)9V#
0/**/<-+# ?@# AB5# >'&,0,()%,/:# 8S,)G-:9"# >W,.H-M# >*).=,+;32# <).# +,G-.%-+# '.,:G# %C-#
.)=-# -:X@=-.# 0/&# 7# C# )%# 7T# UB# ):+# <).# %C-:# ,:('?)%-+# <,%C# ()*0# ,:%-.%,:)*#
>C/.>C)%).-#8A&/=-G)9#0/&#1#C#0/**/<-+#?@#G-*#-*-(%&/>C/&-.,.#):+#-R%&)(%,/:"#HC-#
0&)G=-:%.# <-&-# *,G)%-+# ,:%/# %C-# >*).=,+# ?@# =,R,:G# )%# )# =/*)&# &)%,/# /0# 2Y1# ):+#
,:('?)%,:G#/M-&:,GC%#<,%C#H2#LEN# *,G).-# 8H)Z)&)9#)%#1[# UB"#HC-# .)=>*-.#<-&-# %C-:#
%&):.0/&=-+# ,:%/# (/=>-%-:%# LW!\# +,- ."/0# 8I,/*,:-9# ):+# %C-# LEN# -R%&)(%-+# ?@#
=,:,>&-># 8S,)G-:9"# HC-# (/:.%&'(%.# <-&-# .-]'-:(-+# %/# (/:0,&=# %C-# ,:.-&%# ,+-:%,%@#
8^NHB#I,/%-(C9"##
#
N# !"#$% &#'$#()"*(#%+,-.% &/'#%+0.%
# 1"#F:,%,)*#+-:)%'&)%,/:# 4_# 733#
# ;"#L-:)%'&)%,/:# 4_# 1!#
# 7"#A&,=-&#)::-)*,:G# !!# !#
# 2"#`R%-:.,/:# [_# 7!#
# !"#a,:)*#-R%-:.,/:# [_# 1;3#










&)9:#% 5;<=% -:>3/3?% )3@% '*")?#3#0/0% >A% !0><BC<;# 8N9# AB5# (@(*,:G# >)&)=-%-&.# 0/&# )=>*,0@,:G# %C-#
$./1231E6174# ):+# $./1231B# (/:.%&'(%."# $%->.# ;62# <-&-# >-&0/&=-+# 0/&# 72# (@(*-."# 8I9#








:4,%,)*# -@<&-..,/4# )4+# <'&,0,()%,/4# /0# $./1231# )4+# .-*-4/7-%6,/4,4-A*)8-**-+#
$./1231# B$./1231$-C-%D# E-&-# <-&0/&7-+# 8?# $6,&*-?# F&)6)7# BG4,>-&.,%?# /0# $%#
H4+&-E.D# E6,*.%# %6-# )'%6/&# -@<&-..-+# )4+# <'&,0,-+# )**# /%6-&# <&/%-,4."# I&/%-,4#
-@<&-..,/4#E).#).#+-%),*-+#,4#J6)<%-&#K"2"K#-@(-<%#-@<&-..,/4#E).#,4+'(-+#E,%6#3"!#
7C# :I5F"# I'&,0,()%,/4.# E-&-# ).# +-.(&,8-+# ,4# J6)<%-&# K"2"L# E,%6# %6-# 0/**/E,4;#
-@(-<%,/4."# 56-# 8'00-&.# '.-+# )&-# +-.(&,8-+# ,4# J6)<%-&# !"2"1=# %6-# (-**.# E-&-# *?.-+#
'.,4;#)# (-**#+,.&'<%/&# BJ/4.%)4%#$?.%-7.#M%+"D# )%#L3#NI$:=#K3# OJ#)4+# %6-# .-(/4+#9,A
)00,4,%?#(/*'74#E).#E).6-+#E,%6#K3#7C#:7,+)P/*-#BE).6#8'00-&#KD"#H++,%,/4)**?#%6-#






R<%,7,.)%,/4.#E-&-#<-&0/&7-+# ,4#6)4;,4;#+&/<.#E,%6#+&/<# .,P-.#/0# 1S1#TM=# 1SK#TM#
)4+# KS1# TM# )4+# )# &-.-&>/,&# ./*'%,/4# /0# !33# TM"# H**# <*)%-.# E-&-# .%/&-+# )%# &//7#
%-7<-&)%'&-"#56-#/<%,7,.-+#(&?.%)*.#/0#$./1231$-C-%#;&-E#,4#)#+&/<#/0#K#TM#<&/%-,4#













45-# 6&/%-,7# /0# (5/,(-# 8).# -96&-..-+# ,7# 13# :;# ('*%'&-# '.,7<# =2># ?@A>B# !"# $%&'# ).#
+-.(&,C-+# ,7# =5)6%-&# !"2">"# 45-# (-**.#8-&-# 5)&D-.%-+# ?2333# 9# <E# 13#:,7E# 2# F=B# )7+#
&-.'.6-7+-+# ,7# !33# G;# *H.,.# C'00-&# ?4)C*-# !"IB"# 45-# .):6*-.# 8-&-# *H.-+# /7# ,(-# CH#
./7,()%,/7# ?I# 9# 13# .# )%# 1!# :,(&/7.E# $/7,6&-6# 1!3E# J$AB# )7+# %5-# ./*'C*-# 0&)(%,/7#
(/**-(%-+#)0%-&#(-7%&,0'<)%,/7#?12E333#9#<E#13#:,7E#2#F=B"#45-#):/'7%#/0#K,.LM%)<<-+#
6&/%-,7# ,7# %5-# ./*'C*-# 0&)(%,/7# 8).# +-%-&:,7-+# CH# )'%/:)%-+# N,M)00,7,%H#




























,5('6)%-+#7,%8#9&/%-).-# 0/&#!#/&#13#:,5#9&,/&# %/#$;$<=>?@#)5)*A.,."#B/&# %8-# *)&C-<







=*)%-<*,P-# (&A.%)*.# /0# $./1231# )5+# $./1231$-Q-%# 7-&-# C&/75# ,5# 8)5C,5C# +&/9.# ).#
+-.(&,6-+#,5#G8)9%-&#!"2"2"#?*'%)&)*+-8A+-#D$,C:)E#7).#%8-5#)++-+#%/#%8-#&-.-&K/,&#
./*'%,/5#)%#)#0,5)*#(/5(-5%&)%,/5#/0#3"3!<3"1H#R#)5+#%8-#(/K-&.*,9#&-9*)(-+#/K-&#%8-#
&-.-&K/,&# %/# )**/7# K)9/'&# +,00'.,/5# /0# %8-# C*'%)&)*+-8A+-# ,5%/# %8-# (&A.%)*."# >0%-&# !#
:,5#%8-#(/K-&.*,9#7).#9*)(-+#/K-&#0&-.8#&-.-&K/,&#./*'%,/5#)5+#%8-#(&A.%)*.#:/'5%-+#
0/&# .(&--5,5C"# ;)%)# 7-&-# (/**-(%-+# ,5<8/'.-# )5+# 9&/(-..-+# '.,5C# L,)4"123# J8-#





S-+'(%,K-# :-%8A*)%,/5# /0# $./1231# 7).# ()&&,-+# /'%# ).# +-.(&,6-+# ,5# G8)9%-&# H"2"T#
-L(-9%#%8-#&-)(%,/5#7).#9-&0/&:-+#)%#&//:#%-:9-&)%'&-#'.,5C#%8-#6'00-&.#+-.(&,6-+#
,5# G8)9%-&# !"2"1"# S-+'(%,K-*A#:-%8A*)%-+# $./1231# D$./1231OA.Q-%E# )5+# $./1231$-Q-%#
D$./1231$-Q-%UOA.Q-%E# 7-&-# (/5(-5%&)%-+# %/# V# )5+# 13# :C#:O<1F# &-.9-(%,K-*AF# )5+#




(,%&)%-# 9W# !"HF# 3"1N# Q# >::/5,':# %)&%&)%-F# 3"11# R# O)'&A*+,:-%8A*):,5-# X</L,+-#
DO;>YEF#4"!N#Q#$/+,':#0/&:)%-E#)5+#7-&-#0&)C:-5%-+#,5%/#:,(&/(&A.%)*.#6A#:)5')*#
(&'.8,5C# 7,%8# )# 5--+*-# )5+# %8-5# K/&%-L,5C"# J8-# .--+.# 7-&-# +,*'%-+# ,5%/# )# 0,5)*#






9"4# F# $/+,'B# 0/&B)%-@"# A<-# (&C.%)*# ;).# (&C/M7&/%-(%-+# ,5# 7&-(,7,%)5%# (/5%),5,5D####
2"!#F#$/+,'B#0/&B)%-#N-0/&-#0*).<#(//*,5D#,5#*,O',+#5,%&/D-5"#K)%)#;-&-#(/**-(%-+#/5#
)#.,5D*-#(&C.%)*#)%#133#P#'.,5D#</B-#./'&(-#&)+,)%,/5"#A<-#+)%)#;-&-#7&/(-..-+#;,%<#
Q,)9#)5+# %<-# .%&'(%'&-# ./*?-+#NC#B/*-('*)&# &-7*)(-B-5%#;,%<#R<).-&MFS# ,5#R<-5,Q#




























(*-)5)@-#/0# %8-#>,.?;%)@# %8-#7&/%-,=# &-L',&-+#3"!#M#:)A*# )=+#13#N#@*G(-&/*# ,=# %8-#
7'&,0,()%,/=# 9'00-&.# %/# 7&-5-=%# 7&-(,7,%)%,/="# J0%-&# (*-)5)@-# %8-# 7&/%-,=# 4).#
.,@=,0,()=%*G#</&-#.%)9*-#)=+#%/*-&)%-+#)#9'00-&#4,%8#1!3#<M#:)A*#)=+#=/#@*G(-&/*O#




6/7&,$) !"*8) 9&,/2/:.(/01) .1;) :,-%(.''/%.(/01) 02) 3%0*45*") CJF#H-*# 0,*%&)%,/=# -*'%,/=#7&/0,*-# /0# $./1231#









































9,00&)(%,/7# 5)%%-&7# /0# %>-# /5%,4,.-+# (&<.%)*# '.,7?# .<7(>&/%&/7# &)+,)%,/7# 8@-)4*,7-# A32B#
9,)4/7+:"#8,,:#C*/.-&#D,-E#/0#%>-#+,00&)(%,/7#.5/%.#,7#%>-#@*)(F#&-(%)7?*-#/0#8,:"#
#
$./1231# E).# .(&--7-+# )?),7.%# .5)&.-# 4)%&,6# .(&--7.# )7+# .-D-&)*# (/7+,%,/7.#
5&/+'(-+# 5*)%-G.>)5-+# (&<.%)*."# ;7-# (/7+,%,/7# 5&/+'(-+# )# .*,?>%*<# %>,(F-&# (&<.%)*#
)4/7?.%# %>-#5*)%-.# %>)%#+,00&)(%-+# %/#H"2#I# &-./*'%,/7# ,7#>/'.-# 8J,?'&-#!"1#C:"#K>,.#
(&<.%)*# ?&-E# ,7#)# (/7+,%,/7#/0#3"1#L#M,(,7-#5N#O"3B#PQ#R#S=TLL=!!3#)7+#+,+#7/%#






















$,7(-# 7/# >/4/*/?'-.#E-&-# )D),*)@*-# 0/&# $./1231B#4/*-('*)&# &-5*)(-4-7%#E).# 7/%#
5/..,@*-#)7+#./#-65-&,4-7%)*#5>).,7?#'.,7?#.-*-7/4-%>,/7,7-G*)@-**-+#5&/%-,7#E).#
5'&.'-+# ,7.%-)+"# $./1231# (/7%),7.# .-D-7# 4-%>,/7,7-.B# %>/'?># %>-# 0,&.%# ,.# %>-#
!"#$%&'(%'&)*#$%'+,-.#/0#$./1231#
# 1!4#
,5,%,)%,56# &-.,+'-# 0&/7# %8-#9:# ;&/%-,5# )5+# ,.# %8-&-0/&-# *-..# *,<-*=# %/# >-# /&+-&-+"#
$./1231$-?-%#@).#-A;&-..-+#,5#BCD2#!"#$%&'#,5#7,5,7)*#7-+,)#.';;*-7-5%-+#@,%8#EFGH
.-*-5/7-%8,/5,5-#)5+#;'&,0,-+#).#>-0/&-#>=#$8,&*-=#I&)8)7"#?$#)5)*=.,.#/0#%8-#0,5)*#
.)7;*-# .8/@-+# )#7)..# ,5(&-).-# /0# DD3#J)K# (/&&-.;/5+,56# %/# %8-# ,5(/&;/&)%,/5# /0#
.-L-5#7-%8,/5,5-.# EM,6'&-# !"N# O# )5+#JG"# P/@-L-&K# %8-&-#@).# )5/%8-&# ;-)<# /0# %8-#
.)7-# 8-,68%# (/&&-.;/5+,56# %/# )# 7)..# +,00-&-5(-# /0# DQQ# J)K# -R',L)*-5%# %/# .-L-5#
.-*-5/7-%8,/5,5-# &-.,+'-.# ;*'.# )# 0'&%8-&# 2Q# J)"# $,5(-# %8-&-# @-&-# /5*=# .-L-5#
;/..,>*-#.-*-5/7-%8,/5,5-#&-.,+'-.#,5#%8-#;&/%-,5#,%#@).#5/%#;/..,>*-#%/#-A;*),5#%8,.#



























!"#$%&' ()*+' ' ,$%"-"./0"12' /23' .%450/66"5/0"12' 1-' 75189:87&;&0)' 567# 8-*# 0,*%&)%,/9# -*'%,/9# :&/0,*-# /0#
$./1231$-;-%# 0&/<# )# $':-&+-=># ?33# (/*'<9"# @)%)# :&/A,+-+# BC# $D,&*-C# 8&)D)<#
5E9,A-&.,%C#/0#$%#69+&-F.7"#5G7#$@$HI68J#)9)*C.,.#/0#%D-#0,9)*#.)<:*-#.D/F,9K#,%.#:'&,%C"#
5L7H5@7#;$# )9)*C.,.# /0# 5L7# $./1231# )9+# 5@7# $./1231$-;-%"# MD-# /B.-&A-+# )9+# -=:-(%-+#
<)..-.#)&-#,9+,()%-+#F,%D#%D-#*)%%-&#,9#:)&-9%D-.-."#5J7#N<)K-#/0#%D-#/:%,<,.-+#(&C.%)*#
/0# $./1231$-;-%"# 5O7# PH&)C# 0*'/&-.(-9(-# .()9# )(&/..# %D-# $-HQ# )B./&:%,/9# -+K-"# 587#




































































/7# Q-)G*,7-# R32A# N,)G/7+"# S9-# +)%)# O-&-# ?&/(-..-+# O,%9# TPU@333"# $%)%,.%,(.# )&-#
?&-.-7%-+# ).# )6-&)8-.# O9,*.%# .%)%,.%,(.# 0/&# %9-# 9,89-.%# &-./*'%,/7# .9-**# )&-# .9/O7# ,7#
?)&-7%9-.-."#
#
S9-# )7/G)*/'.# .,87)*# O).# )7)*K.-+# O,%9# $TVUW"1!B# N-.?,%-# %9-# +)%)# (/7%),7,78# )#
.%&/78# )7/G)*/'.# .,87)*# -X%-7+,78# %/#!@"!# ;# &-./*'%,/7# :Y,8'&-# !"I# L<A# ,%# O).# 7/%#
?/..,Q*-# %/# ?9).-# %9-# .%&'(%'&-# O,%9# $TVUW"# S9/'89# %9-&-# )??-)&-+# %/# Q-# %O/#
+,.%&,Q'%,/7.#/0#FF)**#6)*'-.#:Y,8'&-#!"I#Z<A#O9,(9#O/'*+#7/&G)**K#,7+,()%-#.,87)*#)7+#
7/,.-A#%9-#.,%-#/(('?)7(,-.#/0#%9-#9-)6K#)%/G#.'Q.%&'(%'&-#O-&-#*/O#:Y,8'&-#!"I#F<A#
-.?-(,)**K# 8,6-7# %9)%# %9-# L$M# O).# ?&-+,(%-+# %/# (/7%),7# .-6-7# .-*-7/G-%9,/7,7-#
&-.,+'-."# [/# +,6-&8-7(-# O).# /Q.-&6-+# Q-%O--7# %9-# %O/# -7)7%,/G/&?9.# /0# %9-#












.,%-.# G-&-# */G"# 5A7# H/# .-E)&)%,/:# G).# /B.-&D-+# B-%G--:# %9-# %G/# -:):%,/;/&E9."#




N9).,:<# G).# %9-:# )%%-;E%-+# '.,:<# N9-:,=# 6'%/$/*D-V# G9,(9# +,+# 0,:+# )# ./*'%,/:#
(/:%),:,:<# %9&--# .-*-:,';.# */()%-+# G,%9# /(('E):(,-.# W3"X"# 89-# (9),:# %&)(,:<# G).#
E//&#).#E)&%#/0#6'%/$/*D-#):+#./#(9),:#%&)(,:<#G).#E-&0/&;-+#G,%9#N9-:,=#6'%/@',*+#
'.,:<#%9-#-*-(%&/:#+-:.,%F#;)E#0&/;#YS$ZL[S"#89-#+-:.,%F# ,:#%9,.#;)E#G).#(*-)&-&#
%9):# %9)%# /0# %9-# 6'%/$/*D-# /'%E'%# ;)E"# C9),:# %&)(,:<# BF# 6'%/@',*+# G).# *)&<-*F#
.'((-..0'*#):+#%9-#(9),:#G).#%9-:#;):')**F#(/&&-(%-+"#6%#%9,.#E/,:%#,%#B-();-#(*-)&#







0/&# %@-# B5%-&;,9)*# +/;),9# CD,E'&-# !"2# F# )9+# G<"# H@-# :5%-&;,9)*# +/;),9.# =-&-#
)&&)9E-+# ,9#%=/5+,;-9.,/9)*#)&&)A.#=,%@#)# *)&E-#>/,+#C!!3#I<#.-J)&)%,9E#%@-#)&&)A.#
CD,E'&-# !"2# :<"# H@-# )?.-9(-# /0# )9A# (&A.%)*# (/9%)(%.# ?-%=--9# %@-# )&&)A.# .'EE-.%-+#
%@)%# %@-# B5%-&;,9)*# +/;),9# =).# J&-.-9%# ,9# %@-# (&A.%)*# ?'%# =).# 9/%# >,.,?*-# ,9# %@-#
-*-(%&/9# +-9.,%A"# $K$5LFMN# )9)*A.,.# /0# %@-# (&A.%)*.# (/90,&;-+# %@)%# /9*A# 0'**5*-9E%@#
J&/%-,9# =).# J&-.-9%# CD,E'&-# !"2# K<"# M,>-9# %@-# J/.,%,/9# /0# %@-# B5%-&;,9'.# /0#






























@A%-&=,;)*# +/=),;# );+# ./# .-:-&)*# )77&/)(9-.# 6-&-# )%%-=7%-+# %/# =,%,<)%-# %9,."#
$./1231B%-&=# ';+-&6-;%# &/';+.# /0# &-0,;-=-;%# .,;(-# )#=/&-# )(('&)%-#=/+-*#=,<9%#
,=7&/:-#%9-#-*-(%&/;#+-;.,%?#/0#%9-#@A%-&=,;)*#+/=),;"#C/6-:-&D#='*%,7*-#&/';+.#/0#
&-0,;-=-;%#+,+#;/%# ,=7&/:-# %9-#+-;.,%?# 0/&# %9-#@A%-&=,;)*# +/=),;#);+# %9-#EFE0&--#
:)*'-.# 7*)%-)'-+"# $./1231B%-&=# 6).# '.-+# ).# %9-#=/+-*# 0/&#=/*-('*)&# &-7*)(-=-;%#
6,%9#G9).-&1!1#'.,;<#8/%9#%9-#;)%,:-#);+#);/=)*/'.#+)%).-%."#H9-#BA%-&=,;)*#+/=),;#
6).#0/';+#-).,*?#IJA.(/&-K#23D#LLMK#11!3N#8'%#;/#,;%-&7&-%)8*-#-*-(%&/;#+-;.,%?#6).#







8-# ,;+,()%,:-# /0# 8)+#=/+-**,;<#6,%9,;# $./1231B%-&="# E-.,+'-.# 1A123D# 1!3A1!RD# 144A
1T4D# R12ARR1# );+# UR1AURU# (/'*+# ;/%# 8-#=/+-**-+"# H9-# &-0,;-=-;%# );+# :)*,+)%,/;#
.%)%,.%,(.#)&-#7&-.-;%-+#,;#H)8*-#!"!"#
#
V# !"#$%"&"%'# ()*+,-+("."'/ W# .*012*3$'4/1525&"'"2/ 6507"/
# E6/&>FE0&--# 3"R4F3"RS# # B*).9.(/&-D#)**#)%/=.# 12"2U#
# Q-);#WA:)*'-#IXRN# # # G//&#&/%)=-&.#IYN# U"2#
# #####V**#)%/=.# !3# # E)=)(9);+&);#/'%*,-&.#IYN# 3"3#
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Figure 4 Gene content similarity between type I-E and type III-A systems and structural organization of large subunits of different
CRISPR-Cas systems of type I and III. A. Genes in the operons for I-E and III-A subtypes are shown by arrows with size roughly proportion to
the size of the corresponding gene. Homologous genes are shown by the arrows of same color or hashing. RAMPs are shown by pink or pink
hashing. Solid lines connect genes for which homology can be confidently demonstrated, and dashed lines connect genes for which homology
is inferred tentatively. The Cascade complex subunits are shown by square brackets. Two previously published domain annotations are included
for comparison. B. Domain organization of large subunits of different type I and III CRISPR-Cas systems. Domain size is roughly proportional to
correspondent sequence length. The letter “S” marks the regions that could be homologous to small subunits of Cascade complex encoded as
separated genes in Type III systems, I-E subtype and some systems of I-A subtype.
Makarova et al. Biology Direct 2011, 6:38
http://www.biology-direct.com/content/6/1/38
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unaffected by the presence of ASIC2b (Fig. 3, D and F, respec-
tively), whereas the sensitivity of ASIC2a!3 was intermediate
to either homomeric channel (Fig. 3F).
Overall, desensitization kinetics of ASIC2a!2b and
ASIC2b!3 were identical to the kinetics of homomeric ASIC2a
and ASIC3, respectively (p" 0.05) (Fig. 4, F and G). The !desens
values of ASIC2a!3 were independent on the proton concen-
tration (p " 0.54) (Fig. 4G). At pH50 ASIC2a!3 desensitized
significantly faster than ASIC2a (p # 0.01); however, although
desensitization of ASIC2a!3 always appeared faster than
ASIC3 (Fig. 4G), this difference did not reach significance.
Interestingly, the desensitization phase of ASIC2a!3 was
masked at pH " 4.5 due to activation of a prominent sustained
current (see below).
Whole-cell currents measured from cells co-expressing
ASIC2a!2b maintained a level of sustained current of 17% at
FIG. 1. Acid-evoked currents of homo- and heteromeric ASICs. Shown are representative current traces that illustrate the responses of
indicated ASIC subunits to low pH. Cells were bathed in extracellular Na-Ringer, and currents were evoked by rapid application of a test solution
of pH 4.0 as indicated by the bar. Note the different current scale bars. A–E, traces recorded from cells expressing homomeric ASICs. F–I, traces
from cells expressing ASIC1a in combination with one other subunit. J and K, traces from cells expressing ASIC1b in combination with one other
subunit. L–O, traces obtained from dual expression of ASIC2a, ASIC2b, and ASIC3. P–R, traces from triple expression experiments:
ASIC1a!2a!3, ASIC1a!2b!3, and ASIC1b!2a!3.
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Two Arginine Residues in the Extracellular Loop Are Involved in the
Alkaline Sensitivity of Human ASIC3a Channel. Our data strongly
suggested that the sensitivity of hASIC3a to alkaline pH was di-
rectly supported by the channel itself. Therefore, we looked at the
structural elements involved in the alkaline sensitivity of the
channel using a site-directed mutagenesis approach (Fig. 5). An
ASIC3 chimeric channel containing rat ASIC3 transmembrane
and intracellular domains and human ASIC3a extracellular loop
showed alkaline sensitivity (Fig. 5A, Upper); whereas, a human
ASIC3a chimera containing the rat ASIC3 extracellular loop did
not (Fig. 5A, Lower). The human and rat ASIC3 extracellular
loops share a high percentage of homology (∼90%), and we fo-
cused our attention on two arginine residues (R68 and R83) that
are only present in the extracellular loop of the human isoforms
(Fig. 5B). The arginine 68 is located at the junction between the
transmembrane domain 1 (TM1) and the extracellular loop,
a critical hydrophobic location that suggested an unusual pKa for
this arginine, which could be involved in alkaline pH sensing,
similarly to what has been shown for two-pore domain alkali-
activated K+ channel (33). Arginine 83 is located at the junction
between β1 and β2 linkers of the palm domain, a region that has
recently been shown to control the sustained opening of ASIC1
(34). Single (R68G or R83Q) or dual (RR68,83GQ) mutations of
those two arginine residues signiﬁcantly reduced the amplitude of
the alkaline-induced sustained current, compared with the wild-
type hASIC3a current (Fig. 5 C and D). The transient current
amplitudes at pH5.0 were not different between the mutants and
the wild-type channels (Fig. 5E), showing a speciﬁc effect of the
two arginine residues on the alkaline-induced current. Introducing
these two arginine residues within the extracellular loop of the rat
channel (GQ69,84RRmutant) induced a small alkaline sensitivity
in 11 out of the 26 oocytes tested, although this mutant did not
fully reconstitute the human properties (see Fig. S4A). These
results demonstrate that the sustained activation of hASIC3a in
response to extracellular alkalization is fully supported by the
extracellular loop where the R68 and R83 residues are playing an
important role.
Finally, it was possible to strongly reduce the acid sensitivity of
the hASIC3 channel without affecting the alkaline-induced cur-
rent (see Fig. S4B) by mutating two amino acids in the post-TM1
region that are crucial for H+ gating (35) (hASIC3-HH71,72NN).
Thus, our data suggest that it is possible to partially dissociate
both functioning modes by mutating either arginines 68 and 83 or
histidines 71 and 72.
Alkaline Current of hASIC3a Is Modulated by Calcium, Lactic Acid, and
Arachidonic Acid. The alkaline sensitivity of hASIC3a is only ob-
served in about half of the cells, suggesting the existence of
regulatory mechanisms. We have evaluated the effect of several
factors previously described that modulate rat ASIC3, including
extracellular calcium, lactic acid, and arachidonic acid, on the
alkaline sensitivity of hASIC3a. Extracellular calcium ions have
been involved in the gating mechanism of ASIC3 by protons
(36). We thus tested whether the alkaline sensitivity of hASIC3a
was dependent on external calcium concentration. Changing the
extracellular calcium concentration, from normal (2 mM) to high
(10 mM) or low (1 μM) levels, did not induce any alkaline sen-
sitivity in cells only displaying the conventional hASIC3a current;
i.e., not sensitive to external alkaline pH (n = 5). However, the
basal hASIC3a current recorded at pH 8.0 from cells displaying
the alkaline sensitivity was modulated by changes of external
calcium concentration (Fig. 6A). It was increased in low calcium
conditions whereas it was reduced at high calcium concen-
trations, similarly to what was previously described for acid-in-
duced rat ASIC3 current (36). Lactic acid, a potentiator of the
rat ASIC3 current, which acts by lowering the concentration of
Ca2+ and Mg2+ ions (17), also increased the alkaline-induced
hASIC3a current (Fig. 6B).
Arachidonic acid (AA) is awell-knownmediatorof inﬂammation,
which potentiates rat ASIC3 current (16, 19, 36). Over all of the
hASIC3a-expressing F-11 cells tested (n=37), 14 initially displayed
an alkaline-induced sustained current when external pH was
switched from 7.0 to 8.0 (seeMaterials and Methods). This alkaline-
sensitive current was always potentiated by AA, as indicated by the
effect on the basal current recorded at pH 8.0 (Fig. 6C, Left). The
effect of AA was also observed in Xenopus oocytes injected with
hASIC3a (Fig. S5B), butwas absent in F-11 cells transfectedwith rat
ASIC3 (Fig. 6C, Right). It is interesting to note that AA alone was
sufﬁcient to trigger a current at physiological pH 7.4 from cells dis-
playing the alkaline sensitivity (Fig. 6D), and this AA-induced
hASIC3a current was inhibited by APETx2 (Fig.6D, Inset). More-
over, AA was also able to induce, or unmask, the alkaline sensitivity
in 10 of the 23 remaining cells (43%) that initially did not display
an alkaline-induced current in response to a pH switch from 7.0 to



















































Fig. 5. Mapping of the structural elements involved in the alkaline sensi-
tivity of hASIC3. (A) Effect of external alkalization (from pH 6.6 to 8.0) on
oocytes expressing the rat ASIC3 chimera containing the extracellular loop of
hASIC3a; (Upper) rASIC3-hLoop3 or the human ASIC3a chimera containing
the extracellular loop of rASIC3; (Lower) hASIC3-rLoop3. (B) Schematic rep-
resentation of two ASIC subunits in a functional channel. The two arginines
only present in human ASIC3, and not found in rat, are indicated. Adapted
by permission from ref. 4 (Copyright 2007, Macmillan Publishers Ltd). (C )
Effect of external alkalizatio on hASIC3a wild type and mutants. (D) Bar
graph representing the effects observe in (C) (*P < 0.05 and ***P < 0.001,
one-way ANOVA followed by Tukey’s post hoc test). (E) Bar graph of the
amplitudes of the pH 5.0–induced transient currents measured from oocytes
expressing the wild-type or the arginine mutants described in C and D.
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Current Opinion in Structural Biology
The P2X4 receptor and ASIC1a harbor cavities, vestibules and lateral fenestrations. (a) Surface representation of the P2X4 receptor color coded by
electrostatic potential. ‘HOLE’ representation [35] of the apo, closed (b) and ATP-bound, open (c) states of the P2X4 receptor, showing a large pore in
the ATP-bound state. (d) Surface representation of ASIC1a also colored by electrostatic potential. ‘HOLE’ representations of ASIC1a in the low pH
desensitized state (e), the high pH PcTx1 bound state (f) and the low pH PcTx1 bound state, illustrating a large non-selective pore in (f) and small,
asymmetric and selective pore in (g). In both the P2X4 receptor and ASIC1a ions enter and exit the pore from the extracellular site of the membrane by
way of lateral fenestrations. For both channels a possible ion pathway along the 3-fold axis within the extracellular domain remains occluded.
www.sciencedirect.com Current Opinion in Structural Biology 2013, 23:1–8
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to Ala or Ser (Supplementary Fig. 17) demonstrates that Leu 440 is
crucial to the formation and function of the ion channel pore on the
basis of the reduced activity of the mutants compared to the parent
construct.
Ion-binding sites
To map ion-binding sites we soaked crystals in solutions containing
Cs1, a voltage-dependent, open channel blocker of the D13 construct
(Supplementary Fig. 18). Inspection of anomalous difference electron
density maps revealed a site (6–12s) in each subunit, common to the
high- and low-pH D13–PcTx1 crystal forms and located at the inter-
face between the wrist and the extracellular end of TM1 (Fig. 5a and
Supplementary Fig. 19). In both crystal forms, the backbone carbonyl
oxygens of Leu 71, Tyr 72, Pro 287 and Trp 288 coordinate Cs1
(Fig. 5b). Interestingly, the three crystallographically independent
Cs1 sites in the C2 structure vary in strength, with subunit C having
the weakest signal, thus indicating that the binding of ions to these
sites is influenced by the variation in TM1/wrist conformations
between subunits. Because Cs1-soaking experiments with crystals of
the desensitized state failed to reveal ion binding to this site, and TM1
(subunit C) in the low-pHD13–PcTx1 state harbours the weakest Cs1
site, we suggest the occupancy of the site is state-dependent, with ion
binding f voured when the pore i in an open stat , augmenting int r-
actions between Tyr 72 and Trp 288.
We identified two Cs1 sites in the electrostatically negative mouth
of the pore, near Asp 433 in the C2 structure (Fig. 5c, d), residu
implicated in stabilization of the open state yet not crucial to ion
selectivity50. Ions at these sites are approximately 5 A˚ from the closest
protein residues, consistent with the notion that they are low-affinity,
transiently occupied cation sites bound by water-mediated contacts.
We did not observe anomalous difference density features deeper
into the pore, perhaps because the hydrophobic pore is devoid of
favourable binding sites and the structural analysis was carried out
in the absence of a membrane potential.
Mechanism
We used PcTx1 to stabilize open states of the D13 construct at high
and low pH. Comparison of the open state and desensitized state
structures defines the upper palm and knuckle as a structural scaffold
and the lower palm as a conformationally flexible, proton-sensitive
domain at the core of ion channel gating (Supplementary Fig. 7). The
finger and thumb domains flank the palm domain, harbour binding
sites for protons and PcTx1, and modulate movements of the lower
palm domain by alterations in intersubunit contacts. In the open
conformations, the subunit interface between the thumb and the palm
domain separates while the extracellular and transmembrane domain
interface forming the extracellular vestibule expands. The presence of
a modulator, such as PcTx1, precludes ‘collapse’ of the thumb–palm
subunit interface to a desensitized state conformation. hemotions of
the lower palm domain converge at the wrist region, inducing radial
and rotational movements of the transmembrane domains, gating the
ion channel (Fig. 6 and Supplementary Fig. 20).
Conclusion
Our functional and structural studies of the chicken ASIC1a complex
with PcTx1 at two proton concentrations provide new insights into
how the movements of the multiple domains of ASICs are coupled to
ligand- and pH-dependent gating. Channel opening is correlated to
the expansion of the extracellular vestibule and to rearrangements at
subunit interfaces, movements coupled to the ion channel pore by the
direct connections of extracellular b-strands to the transmembrane
a-helices and also by the non-covalent c ntacts between the thumb
and wrist region, a previously unrecognized site of cation binding in
the open state. The non-selective and Na1-selective states of the ion
channel pore illustrate how transmembrane helices can rearrange to
form a large, non-selective pore at high pH and a small, asymmetric
and Na1-selective channel at low pH. Together, these studies
























Figure 5 | Cs1 binding sites. a, Anomalous difference electron density map
contoured at 3.5s. The low-pH complex is in ribbon representation. Caesium
sites in the outer pore region are labelled Cs1 and Cs2. b, Close-up view of the
Cs1 site in thewrist region. Top, electrostatic potential contoured from220 kT
(red) to120 kT (blue). Bottom, Cs1 coordination by backbone carbonyl
oxygens. Themain chain is drawn as sticks. c, d, Close-up view ofCs1 sites near
Asp 433 shown in ribbon and stick representation (c) and solvent-accessible








Figure 6 | Schematic representation of gating. a, The extracellular vestibule
in the closed, desensitized state structure adopts a contracted conformation.
b, In the open pore conformation the vestibule occupies an expanded
conformation, stabilized by the thumb domain. The wrist region, in turn,
couples the conformational changes of the extracellular domain to the
transmembrane domains (red cylinder) of the ion channel pore.
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The P2X4 receptor and ASIC1a harbor cavities, vestibules and lateral fenestrations. (a) Surface representation of the P2X4 receptor color coded by
electrostatic potential. ‘HOLE’ representation [35] of the apo, closed (b) and ATP-bound, o en (c) states of the P2X4 receptor, showing a large pore in
the ATP-bound state. (d) Surface representation of ASIC1a also colored by electrostatic potential. ‘HOLE’ representations of ASIC1a in the low pH
desensitized state (e), the high pH PcTx1 bound state (f) and the low pH PcTx1 bound state, illustrating a large non-selective pore in (f) and small,
asymmetric and selective pore in (g). In both the P2X4 receptor and ASIC1a ions enter and exit the pore from the extracellular site of the membrane by
way of lateral fenestrations. For both channels a possible ion pathway along the 3-fold axis wi hin the extrac llular domain remains occluded.
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oocytes expressing a constitutively open potassium channel
(IRK1). Application of a solution where the impermeant Na!
ions were partially replaced by the permeant K! ions changed
the current amplitude with a time constant of 170" 30ms (five
oocytes) similar to peptide activation of HyNaC2/3. Hence,
Hydra-RFamides induced currents without any apparent delay,
suggesting that the speed of activation by peptides of
HyNaC2/3 was limited only by solution exchange and not by
some additional diffusion-based process that would have been
expected if a second messenger cascade were involved in acti-
vation of HyNaC2/3.
We did several controls to further exclude indirect activation
of HyNaCs. First, we activated a protease-activated receptor
that is endogenous to oocytes by applying 10–100 !M trypsin;
protease-activated receptor activation raises the intracellular
concentration of Ca2! (21), which could be monitored by a
transient inward current due to activation of the Ca2!-acti-
vatedCl# channel of oocytes. Second,we increased the concen-
tration of cAMP in oocytes by simultaneously applying isobu-
tyl-methylxanthine (IBMX; 1mM) and forskolin (50!M); IBMX
inhibits phosphodiesterase and forskolin activates adenylate
cyclase. Bothmaneuvers could not activate anyHyNaC-specific
current. Third, we inhibited G protein signaling by injection of
23 nl of guanosine 5$-["-thio]diphosphate (50 mM) in oocytes.
Injection of guanosine 5$-["-thio]diphosphate reduced the
protease-activated receptor-induced chloride current by 50%
but had only a negligible effect onHyNaCcurrents (not shown).
Fourth, because some effects of RFamides are mediated by
opiate receptors, we inhibited opiate receptors by applying
0.5 mM naloxone. Naloxone had no effect on peptide-acti-
vated HyNaC currents. In summary, therefore, our results
suggest that Hydra-RFamides I and II directly activate
HyNaC2/3 by binding to the channel.
Replacing extracellular Na! by Li! or K! did not strongly
affect the current amplitude (Fig. 4D), suggesting a channel that
does not select between monovalent cations; replacing Na! by
N-methyl-D-glucamine! abolished inward currents (not
shown). The reversal potential was close to 0 mV (Fig. 4E),
confirming that HyNaC2/3 is an unselective cation channel.
Amiloride inhibited the current only at high concentrations:
IC50 was 540 " 40 !M ("S.E., seven oocytes; Fig. 4F). Thus,
HyNaC2/3 has pore properties that are different from other
members of the DEG/ENaC gene family. We confirmed that
the current induced by theHydra-RFamideswas indeed perme-
ating through theHyNaC2/3 pore bymaking amutationwithin
the putative selectivity filter (22): we exchanged glycine 444 by
a serine in themiddle of predicted transmembrane domain 2 of
HyNaC3 (Fig. 1). Co-expression of this mutant channel with
wild-type HyNaC2 significantly (p % 0.01; t test) reduced the
inward current carried by K! and shifted the reversal potential
by &20 mV in the positive direction (Fig. 4G). Thus, this pore
mutation changed the selectivity of the channel, confirming
that HyNaC3 indeed contributes to the ion pore. This result
shows thatNa! selectivity is not a common, primitive feature of
members of this gene family.
Our results show that theDEG/ENaCgene family contains at
least two members that are directly gated by peptides, FaNaC
and HyNaCs. These two members are on different branches of
FIGURE 4. Electrophysiological characterization of the HyNaC2/3 hetero-
mer.A, top, sequences of theHydra-RFamide neuropeptides; pQ represents a
pyro-Glu. Identical amino acids are highlighted with shaded boxes. Bottom,
currents elicited by Hydra-RFamides in Xenopus oocytes injected with
HyNaC2 and 3. B, concentration response curve for Hydra-RFamides I and II.
C, repeated activation of HyNaC2/3 with Hydra-RFamides led to decreased
response; in the example shown, 50!MHydra-RFamide I was used.D, replac-
ing Na! by Li! or K! in the bath did not significantly change the current
amplitude. Error bars represent S.E. (six oocytes). The composition of the bath
solutionwas as follows (inmM): 140 NaCl (or LiCl or KCl), 1.8 CaCl2, 1MgCl2, 10
HEPES;HyNaCwasactivatedwith30!MHydra-RFamide I. E, voltage ramps for
oocytes expressingHyNaC2 and3before (#) andduring (!) applicationof 50
!M Hydra-RFamide I. The composition of the bath solution was as in panel D.
F, concentration response curve for the inhibition of the HyNaC current by
amiloride. Results are from seven oocytes, except for the data point at 5 mM,
which is from three oocytes. G, top, sequence alignment of the second puta-
tive transmembrane domain of HyNaC2 and 3 and of rat ASIC1a and #ENaC;
thepositionof theglycine exchangedbya serine inHyNaC3 is indicatedby an
arrow. Bottom, co-expressing wild-type HyNaC2 with mutant HyNaC3 G444S
significantly (p% 0.01; two-tailed t test) reduced the relative amplitude of the
K! current compared with wild-type HyNaC3 (left). Error bars represent S.E.
(twelve oocytes). The reversal potential was shifted by&20 mV to more pos-
itive potentials (right); the curves shown have been obtained by subtracting
the current before peptide application from the current duringpeptide appli-
cation (50!M Hydra-RFamide I). The composition of the bath solution was as
follows (in mM): 140 NaCl (or LiCl or KCl), 0.1 flufenamic acid, 10 HEPES.
A Peptide-gated Ion Channel fromHydra
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Figure S2:  FSEC analysis.  a, b, FSEC profiles for C- and N-terminally EGFP-tagged chicken 
ASIC1 and ?ASIC1 constructs, respectively.  Whole cells were solubilized in phosphate buffered 
saline containing 20 mM n-dodecyl-?-D-maltoside (DDM) and protease inhibitors for 1h and the 
supernatant was loaded onto a Superose 6 10/300 column equilibrated with 20 mM Tris (pH 8.0), 
150 mM NaCl and 1 mM DDM.  FSEC experiments were carried out as described earlier (Kawate 
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SUMMARY
The prokaryotic clusters of regularly interspaced
palindromic repeats (CRISPR) system utilizes ge-
nomically encoded CRISPR RNA (crRNA), derived
from invading viruses and incorporated into ribonu-
cleoprotein complexes with CRISPR-associated
(CAS) proteins, to target and degrade viral DNA or
RNA on subsequent infection. RNA is targeted by
the CMR complex. In Sulfolobus solfataricus, this
complex is composed of seven CAS protein subunits
(Cmr1-7) and carries a diverse ‘‘payload’’ of targeting
crRNA. The crystal structure of Cmr7 and low-resolu-
tion structure of the complex are presented.
S. solfataricus CMR cleaves RNA targets in an endo-
nucleolytic reaction at UA dinucleotides. This activity
is dependent on the 8 nt repeat-derived 50 sequence
in the crRNA, but not on the presence of a proto-
spacer-associated motif (PAM) in the target. Both
target and guide RNAs can be cleaved, although a
single molecule of guide RNA can support the degra-
dation of multiple targets.
INTRODUCTION
The CRISPR system has recently come to light as a complex
mechanism of cell-mediated antiviral immunity (see Horvath
and Barrangou, 2010; Karginov and Hannon, 2010; Marraffini
and Sontheimer, 2010a for recent reviews). CRISPRs are ge-
nomically encoded arrays of short ‘‘spacer’’ sequences (20–
72 bp, depending on the species), each flanked by a repeat
sequence with an average length around 25–30 nt. CRISPR
arrays are transcribed by the cellular RNA polymerase and
processed to generate small crRNAs by nucleolytic cleavage
within the repeat sequences (Brouns et al., 2008; Carte et al.,
2008; Deltcheva et al., 2011). Processed crRNAs are utilized
by a variety of CRISPR-associated (CAS) protein complexes
as a guide RNA to target (and degrade the nucleic acid of)
invading genetic entities with complementary nucleic acid
sequences. This defensive ‘‘interference’’ process works in
tandem with an adaptive ‘‘capture’’ process that allows the
incorporation of new spacer sequences derived from viruses
into the genomic CRISPR arrays.
The viral DNA sequences that become incorporated into
CRISPR arrays are known as ‘‘protospacers’’ (Horvath et al.,
2008). Protospacers are derived from both coding and noncod-
ing regions of viral genomes, suggesting that the viral DNA,
rather than RNA, is targeted by the process that captures new
spacers (Horvath et al., 2008; Shah et al., 2009). Examination
of the sequence context of protospacers revealed the presence
of a conserved ‘‘protospacer-associated motif’’ (PAM) consist-
ing of a di- or trinucleotide signature, immediately adjacent to
the protospacer sequence (Bolotin et al., 2005; Deveau et al.,
2008; Horvath et al., 2008; Mojica et al., 2009). The presence
of a PAM is important for the recognition and restriction of
invading mobile DNA elements (Deveau et al., 2008; Gudbergs-
dottir et al., 2011).
CAS protein complexes have recently been classified into
three main subtypes (Makarova et al., 2011b). In Escherichia
coli, the type I-E complex, commonly known as ‘‘CASCADE,’’
consists of five protein subunits (CasA-E). CASCADE processes
CRISPR transcripts into!57 nt crRNAs and uses them to recog-
nize invading viral DNA, which is subsequently cleaved by Cas3
(Brouns et al., 2008). A similar complex (type I-A) with several
conserved subunits has been described in Sulfolobus solfatari-
cus (Lintner et al., 2011). Many archaea and some bacteria
also encode a type III-B system, known as the CMR complex
(Haft et al., 2005). In the euryarchaeon Pyrococcus furiosus,
the Cmr1-6 proteins have been purified as a complex that uses
crRNA to target RNA (presumably viral mRNA in vivo), cleaving
it with a molecular ruler mechanism guided by the 30 end of the
crRNA (Hale et al., 2009).
Here, we report the purification and characterization of the
CMR complex from S. solfataricus. There are seven subunits,
comprising Cmr1-7 and a crRNA component. Deep sequencing
reveals a biased composition for the crRNA, which is largely
derived from 2 of the 6 CRISPR loci. The crystal structure of
the Cmr7 subunit has been solved and consists of a protein
fold with a conserved surface that may mediate molecular
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interactions. The EM structure of the full CMR complex and
a defined subcomplex are presented. We demonstrate that
S. solfataricus CMR (SsoCMR) utilizes a sequence-dependent
RNA cleavage mechanism without a molecular ruler.
RESULTS
Purification of the CMR Complex from S. solfataricus
The native CMR complex was purified from S. solfataricus using
four sequential column chromatography steps (heparin, gel
filtration, MonoS, and MonoQ). At each stage, column fractions
were checked for the presence of the Cmr7 subunit by ‘‘dot
blot’’ with a specific polyclonal antibody. SsoCMR copurified
with the cellular RNA polymerase through the first three columns
and was separated by the final anion exchange step (Figure 1A).
The purified complex contained seven subunits corresponding
to the products of genes sso1986 through sso1992. Subunits
1–6 were judged present at a 1:1 stoichiometry; densitometric
analysis suggested that the Cmr7 subunit was present at a stoi-
chiometry of three dimers in each complex (Figures 1 and S1).
This was consistent with an overall size for the complex of
415 kDa (or 430 kDa including the RNA component), explaining
the copurification on gel filtration with the 410 kDa RNA poly-
merase. The presence of RNA, with a variable fragment size
centered on 46 nt, was confirmed (Figure 1C). This was in
good agreement with the size of the crRNA species isolated
from P. furiosus CMR (PfuCMR) (Hale et al., 2009), consistent
with the presence of a spacer sequence of variable length with
a CRISPR repeat-derived 8 nt tag at the 50 end. By expressing
Figure 1. Purification of the CMR Complex of
S. solfataricus
(A) UV trace showing fractions eluting from final MonoQ
column, with CMR and RNAP complexes resolved.
(B) SDS-PAGE analysis of fractions from MonoQ column,
showing separation of RNAP (fraction 30) from the
7-subunit CMR complex.
(C) Denaturing gel electrophoresis of end-labeled nucleic
acid reveals the presence of RNA copurifying with the
CMR complex. The size range centered on 46 nt corre-
sponds to a spacer with an 8 nt repeat-derived 50 tag.
(D) Comparison of native and tagged versions of the CMR
complex purified from S. solfataricus. Both tagged and
untagged versions of Cmr7 are apparent, reflecting its
higher stoichiometry in the complex.
(E) Mapping of Cmr1–7 onto the gene locus sso1986 to
sso1992.
subunits (Cmr7 or Cmr3) of SsoCMR with a
polyhistidine tag in S. solfataricus, the intact
complex could be isolated by incorporating an
affinity chromatography step (Figure 1D).
RNA Content of the CMR Complex
To determine the specific characteristics of
the RNA component of SsoCMR, isolated
RNA was cloned and deep-sequenced. We
mapped 1.88 million sequence reads of 36 nt
length onto the S. solfataricus spacers (Table S1). Analysis of
the start and stop positions of the sequence reads for a subset
of highly represented spacers from the A and D loci revealed
the presence of sequence corresponding to the 50 tag derived
from the CRISPR repeat, with a clear demarcation at the eighth
nucleotide, which corresponds to the site of cleavage by
Cas6 (Carte et al., 2008; Lintner et al., 2011) (Figure S2). The 30
ends of the sequenced RNA were more variable. Some spacers
such as A2 and D43 displayed a short 30 handle, while others
appeared to have very little repeat-derived sequence at the 30
end. Overall, this fits the suggestion that crRNA is processed
by the Cas6 endoribonuclease followed by exonucleolytic
digestion of the 30 end (Hale et al., 2009). By contrast, crRNA
isolated from the S. solfataricusCASCADE complex still includes
the 30 repeat-derived sequence (Lintner et al., 2011), suggesting
that crRNAs are differentially processed depending on their
ultimate destination in CASCADE or CMR.
S. solfataricus P2 has six CRISPR loci, denoted A–F, ranging
from 8 to 103 repeats in length (Lillestøl et al., 2006). Whole-
genome transcription data suggested that loci A, B, C, and D
are all highly transcribed, while E and F are very weakly tran-
scribed (Wurtzel et al., 2010). Examples of spacers derived
from all six loci were detected in the CMR complex, but the
distribution was highly biased. The majority of CMR-bound
crRNAs were derived from locus D, followed by locus C, with
significant underrepresentation from the other four loci (Fig-
ure 2). Within a locus, spacer representation in the CMR com-
plex was highly variable, with numbers of sequenced crRNAs
from adjacent spacers frequently differing by several orders of
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magnitude (Figure 2). In particular, one spacer (D63) accounted
for 45% of the sequence reads, and the top ten spacers ac-
counted for 79% of the total reads mapped to spacers (Table
S2). Reverse transcripts of CRISPR arrays have been detected
in Sulfolobus species (Lillestøl et al., 2009), but their signifi-
cance remains unclear. Only 209 RNAs corresponding to
reverse transcripts were sequenced, corresponding to 0.01%
of the total (Table S1).
The Crystal Structure of Cmr7
The crystal structure of Cmr7 (Sso1986) was solved to 2.05 A˚
resolution (PDB 2X5Q) (Figure 3). Sso1986 exhibits a fold con-
sisting of six b sheets and four a helices, forming a dimer with
a buried surface area of 1177 A˚2 and a concave face (Figures 3
and S3A). Homologs of Cmr7 are only detectable in the
Sulfolobales, but given the rapid evolution of the CRISPR
system, it is possible that distant homologs sharing this fold exist
Figure 2. Distribution of crRNA Bound by the S. solfataricus CMR Complex
(A–F) Examples of crRNAs from all six CRISPR loci were observed, with a clear bias toward locus D, followed by locus C. The individual plots for each locus show
that crRNA representation was highly variable, with adjacent spacers represented at levels that often varied by several orders of magnitude. For each graph, the x
axis represents the position of each spacer in the locus and the y axis represents the number of sequenced matches to each spacer. 88% of the total sequence
reads were derived from locus D, which represents a nearly 4-fold overrepresentation compared to the proportion of crRNAs encoded by that locus. CRISPR loci
E and F, which are poorly transcribed, were significantly underrepresented, as expected. However, crRNAs from CRISPRs A and B, which are highly transcribed
and thought to be actively adding spacers in vivo, are also significantly underrepresented in the CMR complex. The table shows the properties and representation
in CMR of each CRISPR locus.
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more widely. To help determine the most important features of
Cmr7, we solved the structure of a second Cmr7 subunit,
Sso1725. The sequence similarity between the two proteins is
low (19% identity), and the crystal structure of Sso1725 (solved
to 2.08 A˚ resolution; Table 1) shows limited structural similarity
(Ca rmsd of 2.39 A˚ over 121 atoms for each monomer). The
majority of the residues conserved in the six known orthologs
of Cmr7 are located in the dimer interface and concave face
(Figures 3C and S3). The electrostatic surfaces of the two
proteins show broad similarities at the dimer interface, with
symmetrical patches of negative charge at the poles and positive
charge at the edges (Figure 3D). Given this level of conservation
on only one face of the protein, we hypothesize that this region is
important for function, possibly as a binding site for other CMR
subunits. The stoichiometry of three dimers of Cmr7 per CMR
complex is most easily accommodated if they form a trimeric
(pseudo-hexamer) structure in the context of the complex.
Electron Microscopy Reveals the Architecture of the
CMR Complex
To elucidate the three-dimensional architecture of the CMR
complex, we performed electron microscopy coupled to
single-particle analysis experiments for the full complex and
additionally for Cmr2/Cmr3/Cmr7 subcomplex, devoid of RNA
(Figures 4 and S4). Projections of the maps matched with 2D
averages assigned the same Euler angles (Figure S4), high-
lighting the validity of the maps. The resolution for both maps
was !25 A˚, calculated at 0.5 Fourier Shell Correlation (3 sigma).
The CMR complex exhibited cavities, compatible with an RNA
threading machine. There was no obvious similarity to the ‘‘sea-
horse’’ structure of E. coli CASCADE (Jore et al., 2011). The
Cmr2/Cmr3/Cmr7 subcomplex, which lacked bound crRNA,
hadoverall dimensions of 903 1203 110 A˚, organized in a clamp
or ‘‘crab claw’’ structure (Figure 4A). The intact CMR complex
with loaded crRNA had overall dimensions of 160 3 120 3
110 A˚ with an upper ‘‘crab claw’’ connected to a protruding
region (Figure 4B). These dimensions were compatible with the
expected molecular masses of !290 and !430 kDa, respec-
tively. The Cmr2/Cmr3/Cmr7 subcomplex fitted well to the upper
region of intact CMR (Figure 4C), consistent with a role as
Figure 3. Crystal Structures of Two Members of the Cmr7 Family,
Viewed from the Concave Face of the Dimer
(A) The Cmr7 proteins Sso1986 (left) and Sso1725 (right) contain a structurally
conserved core (yellow) and a variable region (blue and cyan for Sso1986 and
Sso1725, respectively). The b13-b14 loop of Sso1986 is disordered and is
represented as a dashed, black line. The N and C termini are represented as
blue and red spheres, respectively.
(B) Sso1986 and Sso1725 both form dimers, and the structurally conserved
core is located at the dimer interface. The interface itself is also conserved
between the two proteins.
(C) The structurally conserved residues (green) and secondary structure
(yellow) are located close to the dimer interface with a significant proportion
positioned at the concave face.
(D) Electrostatic surface images show that the regions of the concave face
proximal to the dimer interface in both proteins (black box) have broad
similarities.
Table 1. Data Collection and Refinement Statistics for Sso1725
Data collection Native Anomalous
Wavelength (A˚) 0.97 1.60
Space group P212121 P212121
a, b, c (A˚) 77.75, 90.29, 111.65 77.71, 91.08, 111.94





I/sI 19.2 (2.2) 20.7 (2.8)
Rmerge 0.04 (0.57) 0.06 (0.71)
Completeness 97.8 (86.1) 99.9 (99.8)
Multiplicity 4.7 (3.7) 7.8 (7.9)
Anomalous completeness - 99.9 (99.7)
Anomalous multiplicity - 4.1 (4.1)
Refinement Sso1725
Rwork/Rfree 0.199/0.231





Bond lengths (A˚) 0.01
Angles (") 1.31
Each data set was collected on a single crystal at 100 K. Statistics are
presented as averages with values for the highest-resolution shell in
parentheses. Rfree was calculated from a random 5% of the reflection
data that was omitted from the subsequent refinement.
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a scaffold for the assembly of the other Cmr subunits around the
periphery (black arrows in Figure 4C).
Ribonuclease Activity of SsoCMR
We tested the ability of SsoCMR to recognize and cleave RNA
targets corresponding to spacers A1 and D63 in vitro. Both RNA
targets were cleaved efficiently when a cognate crRNA (guide
RNA) with an 8 nt 50 tag was present (Figure 5). Manganese ions
were essential for this activity, and magnesium could not substi-
tute. ATP was not essential, but clearly stimulated the cleavage
reaction (Figure S5). No crRNA-directed cleavage of DNA targets
was observed (data not shown). To rule out the possibility of
activity from a contaminating ribonuclease, the CMR complex
was immunodepleted using antibodies raised against the Cmr7
subunit. Immunodepletion abolished the nuclease activity, sug-
gesting strongly that the activity was associated with the CMR
complex (Figure S5A). As a further control, native untagged
SsoCMR purified from S. solfataricus cell extract by immunopre-
cipitation using the anti-Cmr7 antibody had the same activity as
the column-purified, tagged protein complex (Figure S5B).
Features of Guide and Target RNAs Important
for Cleavage by CMR
The sequence and structural requirements of RNA cleavage by
CMR were investigated by constructing a range of target and
guide RNA molecules based on the spacer A1 and D63
sequences. To test for a molecular ruler mechanism as observed
for PfuCMR, we reduced the length of the guide RNA (Figure 5A,
panel ii). The cleavage sites did not move in register with the 30
end of the guide RNA, suggesting that Sulfolobus and
Pyrococcus CMR differ fundamentally in this respect. Deletion
of the repeat-derived 50 tag from the guide RNA abolished
cleavage activity (Figure 5A, panel iii) and could not be rescued
by substitution with a 50 8A sequence (panel iv), showing that
this 50 tag sequence is essential for cleavage, ruling out the
possibility of a contaminating nuclease. The presence of an
unpaired flap at the 30 end of the target RNA was also required
for activity (panel vi). This corresponds to the position of the
PAM that is essential for cleavage of viral DNA targets by
CASCADE (Gudbergsdottir et al., 2011; Lintner et al., 2011).
However, for target RNA cleavage by CMR, the PAM sequence
at this position was not essential, as a 6A sequence could substi-
tute (Figure 5B, panel vii).
In addition to the target RNA, the guide RNA strand could also
be cleaved by SsoCMR (Figure 5C, panel viii). Cleavage of the
guide RNA was dependent on the presence of a 30 overhang
on the target RNA (Figure 5C, panel ix, xi). Guide and target
were cleaved at approximately equal rates when present at an
equimolar ratio, but at ratios of 20:1 or 5:1 excess of target
over guide, the guide RNAwas cleaved significantly more slowly.
Under these conditions, multiple turnover cleavage of the target
RNA was observed, suggesting that cleavage of the guide RNA
was not essential for catalysis (Figure S5D).
Sequence-Specific Cleavage by SsoCMR
The cleavage patterns observed for SsoCMR suggested a
sequence- or structure-specific component to the activity.
Sequence mapping suggested that strong cleavage always
occurred at a UA dinucleotide in both the A1 and D63 target
RNAs and the A1 guide RNA (Figure 5). Weaker cleavage was
observed at UU dinucleotides. RNA cleavage by SsoCMR re-
sulted in products with 30-hydroxyl termini that could be
extended by PolyA polymerase (Figure S6A). This is similar to
the metal-dependent RNaseH-type activity observed for Piwi
and Argonaute (Hutvagner and Simard, 2008). In contrast, the
(metal-independent) Cas6 endonuclease yields 30-cyclic phos-
phate products that are not extended by PolyA polymerase
(Figure S6B). PfuCMR is also reported to generate 30-cyclic
phosphate products (Hale et al., 2009), another distinction
between the two enzymes. To map the cleavage site of SsoCMR
precisely, the cleavage at site 2 in the D63 target RNA was
compared to a synthetic oligonucleotide terminating after the
relevant UA dinucleotide (Figure S6C). The cleavage product
generated by SsoCMRwas 1 nt shorter than the oligonucleotide,
consistent with cleavage at this position (and by extension at the
other sites) as occurring at the center of the UA sequence.
To examine the importance of sequence for CMR-mediated
cleavage of RNA, a D63-derived target RNA with only one
UA site, corresponding to position 2, was synthesized. In the
Figure 4. 3D EM Visualization of CMR Complex
(A) Surface representation of the Cmr2/Cmr3/Cmr7 subcomplex devoid of
crRNA.
(B) Surface representation of the full CMR complex with bound crRNA.
(C) Superposition of Cmr2/Cmr3/Cmr7 (blue surface) on CMR/RNA (black
mesh). Black arrowheads point to regions of additional density on the full CMR
complex with bound crRNA compared to Cmr2/Cmr3/Cmr7. Gray arrows
indicate dimensions in angstroms.
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presence of the CMR complex and a cognate guide RNA
sequence, this target was cleaved strongly at position 2, with
only weak background cleavage elsewhere (Figure 6B). The
same reaction product was observed when pairing this target
with the wild-type guide, despite the presence of mismatches
at the mutated UA sites. A modified version of the D63 guide
Figure 5. Characterization of the S. solfataricus CMR Complex Activity In Vitro
(A)Radiolabeled targetRNA (5mM)corresponding to spacerA1was incubatedwith theCmr7-taggedSsoCMRcomplex (0.5mM)andguideRNA (1mM).Cleavageof
the targetRNAwasobserved at six sites (labeled 1–6) (i). 30 truncationof the guideRNAdidnot change the cleavagepattern of the targetRNA, rulingout amolecular
ruler mechanism (ii). The 8 nt 50 tag was essential for cleavage activity, as either deletion (iii) or replacement with an 8A sequence (iv) abolished nuclease activity.
(B) The D63 target (0.5 mM) was cleaved in the presence of Cmr7-tagged SsoCMR complex (0.5 mM), cognate guide RNA (0.1 mM) (v). Deletion of the unpaired
30 end of the target RNA, which corresponds to the position of the PAM sequence, abolished activity (vi). The presence of an unpaired 6A sequence at this position
restored activity (vii).
(C) Radiolabeled guide RNA corresponding to spacer A1 (3 mM) was incubated with the Cmr7-tagged SsoCMR complex (0.5 mM) and cognate target RNA (1 mM).
Cleavage was observed at up to five positions, labeled 20 to 60 (viii). This activity was dependent on the presence of the 30 unpaired spacer sequence (ix) and was
not influenced by the presence of an additional unpaired extension at the 30 end of the guide RNA (x, xi). For each figure part, the 50 end-labeled RNA strand is
indicated with an asterisk. Labeled decade RNA markers (Ambion) are shown.
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RNA lacking any UA sites was not cleaved by CMR in the pres-
ence of a target RNA with 1 UA site (Figure 6C). The presence of
mismatches in the guide RNA opposite the target cleavage site
did not abolish cleavage (Figure S6D), consistent with the
mismatch tolerance observed previously for CASCADE (Gud-
bergsdottir et al., 2011; Semenova et al., 2011). Overall, these
data confirmed that sequence-dependent cleavage of both the
guide and target RNAs is a defining feature of SsoCMR and
demonstrated that cleavage of the guide is not necessary for
cleavage of the target, consistent with the observation of
multiple turnover by the complex.
DISCUSSION
crRNA Content of SsoCMR
There are six CRISPR loci in S. solfataricus P2, named A–F
(Lillestøl et al., 2006). Deep sequencing of 1.88 million crRNAs
isolated from the CMR complex revealed a highly biased distri-
bution, with 98% of the total crRNAs derived from locus D and
C, an overrepresentation of 3.8- and 1.3-fold, respectively. The
underrepresentation of crRNAs from highly transcribed loci A
and B may be explained by differences in the processing of
repeats by Cas6. It is notable that the CRISPR repeat sequence
associated with the A and B loci is longer than those of C–F,
which could provide a plausible basis for differential processing
by Cas6. As S. solfataricus encodes five different Cas6 proteins,
thesemay be specialized for the cleavage of particular classes of
Figure 6. The S. solfataricus CMR Complex
Cleaves RNA Selectively at UA Sites
(A) Sequence map of the D63 target and guide RNA.
(B) A D63 target oligonucleotide (D631UA, 0.5 mM) with UA
cleavage sites 1, 3, 4, and 5 mutated to UG, was labeled
and incubated with the Cmr3-tagged CMR complex
(0.5 mM) and a cognate guide RNA (crD631UA, 0.05 mM).
Cleavage of the target RNA was only observed at the
single remaining UA site, site 2. The same target paired
with the wild-type guide RNA gave identical cleavage
products despite the presence of three mismatches.
(C) A D63 guide RNA sequence with all four UA sites
mutated to CA (crD630UA, 0.5 mM) was labeled and incu-
bated with the Cmr3-tagged CMR complex (0.5 mM) and
a target RNA containing a single UA site at position 2
(D631UA, 0.05 mM). No significant cleavage of this target
sequence was observed. The standard guide RNA (crD63)
was cleaved at all four UA sites under the same conditions,
despite the presence of mismatches at three positions in
the RNA duplex. Control lanes for all gels are: m1, Ambion
Decade markers; c1, labeled RNA alone; c2, labeled RNA
and CMR; c3, both RNA strands without CMR. Asterisks
indicate the 50 RNA end labeled by 32P.
CRISPR repeat and/or may interact differently
with the multiple CASCADE and CMR com-
plexes in this organism. Another possibility is
that differences in the removal of the repeat-
derived sequence 30 of the spacer by an
unknown nuclease after Cas6 processing (Hale
et al., 2009) influence incorporation efficiency.
The extreme variation in crRNA sequence numbers obtained
from adjacent spacers in all the CRISPR arrays was also unex-
pected. In some cases, this is probably explained by the pres-
ence of internal promoter sequences encoded by adjacent
spacers, driving higher transcript levels for particular regions of
crRNA. Another variable that could influence crRNA processing
is the potential for the formation of stable folded RNA structures
following transcription that could influence crRNA processing by
Cas6 and loading into the CMR complex. Each spacer has
a unique sequence that confers a particular capacity to fold on
the local crRNA structure. To address this further, we analyzed
the thermodynamic stability of folded RNA structures for each
crRNA derived from CRISPR locus C and plotted these against
the frequency of occurrence of each crRNA in the CMR
sequencing sample (Figure S2). The crRNAs with the potential
to fold into themost stable structures were clearly not highly rep-
resented in the data set, while the most highly represented
sequences had similar, modest folding propensity. This is
suggestive of an influence of the secondary structure of the
crRNA locally on the efficiency of cleavage by Cas6 and possibly
on the loading of crRNA into the CMR complex. Such effects
may be ameliorated in the thermophiles by the high growth
temperature, but could constitute a significant problem in
temperature mesophiles. In organisms such as E. coli, the repeat
sequence is palindromic, folding into a stable hairpin structure
that is recognized by the CasE nuclease (Brouns et al., 2008).
This may be an evolutionary mechanism that helps impose an
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ordered secondary structure on the crRNA to avoid problems
due to folding of spacer sequences. In contrast, Cas6, which is
present in many thermophiles, binds unstructured crRNA
repeats (Wang et al., 2011).
Structure of the CMR Complex
The EM envelope of the Cmr2/Cmr3/Cmr7 subcomplex bears
some similarity to the clamp region of RNA polymerase. In partic-
ular, the distance between the two sides of the ‘‘claw’’ is !30 A˚
wide, and their length is !40 A˚. It is tempting to view this feature
as a dsRNA binding cleft, particularly as Cmr2 is assumed to
harbor the active site of the CMR complex. In support of this,
the cleft is somewhat deeper in the Cmr2/Cmr3/Cmr7 subcom-
plex, which contains no bound crRNA, in comparison to the full
complex. The lack of crRNA in the Cmr2/Cmr3/Cmr7 subcom-
plex fits with a presumed role for the RAMP-containing Cmr
subunits (Cmr1, Cmr4, and Cmr6) in RNA binding (Makarova
et al., 2011a). This is consistent with the recent prediction that
Cmr3 is most closely related to the Cas5 subunit of CASCADE,
while Cmr1, Cmr4, and Cmr6 are closer matches to the Cas7
subunit (CasC inE. coli), which is known tobindcrRNA (Makarova
et al., 2011a). Compared to Cmr2/Cmr3/Cmr7, the additional
Cmr subunits are distributedmainly at the front and at the bottom
of the complete CMR complex and may form a structure related
to the crRNAbindingCasCbackbone of CASCADE. Visualization
of the path of RNA in theCMR structure remains a key aim to help
elucidate the mechanism and molecular organization.
The Mechanism of SsoCMR in Viral RNA Cleavage
We have demonstrated that the SsoCMR complex cleaves
target RNA in a sequence-specific manner that is dependent
on the presence of a guide crRNA with a cognate sequence
and an 8 nt repeat-derived tag at the 50 end. Cleavage occurs
at UA dinucleotides, generating products with 30-OH and
50-phosphate ends, like those produced by Argonaute and Piwi
(Hutvagner and Simard, 2008). The cleavage sequence is
extremely common in the Sulfolobales and their viruses. Of the
>400 spacers in the CRISPR loci of the S. solfataricus P2
genome, only 11 lack a UA dinucleotide. The palindromic nature
of this dinucleotide ensures that an equivalent UA sequence is
always present in the guide RNA. Cleavage of both the target
and guide RNA at UA sites was observed, with the guide cleaved
significantly more slowly at high ratios of target:substrate. Under
these conditions, one guide RNA molecule could support the
cleavage of several target RNAs, demonstrating that cleavage
of the guide is not essential for target RNA destruction.
Although not yet shown directly, the N-terminal permuted
HD nuclease domain present in Cmr2 is generally assumed to
be the nuclease site of the CMR complex. The distantly related
HD domain present in Cas3 has been shown capable of cleaving
both RNA and DNA, although they are specific for single-
stranded nucleic acids and generate products with 30-cyclic
phosphates (Mulepati and Bailey, 2011; Beloglazova et al.,
2011). It is also possible that the RNA cleavage activity resides
elsewhere in the Cmr2 subunit or in one or more of the
RAMP-containing subunits (Cmr1, Cmr2, Cmr4, and Cmr6),
which are distantly related to Cas5, Cas6, and Cas7 (Makarova
et al., 2011a).
We observed no requirement for a PAM sequence adjacent to
the protospacer in RNA targets. This is a marked difference from
the DNA targeting CASCADE in archaea, which only cleaves
substrates containing a PAM (Gudbergsdottir et al., 2011;
Manica et al., 2011). The primary role of the PAM may be to
maintain a mismatched region between the 50 tag of the crRNA
and the sequence immediately adjacent to the spacer of the
target. For DNA targeting systems, this ensures that the chro-
mosomal CRISPR locus is not targeted for cleavage (Marraffini
and Sontheimer, 2010b; Mojica et al., 2009). Given that the
CMR complex only targets viral RNA, there is no requirement
for PAM detection to operate in this case, as the host genome
will not be a target. Although no PAM is required, CMR-mediated
cleavage requires an unpaired RNA region at the 30 end of
the target RNA, downstream of the protospacer. This discrimina-
tion may be at the structural rather than sequence level and is
consistent with a role in vivo in targeting viral mRNA sequences,
which will typically be considerably longer than the guide RNA
species.
The observed activity of SsoCMR differs markedly from that
reported previously for the enzyme from P. furiosus (Hale et al.,
2009). PfuCMR operates by a molecular ruler mechanism
without sequence-dependent cleavage, generates 30-cyclic
phosphate products, and does not require an extension at the
30 end of the target RNA, at least in vitro. The long evolutionary
distance between the two species may explain these differ-
ences. CMR complexes have been classified into five families
(A–E) on the basis of the sequence of the large subunit, Cmr2
(Garrett et al., 2011). On this basis, the SsoCMR complex
belongs to family B while PfuCMR is one of the very few repre-
sentatives of family C. To put these differences in context, the
type IIIA, CMR-like complex from Staphylococcus epidermidis
targets DNA rather than RNA (Marraffini and Sontheimer,
2008). This may therefore reflect the plasticity inherent in the
CRISPR system.
The RNA targeting functionality of the CMR complex in
prokaryotes has parallels with the eukaryal piRNA pathway
that uses guide RNA to recognize and cleave the mRNA of
mobile genetic elements (Aravin et al., 2007). As in the CRISPR
system, in the piRNA pathway, the small guide RNAs are gener-
ated by cleavage of a long mRNA transcript, loaded into an
endoribonuclease (Piwi), and used to target and degrade the
mobile mRNA by means of dsRNA cleavage, yielding products
with 30-OH termini (reviewed in Nowotny and Yang, 2009). There
are, though, important differences. Piwi recognizes the 50 phos-
phate of the guide RNA specifically (Ma et al., 2005; Parker et al.,
2005), while the guide RNA generated by Cas6 and utilized by
CMR lacks a 50 phosphate and has an essential 8 nt 50 tag.
More fundamentally, there is no obvious homology between
the Piwi and CMR proteins. Piwi uses an RNaseH domain for
dsRNA cleavage, which is absent from the CMR complex. The
stimulation of CMR cleavage activity by ATP suggests that an
ATP-driven conformational change may be utilized to reposition
the dsRNA with respect to the active site. In the absence of
any detectable Walker A or B motifs, the likely site for ATP
binding is the C-terminal polymerase/cyclase domain of Cmr2.
This domain has no known function but is expected to bind
nucleotide triphosphates. If such an ATP-dependent RNA
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repositioning mechanism were in operation, it would constitute
another aspect of the CMR complex.
Concluding Remarks
In summary, we provide a low-resolution structure of the
CMR complex for prokaryotic viral RNA degradation. Deep
sequencing suggests that posttranscriptional processing may
exert considerable influence on the loading of its crRNA compo-
nent. The reaction mechanism involves manganese-dependent
and ATP-stimulated ribonuclease activity that degrades both
target and guide RNA in a sequence-dependent manner. Future
studies will aim in particular to map the individual subunits within
the EM envelope and the course of the bound crRNA in the
complex and to define the function of the polymerase/cyclase
domain and the role of ATP in the reaction.
EXPERIMENTAL PROCEDURES
Cloning, Expression, and Purification of Cmr7 Paralogs
Details of cloning, purification, and crystal structure solution for Sso1986 were
reported previously (Oke et al., 2010). Sso1725 was expressed and purified
according to published protocols (Oke et al., 2010). Briefly, full-length
sso1725 was cloned into the pDEST14 vector with an N-terminal 6xHis tag
and overexpressed in C43 (DE3) E. coli at 37!C in LB medium. Expression
was induced using 0.4 mM IPTG, and the cultures were harvested after over-
night incubation at 25!C. The cell pellets were resuspended and lysed (Soni-
prep 150, MSE). The lysate was clarified by centrifugation, and then protein
was purified by immobilized nickel affinity chromatography and size-exclusion
chromatography (Superdex 75 column, GE Healthcare). Sso1725 was
concentrated to 10 mg.ml"1 for crystallization.
Antibody Generation
Sheep polyclonal antibodies were raised against the recombinant Cmr7
(Sso1986) protein and supplied by the Scottish National Blood Transfusion
Service, Pentlands Science Park, Midlothian.
RNA Oligonucleotides Used for CMR Activity Assays
RNA oligonucleotides were chemically synthesized (Integrated DNA Technol-
ogies), end labeled with 32P-ATP, and purified by denaturing gel electropho-
resis. The sequences used are listed in the Supplemental Experimental
Procedures.
Purification of the Native CMR Complex from S. solfataricus
S. solfataricus strain P2 biomass was grown as described previously (Go¨tz
et al., 2007). TheCMR complex was purified over four column chromatography
steps, and purification was followed using an antibody raised against subunit
Cmr7, as described in the Supplemental Experimental Procedures. This
yielded the homogeneous complex shown in Figure 1.
Expression and Purification of Tagged CMR Complex in
S. solfataricus
This was carried out as described previously by cloning the relevant gene into
entry vector pMZ1 (Zolghadr et al., 2007), followed by subcloning into expres-
sion vector pSVA9, expressing the relevant subunit with a C-terminal strep-His
tag (Albers et al., 2006), described in detail in the Supplemental Experimental
Procedures. The Cmr2/Cmr3/Cmr7 subcomplex analyzed by electron micros-
copy was obtained during purification of the CMR complex with a tagged
Cmr3 subunit. The subcomplex eluted separately from the full complex on
gel filtration and contained no bound crRNA (Figure S5).
RNA Isolation and Sequencing
RNA was extracted from the purified native CMR complex by the classical
phenol/chloroform method followed by ethanol precipitation and vacuum
desiccation. Dried RNA was resuspended in 5 ml water and directly labeled
in a 10 ml reaction containing polynucleotide kinase and 2 mCi g32P-ATP.
Labeled RNAs were analyzed by electrophoresis on a 15% acrylamide, 7 M
urea, TBE denaturing gel and visualized by phosphorimaging. For crRNA
deep sequencing, small RNA sequences were generated by the GenePool
at the University of Edinburgh using the Illumina small RNA prep kit v1 and sub-
jected to high-throughput sequencing using a Genome Analyzer IIx. This re-
sulted in the addition of the adaptor sequence TCGTATGCCGTCTTCTGCTTG
at the 30 end of each sequence. The adaptor sequencewas trimmed away from
the reads with a bespoke Perl script. Reads were mapped against the S. solfa-
taricus P2 genome with BWA (Li and Durbin, 2009) using default parameters
and converted into BAM using SAMtools (Li et al., 2009). Of the 2,527,217
reads, 1,997,151 were mapped (79%). The number and strand orientation of
the reads mapping to each spacer were quantified. The raw data from
the sequencing run is available from the corresponding author on request,
and the sequences mapping onto each spacer are listed in Table S1.
The raw sequence data have been uploaded to the Sequence Read Archive
with accession number ERP001053 (http://www.ebi.ac.uk/ena/data/view/
ERP001053).
RNA Cleavage Assays
Purified SsoCMR complex and unlabeled guide RNA were mixed in buffer
(20 mM Mes$HCl [pH 6.0], 100 mM potassium glutamate, 10 mM DTT,
10 mM MnCl2, and the RNase inhibitor SUPERase.In [Ambion]) and preincu-
bated at room temperature for 10 min prior to the addition of 50-32P-end-
labeled synthetic target RNA to the reaction mix. Target and guide RNA and
CMR complex concentrations are indicated in the figure legends. The reaction
was further incubated at 75!C for 10 min in standard assays or for the time
indicated in the figure. Reactions were stopped by chilling on ice and addition
of formamide loading buffer. Samples were separated on 20% polyacryl-
amide, 7 M urea, 13 TBE gels. Electrophoresis was completed at 90 W,
50!C for 90 min, and the gels were visualized by phosphorimaging. 50 end-
labeled RNA size standards (Decade Markers, Ambion) were used to
determine the sizes of the observed products. Cas6 activity was assayed as
described previously (Lintner et al., 2011).
Crystallography of Sso1725
Sso1725 crystals were grown at 20!C using the sitting drop vapor diffusion
method. A reservoir of 0.15 M sodium acetate (pH 5.6), 2.0 M ammonium
sulfate was used, and protein was mixed with the precipitant at a ratio of
2:1. Crystals were cryoprotected by successively soaking in solutions of reser-
voir containing 8%, 16%, 20%, and 25% glycerol before freezing in liquid
nitrogen. A native data set at 2.08 A˚ resolution was collected at Diamond Light
Source (Beamline I03). An anomalous SAD data set was collected at the same
beamline using a native crystal briefly soaked in reservoir solution containing
42 mM samarium chloride before cryoprotecting as described above. Data
sets were processed and refined using the methods described in the Supple-
mental Experimental Procedures. The coordinates were deposited in the PDB
under the accession code 2XVO.
EM Studies
The intact CMR complex bound to crRNA and the Cmr2/Cmr3/Cmr7 subcom-
plex were studied by negative-staining electron microscopy and single-
particle analysis. Data were collected on an FEI F20 FEG microscope,
equipped with an 8 k 3 8 k CCD camera. Images were collected under low-
dose mode at a magnification of 50,0003, at a final sampling of 1.6 A˚/pixel
at the specimen level. Single-particle images were selected interactively using
the Boxer program from the EMAN single-particle analysis package (Ludtke
et al., 1999) and extracted into boxes. Image processing was performed using
the IMAGIC-5 package (van Heel et al., 1996). The data set was resampled at
6.4 A˚/pixel. 10,235 (CMR/RNA) and 5,612 (Cmr2/Cmr3/Cmr7) images were
band-pass filtered with a high pass cutoff of 110 A˚ and a low pass cutoff of
18 A˚. The single-particle images were analyzed by Multivariate Statistical
Analysis with IMAGIC-5. The data set was subjected to successive rounds
of alignment and classification in order to improve the resulting image class
averages. Selected CMR/RNA class averageswere used to calculate a starting
3D volume by common lines using the Euler program in the IMAGIC-5
package. The CMR/RNA structure was refined until the map converged.
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We used the CMR/RNA map to align Cmr2/Cmr3/Cmr7 images and to assign
Euler angles by projection matching. Subsequent refinement was carried out
until the Cmr2/Cmr3/Cmr7 map converged. Figures were prepared with
UCSF Chimera (Goddard et al., 2007).
ACCESSION NUMBERS
The crystal structure of the Cmr7 subunit of CMR (Sso1725) has been
submitted to the Protein Data Bank with accession number 2X5Q. The deep
sequencing data for the RNA bound to the CMR complex has been uploaded
to the Sequence Read Archive with accession number ERP001053.
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Structure of a dimeric crenarchaeal Cas6 enzyme with an atypical active
site for CRISPR RNA processing
Judith REEKS1, Richard D. SOKOLOWSKI1, Shirley GRAHAM, Huanting LIU, James H. NAISMITH2 and Malcolm F. WHITE2
Biomedical Sciences Research Complex, University of St Andrews, North Haugh, St Andrews, Fife KY16 9ST, U.K.
The competition between viruses and hosts is played out in all
branches of life. Many prokaryotes have an adaptive immune
system termed ‘CRISPR’ (clustered regularly interspaced short
palindromic repeats) which is based on the capture of short pieces
of viral DNA. The captured DNA is integrated into the genomic
DNA of the organism flanked by direct repeats, transcribed and
processed to generate crRNA (CRISPR RNA) that is loaded
into a variety of effector complexes. These complexes carry out
sequence-specific detection and destruction of invading mobile
genetic elements. In the present paper, we report the structure and
activity of a Cas6 (CRISPR-associated 6) enzyme (Sso1437) from
Sulfolobus solfataricus responsible for the generation of unit-
length crRNA species. The crystal structure reveals an unusual
dimeric organization that is important for the enzyme’s activity.
In addition, the active site lacks the canonical catalytic histidine
residue that has been viewed as an essential feature of the Cas6
family. Although several residues contribute towards catalysis,
none is absolutely essential. Coupled with the very low catalytic
rate constants of the Cas6 family and the plasticity of the active
site, this suggests that the crRNA recognition and chaperone-like
activities of the Cas6 family should be considered as equal to or
even more important than their role as traditional enzymes.
Key words: antiviral defence, Cas6, clustered regularly
interspaced short palindromic repeats (CRISPR), ribonuclease,
Sulfolobus.
INTRODUCTION
The CRISPR (clustered regularly interspaced short palindromic
repeats) system is an adaptive antiviral defence system found in
many bacteria and most archaea. In organisms with an active
CRISPR system, invading viral DNA can be captured and
incorporated into the genome. This process, known as adaptation,
requires the Cas (CRISPR-associated) proteins Cas1 and Cas2
and results in the insertion of a short piece (typically 25–50 bp)
of foreign DNA into a region of the genome known as the
CRISPR locus [1,2]. The inserted sequence, known as a ‘spacer’,
is flanked by direct repeat sequences in an array; a locus can
grow to comprise >100 repeat–spacer units. A promoter in the
CRISPR locus drives transcription of the array, generating a pre-
crRNA (crRNA is CRISPR RNA) that is processed into unit-
length mature crRNA species [3–5]. These are loaded into effector
complexes, which use the crRNA sequence to detect and degrade
invading DNA or RNA during interference, providing immunity
from infection (reviewed in [6]).
Three main types of CRISPR system (I, II and III) have
been defined on the basis of the presence of the key protein
subunits Cas3, Cas9 and Cas10 respectively [7]. These are defined
further into specific subtypes, such as type I-A–I-F, depending
on the particular proteins present. In type I and III systems,
pre-crRNA is processed by the Cas6 endonuclease, whereas
type II systems utilize an alternative method involving host
RNase III [8]. Cas6 is thus a key component of the majority of
CRISPR effector systems. Cas6 proteins typically consist of two
tandem RRM (RNA-recognition motif)-like folds {also known
as RAMP (repeat-associated mysterious protein) domains [9]}
with a diagnostic glycine-rich loop near the C-terminus. Although
this core fold is conserved, there are significant differences in
Cas6 enzymes from different species. Many, such as TtCas6e
(Thermus thermophilus Cas6, also known as Cse3) and PaCas6f
(Pseudomonas aeruginosa Cas6, also known as Csy4) recognize
an RNA hairpin structure formed by the CRISPR repeat [10,11].
RNA cleavage typically occurs at the base of the hairpin,
whereupon the enzyme remains tightly bound to the product
and chaperones it to the effector complex. In most cases, these
Cas6 enzymes are integral subunits of the effector complexes and
catalyse only single-turnover cleavage of the pre-crRNA [12].
In many of the archaea, CRISPR repeats are not palindromic
and are thus unable to form stable hairpin structures [13]. The
structure of PfuCas6 (Pyrococcus furiosus Cas6) in complex with
repeat RNA revealed that the RNA is wound around the outside
of the enzyme between the two RAMP domains, analogous to the
string around a yo-yo [14]. The pre-crRNA is engaged in a binding
cleft on one side of the protein and cleaved in the active site on the
other side of the enzyme. However, it is unclear whether this is a
general mode for binding unstructured RNA in archaeal Cas6
homologues. For the archaeal type I-A and III-B systems,
Cas6 appears to be more loosely associated with the effector
complexes [15–17] and should, in theory, be capable of true
multiple turnover to generate crRNAs for different clients.
All Cas6 variants studied to date are monomeric proteins with
an active-site histidine side chain that is thought to act as a general
acid or base [12] during the catalytic cycle. In the present paper,
we report the crystal structure and accompanying biochemical
data for Cas6 from the crenarchaeon Sulfolobus solfataricus.
This enzyme has a novel dimeric arrangement that appears to
be important for catalysis, as a monomeric variant is significantly
less active. Furthermore S. solfataricus Cas6, in common with
Abbreviations used: CRISPR, clustered regularly interspaced short palindromic repeats; Cas, CRISPR-associated; crRNA, CRISPR RNA; Ni-NTA,
Ni2+ -nitrilotriacetate; PaCas6f, Pseudomonas aeruginosa Cas6; PfuCas6, Pyrococcus furiosus Cas6; RAMP, repeat-associated mysterious protein; RMSD,
root mean square deviation; RRM, RNA-recognition motif; SAD, single-wavelength anomalous dispersion; SsoCas6, Sulfolobus solfataricus Cas6; TBE,
Tris/borate/EDTA; TEV, tobacco etch virus; TtCas6e, Thermus thermophilus Cas6.
1 These authors contributed equally to this work.
2 Correspondence may be addressed to either of these authors (email jhn@st-andrews.ac.uk or mfw2@st-andrews.ac.uk).
The co-ordinates and data for the structure of Sulfolobus solfataricus Cas6 have been deposited in the PDB under code 3ZFV.
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many other crenarchaeal enzymes, lacks the ‘essential’ histidine
moiety. This suggests a different mechanism of catalysis, which
is probed by site-directed mutagenesis.
EXPERIMENTAL
Cloning and site-directed mutagenesis
The sso1437 gene was amplified by PCR from S. solfataricus
genomic DNA and cloned into the pET151-TOPO plasmid by
TOPO cloning with a cleavable N-terminal His6-tag as described
previously [18]. Site-directed mutagenesis was performed
following standard protocols (QuikChange®, Stratagene). The
sequences of oligonucleotides used for cloning and mutagenesis
are available from M.F.W. upon request.
Expression and purification
Sso1437 [SsoCas6 (S. solfataricus Cas6)] was expressed in
C43(DE3) Escherichia coli cells in LB (Luria–Bertani) medium
at 37 ◦C until reaching a D600 of 0.6, followed by induction
with 1 mM IPTG (isopropyl β-D-thiogalactopyranoside) and
overnight incubation at 25 ◦C. Cell pellets were resuspended in
PBS with 1 M NaCl, 10 mM imidazole, 10% glycerol, 9 mM 2-
mercaptoethanol, 10 µg·ml− 1 lysozyme, 0.05 unit·ml− 1 DNase I
and EDTA-free protease inhibitor tablets (Roche). The cells were
lysed using a cell disruptor (Constant Systems) at 30000 psi (1
psi= 6.9 kPa) and the lysate was cleared by centrifugation at
40 000 g for 45 min at 25 ◦C. The soluble fraction was applied to
an Ni-NTA (Ni2+ -nitrilotriacetate) column (Qiagen), washed with
30 mM imidazole and eluted with 400 mM imidazole. The sample
was dialysed into PBS with 1 M NaCl, 10% glycerol and the His6-
tag cleaved with TEV (tobacco etch virus) protease overnight. The
sample was reapplied and washed through the Ni-NTA column
in 30 mM imidazole and the cleaved protein was applied to a
SuperdexTM 75 gel-filtration column (GE Healthcare) equilibrated
in 20 mM Tris/HCl (pH 7.5), 1 M NaCl and 10% glycerol. All
mutants were purified according to the same protocol.
An (L)-selenomethionine derivative of SsoCas6 was expressed
in B834(DE3) E. coli cells in M9 medium supplemented with
Selenomethionine Nutrient Mix (Molecular Dimensions) and
50 mg·l− 1 (L)-selenomethionine. The expression protocol was as
above except that the cells were harvested after 30 h. The sample
was purified as above except that 1 mM 2-mercaptoethanol was
added to all buffers.
Reductive methylation of surface lysine residues
Selenomethionine-labelled SsoCas6 was dialysed into 50 mM
Hepes (pH 7.5), 1 M NaCl and 10% glycerol, and the
surface lysine residues were reductively methylated using
dimethylamine borane complex and formaldehyde as part of
the JBS Methylation Kit (Jena Bioscience) according to the
manufacturer’s instructions. The methylated protein was applied
to an S75 column equilibrated in 20 mM Tris/HCl (pH 7.5), 1 M
NaCl and 10% glycerol and then concentrated to 8 mg·ml− 1 for
crystallography.
Structural biology
Optimized crystals of selenomethionine-labelled methylated
SsoCas6 were grown under conditions of 0.05 M bicine (pH 9.1)
and 28% PEG [poly(ethylene glycol)] 3350 using vapour
diffusion with a protein/precipitant ratio of 1:1. The crystal
Table 1 Data collection and refinement statistics for the structure of
selenomethionine-labelled methylated SsoCas6






a, b, c (A˚) 71.7, 127.5, 83.6
α, β , γ (◦) 90.0, 110.5, 90.0
Resolution 73.33–2.80 (2.87–2.80)
Rmerge 0.07 (0.71)
I/σ I 23.3 (3.7)
Completeness 99.9 (99.1)
Multiplicity 10.4 (10.2)
Anomalous completeness 99.7 (98.5)









Bond lengths (A˚) 0.01
Angles (◦) 1.45
was cryoprotected in mother liquor supplemented with 20%
glycerol and flash-cooled in liquid nitrogen. A SAD (single-
wavelength anomalous diffraction) dataset was collected on
the ESRF (European Synchrotron Radiation Facility, Grenoble,
France) ID14-4 beamline at the Se–K absorption edge using a
single crystal cooled to 100 K. The data were processed with
xia2 [19] using XDS [20] and SCALA [21] and the heavy
atom sites located using Phenix AutoSol [22]. The map was
improved further using Parrot [23] and the chains were traced
using Buccaneer [24], both as part of the CCP4 suite [25].
The structure was refined with cycles of correction in COOT
[26] and refinement with REFMAC version 5.6 [27] using TLS
(Translation–Libration–Screw-rotation) parameters generated by
the TLSMD server [28,29]. The side chains of residues in β3
and the β2–β3 loop were disordered and real-space averaging,
using AVE as part of the Uppsala Software Factory [30], was
required to assign the residues correctly. Methyl groups were not
modelled on to the lysine residues owing to insufficient density.
The structure was validated using the MolProbity server [31]. Data
collection and refinement statistics are presented in Table 1. The
co-ordinates and data for the structure of SsoCas6 were deposited
in the PDB under code 3ZFV.
RNA oligonucleotide purification, end labelling and marker ladder
The RNA sequence corresponding to the repeat of the C and
D CRISPR loci of S. solfataricus P2 was ordered from IDT,
with the sequence 5′-GAUAAUCUCUUAUAGAAUUGAAAG-
3′. The oligonucleotide was gel-purified and end-labelled with
[γ -32P]ATP as described previously [15]. The RNA marker ladder
was generated by alkaline hydrolysis as described previously [16].
Single-turnover endonuclease assays
SsoCas6 protein (0.5 µM) was incubated with 1–5 nM labelled
RNA in nuclease assay buffer [20 mM sodium phosphate
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(pH 7.5), 100 mM potassium glutamate, 5 mM EDTA and 0.5 mM
DTT (dithiothreitol)] at the temperature indicated. At relevant
time points, 10 µl samples were removed from the main reaction
volume and quenched by addition to 30 µl of pre-distributed
acid phenol/chloroform (Ambion), vortex-mixed for ∼10 s and
centrifuged at 15000 g for 1 min. Then, 5 µl of the upper aqueous
phase was removed and mixed 1:1 with formamide. Samples were
heated at 95 ◦C for 2 min immediately before loading on to a pre-
warmed 20% denaturing polyacrylamide gel [20% acrylamide,
8 M urea and 1× TBE (45 mM Tris/borate and 1 mM EDTA)]
and the products were separated by electrophoresis at 80 W for
90 min in 1× TBE running buffer. Following electrophoresis,
gels were scanned by phosphorimaging and analysed using Fuji
Imagegauge software as described previously [32].
Thermofluor assay for protein stability
Protein (SsoCas6 wild-type or SsoCas6-L170D/V202D) (5 µM)
was incubated in nuclease assay buffer supplemented with 2×
SyproOrange® (Invitrogen). Volumes of 100 µl were accom-
modated in a 96-well propylene plate (Agilent Technologies)
and covered with an optically clear adhesive film (Molecular
Dimensions). Plates were spun briefly at 1500 g before commen-
cing the assay. The temperature was raised from 25 to 95 ◦C in
0.5 ◦C increments, 1 min cycles and the fluorescence levels were
monitored in a QPCR System (Stratagene® Mx3005pTM) using
a FFROX filter set with excitation and emission wavelengths of
492 and 610 nm respectively. Post-assay manipulation of data was
undertaken using the DFS analysis (version 2.5) tool developed
(and kindly provided) by Niesen et al. [33] (downloadable at
ftp://ftp.sgc.ox.ac.uk/pub/biophysics). The inflection point of the
sigmoidal monophasic thermal profile of the protein was taken to
be the melting temperature (Tm) of the protein [33].
Calibrated gel filtration
SsoCas6 (the K28H variant, which has the same elution profile
as that of wild-type protein) and SsoCas6-L170D/V202D were
applied to a HiLoad 26/600 Superdex 200TM gel-filtration column
(GE Healthcare) equilibrated in 20 mM Tris/HCl (pH 7.5) and
1 M NaCl. The column was calibrated using gel-filtration
standards (Bio-Rad Laboratories) and the molecular masses were
estimated as described previously [34].
RESULTS
Sso1437: an authentic Cas6 enzyme
The genome of S. solfataricus contains five Cas6 paralogues,
one of which (Sso2004) was shown previously to be an active
ribonuclease by Lintner et al. [15]. Sso2004 shares 90%
sequence identity with its paralogue Sso1437, hereafter called
SsoCas6. This paralogue was cloned and expressed in E. coli
with an N-terminal polyhistidine tag. SsoCas6 was purified to
homogeneity by a combination of immobilized metal-affinity
chromatography and gel filtration, and the polyhistidine tag was
removed using TEV protease as described previously [35]. The
purified protein was assayed for ribonuclease activity using a 32P-
end-labelled oligonucleotide corresponding to the CRISPR RNA
repeat sequence, 5′-GAUAAUCUCUUAUAGAAUUGAAAG-3′,
which matches the CRISPR repeat found in the C and D loci of the
S. solfataricus P2 genome [36]. Cleavage occurred specifically
8 nucleotides from the 3′ end, generating the conserved ‘5′
handle’ motif [15]. The single-turnover catalytic rate constant
for Sso1437 was measured at a range of temperatures from
Figure 1 SsoCas6 cleaves a CRISPR RNA repeat
(A) Representative time course of RNA cleavage by SsoCas6 at 60◦C under single-turnover
conditions, analysed by gel electrophoresis and phosphorimaging. Labels ‘s’ and ‘p’ indicate
substrates and products respectively. The control reaction ‘c’ was carried out in the absence
of SsoCas6 for 25 min. (B) Single-turnover kinetic rates for cleavage of a CRISPR repeat RNA
by SsoCas6 as a function of reaction temperature. The sequence of the RNA oligonucleotide
substrate is shown at the top with the cleavage position indicated with an arrow. Each rate
was calculated from at least six data points as described in the Experimental section, with
means+− S.E.M. calculated from curve fitting shown.
20 to 80 ◦C (Figure 1). As expected for an enzyme from a
thermophile, maximal activity was observed at 70 ◦C, close to the
optimum growth temperature of the organism of 80 ◦C. Reaction
rates for thermostable enzymes from S. solfataricus typically
increase 2-fold for each 10 ◦C rise in incubation temperature
[37]. This pattern was followed by SsoCas6 up to 60 ◦C, with
a modest increase at 70 ◦C and a significant fall in activity
thereafter, suggesting that the protein is heat-denatured under
these conditions in vitro at temperatures above 70 ◦C. The first-
order reaction rate of the enzyme in vivo at 80 ◦C may thus
approach 3–4 min− 1. SsoCas6 was studied further using a
combination of crystallography and site-directed mutagenesis to
elucidate its structure and catalytic mechanism.
The crystal structure of SsoCas6
Although native SsoCas6 crystallized readily, reductive
methylation of the surface lysine residues was required to
produce well-diffracting crystals. A selenomethionine derivative
of the methylated protein was used to solve the structure with
a SAD dataset collected to 2.8 Å (1 Å= 0.1 nm) resolution.
Data collection and refinement statistics are presented in Table 1.
Residues 43–50 and 90–93 are disordered in each of the four
monomers in the crystallographic asymmetric unit.
Structural homology with other Cas6 proteins was determined
with the PDBeFold server [38], which identified the non-catalytic
P. furiosus Cas6 (PfuCas6nc) as the most structurally similar
[PDB code 3UFC, Cα RMSD (root mean square deviation) of
3.4 Å over 187 residues], followed by its catalytic paralogue
PfuCas6 (PDB code 3I4H, RMSD 3.4 Å over 179 residues). The
monomer consists of eleven β-strands and eight helices arranged
as two tandem RAMP folds linked by a single helix, consistent
with the canonical Cas6 fold [3] (Figures 2A and 2B). RAMP
domains are similar to ferredoxin-like and RRM folds, comprising
a central four-stranded antiparallel β-sheet (β4β1β3β2) flanked on
one face by two α-helices (α1 and α2). The N-terminal RAMP
domain of SsoCas6 deviates from the standard motif in that the
second RAMP helix (α2) that normally precedes β4 is missing and
replaced by a loop with an extended conformation. In addition
to the standard RAMP elements, the N-terminal domain contains
a short β-stand located after the missing RAMP α2, which forms a
small three-stranded antiparallelβ-sheet with two strands from the
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Figure 2 The crystal structure of SsoCas6
(A) Schematic representation of a typical ferredoxin-like fold with the β-strands as blue arrows and the α-helices as cyan cylinders. The N- and C-termini are shown as blue and red spheres
respectively. (B) The structure of SsoCas6 with secondary-structure elements labelled. Disordered loops are shown as broken black lines and the glycine-rich loop shown in yellow. The location of
the missing α-helix of the N-terminal domain is indicated. (C) View of the SsoCas6 dimer. (D) Electrostatic surface potential of the SsoCas6 dimer generated using CCP4MG [50]. The black boxes
indicate the active-site region, with the broken box indicating the active site on the non-visible face of the dimer.
central β-sheet. In the C-terminal RAMP domain, there are three
additional helices located on the helical face of the domain as well
as a β-hairpin that connects two strands of the central β-sheet. The
characteristic glycine-rich loop of the RAMP superfamily is found
only in the C-terminal domain and is in the same conformation
seen in the other Cas6 homologues.
Dimerization of SsoCas6
Analysis with the PDBePISA server [39] indicates that the
four SsoCas6 monomers in the asymmetric unit assemble into
two identical dimers (complexation significance score of 1),
consistent with gel-filtration data that also suggested a dimer
(Figures 2C and 3B). The dimer interface was formed between
the C-terminal domains of both proteins with an average buried
surface area of 1349 Å2. The three non-conserved helices of
the C-terminal domain are positioned at the interface and may
be responsible for causing dimerization in a Cas6 protein that
is typically monomeric. Introduction of charged resides at the
centre of the interface (SsoCas6-L170D/V202D, Figure 3A)
resulted in a protein that ran on gel filtration as a monomer
(Figure 3B). The same dimeric arrangement was seen in low-
resolution structures of methylated and non-methylated SsoCas6
crystallized under different conditions (Supplementary Figure
S1 at http://www.biochemj.org/bj/452/bj4520223add.htm). This
is the first time that a Cas6 protein has been confirmed to be a
dimer in the absence of RNA.
The dimeric wild-type enzyme was observed to undergo
thermal melting with a melting temperature (Tm) of 75 ◦C. For the
monomeric variant, the equivalent Tm was 68 ◦C. Although 7 ◦C
lower than the wild-type enzyme, the monomer remained heat-
stable under the assay conditions. The monomeric Cas6 variant
had a single-turnover catalytic rate constant of 0.034 min− 1 at
60 ◦C, equivalent to 4% of the wild-type rate. A similar reduction
in rate for the monomeric variant was observed at lower reaction
temperatures, suggesting that the loss of activity is not simply due
to protein instability (results not shown).
Delineation of catalytically important residues
The PfuCas6 active site contains a triad of Tyr31, His46 and Lys52
[40]. The Y31A and H46A variants had no detectable enzyme
activity, whereas the K52A variant resulted in a 40-fold reduction
in nuclease activity. In SsoCas6, the catalytic lysine residue is
conserved at position 51 (main chain ordered only in protomer
D), whereas Tyr31 is not conserved (Supplementary Figure
S2 at http://www.biochemj.org/bj/452/bj4520223add.htm). The
essential histidine residue, which is also found in more divergent
Cas6 orthologues such as Cas6e and Cas6f, is not present in
SsoCas6. In fact, there were no histidine residues located around
the putative active site. This is also true for the majority of
crenarchaeal Cas6 orthologues, suggesting that there may be
considerable mechanistic diversity within the archaeal Cas6 fam-
ily (Supplementary Figure S3 at http://www.biochemj.org/bj/452/
bj4520223add.htm).
In order to identify residues important for catalysis, 12
conserved residues present around the putative catalytic
site of SsoCas6 were targeted by site-directed mutagenesis
(Supplementary Figure S3). The variant proteins were all
purified as for the wild-type enzyme and were assayed using a
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Figure 3 Dimerization of SsoCas6
(A) View of Leu170 and Val202 at the dimer interface. These residues were each changed to aspartate to disrupt the interface. (B) Gel-filtration elution profiles of dimeric SsoCas6 and the
SsoCas6-L170D/V202D variant, which elutes with a retention volume consistent with a monomeric composition (expected molecular mass of 33 kDa). (C) Thermofluor analysis of heat-induced
denaturation of wild-type (WT) and monomeric SsoCas6, showing the 7◦C difference in melting temperatures (Tm). (D) Single-turnover kinetic comparison of wild-type and monomeric SsoCas6.
The catalytic activity of the monomer is reduced by 95% compared with the wild-type (WT) enzyme.
single-turnover kinetic assay with radioactively labelled repeat
RNA as a substrate. Under single-turnover conditions at 60 ◦C,
wild-type SsoCas6 cleaved the RNA with a catalytic rate constant
of 0.80 min− 1 (Figure 4). Of the variant proteins assayed, the
replacement of Lys28 with alanine caused the largest reduction in
catalytic rate constant (>200-fold), suggesting that this residue,
which is strongly conserved in crenarchaeal Cas6 proteins
(Supplementary Figure S3), plays an important role in catalysis.
The K28H variant had equally low levels of activity, suggesting
that a histidine residue cannot substitute for a lysine in this context.
Other basic residues around the active site were also investigated.
The K25A, K51A, R231A and R269A variants all had catalytic
rate constants reduced at least 10-fold compared with the wild-
type protein (Figure 4D). The 40-fold decrease in rate observed
for K51A compared with the wild-type protein was similar to
that observed for the equivalent mutation of K52A in PfuCas6
[40]. Ser268, which sits in the highly conserved glycine-rich loop
between two conserved arginine residues, was changed to an alan-
ine, but the S268A variant showed only a modest effect on cata-
lytic rate. Changes to other potential active site residues, including
T21A, S46A, K161A, Y179F, E192A and S226A, had modest or
negligible effects on the activity of the enzyme (results not shown).
DISCUSSION
Dimerization of crenarchaeal Cas6 enzymes
The observation that SsoCas6 is a dimer was unexpected. The
hydrophobic dimer interface appears to be conserved in the
other crenarchaeal Cas6 orthologues, suggesting that this may
be a conserved feature of this family (Supplementary Figure
S3). In contrast, the other Cas6 enzymes studied to date are all
monomeric. This is likely to be a required property for the I-E
and I-F systems, where only a single copy of Cas6 is present in
the interference complex [41]. A monomeric protein would also
ensure the delivery of a single crRNA to the complex. However,
for PfuCas6, which is not strongly associated with effector
complexes, the paradigm still holds [3]. Dimerization of both the
Cas6 of Pyrococcus horikoshii and the Cas6b of Methanococcus
maripaludis has been noted, but only in the presence of pre-
crRNA [42,43]. Nevertheless, whereas the monomeric form of
SsoCas6 generated in the present study is soluble, the enzyme
is much less active than the wild-type dimeric protein. This
suggests that the dimeric organization may have some bearing on
catalysis, perhaps due to allosteric communication between the
two active sites. It is worth bearing in mind that the substrate
of Cas6 is a large pre-crRNA with many cleavage sites and
that two RNA-cleavage events are required to generate one unit-
length crRNA. The dimeric SsoCas6 structure has a broad area
of positive charge in the region spanning the dimer interface and
the two active sites (Figure 2D). It is possible that pre-crRNA
spans this region, allowing both active sites to engage and cleave
consecutive recognition sites. This would represent a departure
from the simple crRNA wrapping proposed for PfuCas6 [14].
Alternatively, the reduced activity of the monomer may simply
be a consequence of its reduced stability or of perturbation of the
active site geometry.
The active site of crenarchaeal Cas6
All Cas6 proteins studied in detail to date have an essential
histidine residue in the active site: for example, His46 in PfuCas6
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Figure 4 Delineating the SsoCas6 active site
(A) Phosphorimage of a denaturing polyacrylamide gel showing the reaction products of repeat RNA incubated with wild-type (WT) and selected variant Cas6 enzymes. Lane m shows an RNA ladder
generated by alkaline hydrolysis and lane c shows RNA incubated for 60 min in the absence of protein. Time points correspond to 1, 5 and 50 min incubations at 60◦C. The cleavage site is indicated
in the RNA sequence below the image. (B) Plot of the reaction kinetics for selected variants of SsoCas6 (red, wild-type, WT; black, S268A; green, K51A; blue, K28A). All data points were measured in
triplicate and are means+− S.E.M. (C) Structure of the SsoCas6 monomer. The glycine-rich loop is shown in yellow to highlight the approximate position of the active site. The positions of selected
side chains targeted by site-directed mutagenesis are shown as magenta sticks. Of these residues, it was not possible to define the absolute conformation of the side chains of Lys25, Lys28 and Lys51
from the electron density. Chains B and D are superimposed on chain A to include all of the desired residues. (D) First-order rate constants for wild-type and selected variant SsoCas6 enzymes.
Relative activity (Rel. act.) is expressed as a percentage of wild-type (WT) activity.
[40], His29 in PaCas6f [12] and His26 in TtCas6e [44]. The exact
location of the histidine residue differs in each of the available
crystal structures, but is located either in the N-terminal RAMP
α1 (TtCas6e and PaCas6f) or a non-conserved helix before α1
(PfuCas6) (Supplementary Figure S2). In M. maripaludis Cas6b,
two histidine residues have also been implicated in the catalytic
cycle, one of which probably corresponds to His46 of PfuCas6 [45].
The role of the catalytic histidine residue was originally thought
to be that of a general acid, donating a proton to the leaving
group during catalysis [40]. However, in Cas6f, the histidine is
deprotonated and acts as a general base, abstracting a proton
from the 2′-hydroxy nucleophile during the catalytic cycle [12].
Regardless, the crenarchaeal Cas6 enzymes lack any histidine
residues in proximity to the presumed active site, suggesting
that these enzymes employ another mechanism. Site-directed
mutagenesis suggests that Lys25, Lys28, Lys51 and Arg231, which
are conserved in crenarchaeal Cas6s (Supplementary Figure S3),
are important for catalysis. These residues may play a role in sta-
bilizing the pentacovalent phosphate transition state. Of the four,
Lys28 appears to be the closest to an essential catalytic residue.
Other residues targeted by mutation had rather modest effects
on catalysis. Tyr179 is well conserved in the crenarchaeal Cas6
family members and is suitably positioned to participate in
catalysis, situated on the right-hand side of the active-site cleft.
However, the fact that a phenylalanine residue is well-tolerated
at this position suggests that its role may relate to positioning of
other side chains or an RNA base. The only conserved acidic
residue near the active site, Glu192, is clearly not involved in
the catalytic cycle as the E192A variant retained full activity.
The catalytic site of SsoCas6 thus appears to be unusually
resistant to inactivation by targeted mutagenesis, with many
highly conserved residues apparently not essential for catalysis.
It is possible that many of these residues play a role in crRNA
binding, as the single-turnover assay employed in the present
study focuses purely on the chemical step of catalysis.
The single-turnover rate constant of SsoCas6, approximately 1
min− 1 at 60 ◦C, is rather low, although comparable with those of
the other Cas6 family enzymes that have been studied [12]. These
rates are more akin to those observed for ribozymes than for
ribonucleases [46]. However, they are presumably high enough to
c© The Authors Journal compilation c© 2013 Biochemical Society© 2013 The Author(s)
The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Licence (CC-BY) (http://creativecommons.org/licenses/by/3.0/)
which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.
Structure of crenarchaeal Cas6 229
fulfil the proteins’ functions in pre-crRNA processing in vivo,
where it is probably more important to be a highly specific
ribonuclease than a highly active one. The ease with which
crRNA cleavage sites can evolve is exemplified by the type I-C
CRISPR system. This subtype lacks a cas6 gene and instead the
Cas5d protein is catalytic, cleaving pre-crRNA in vitro [47,48].
A putative catalytic triad consisting of Tyr46, Lys116 and His117 has
been identified [47], but these residues are located on a different
part of the RAMP domain compared with the active site of Cas6
proteins, suggesting that the active site has evolved independently.
The crystal structure of S. solfataricus Cas6 has revealed a
dimeric organization that may be relevant for its in vivo function
as a stand-alone crRNA-processing endonuclease. The paradigm
of an ‘active-site histidine residue’ for this enzyme family seems
untenable, as no such residue exists within range of the active
site. Instead, site-directed mutagenesis has revealed a network
of basic residues that each contribute towards catalytic activity
without being absolutely essential. The catalytic rate constants of
Cas6 family enzymes are so low that they could be considered as
much as RNA chaperones as true enzymes. This is particularly
relevant for the enzymes that bind hairpin RNA structures very
tightly and do not support multiple-turnover catalysis.
While this paper was in revision, Shao and Li [49] reported
the crystal structure of a closely related SsoCas6 enzyme in
complex with crRNA. This structure is also dimeric and site-
directed mutagenesis confirmed the importance of Lys25, Lys28,
Lys51 and Arg232 for catalysis.
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Introduction
Clustered regularly interspaced short palindromic repeats 
(CRISPRs) are a prokaryotic mechanism for preventing hori-
zontal gene transfer (HGT) and infection by mobile genetic ele-
ments.1-3 The CRISPR array consists of identical repeats separated 
by short “spacers” derived from previously encountered foreign 
genetic elements.4-7 Linked to the CRISPR array are CRISPR-
associated (cas) genes, which encode the proteins that mediate 
the CRISPR response to the insertion of foreign double-stranded 
DNA (dsDNA) or single-stranded RNA (ssRNA) into the cell.8-
10 The response can be divided into three stages: adaptation, the 
integration of new spacers into the CRISPR array; expression, 
the transcription of the array and processing of the transcript to 
short, mature CRISPR RNAs (crRNA); interference, the recog-
nition and degradation of foreign dsDNA or ssRNA.
cas genes are arranged in loci, which can be classified into one 
of three main systems (types I, II and III) based on the identity 
and order of genes in the locus.10 The CRISPR/Cas systems can 
be further subdivided into a total of 10 subtypes (Fig. S1), all of 
The Cascade complex for CRISPR-mediated antiviral immunity uses CRISPR RNA (crRNA) to target invading DNA species 
from mobile elements such as viruses, leading to their destruction. The core of the Cascade e!ector complex consists 
of the Cas5 and Cas7 subunits, which are widely conserved in prokaryotes. Cas7 binds crRNA and forms the helical 
backbone of Cascade. Many archaea encode a version of the Cascade complex (denoted Type I-A) that includes a Csa5 
(or small) subunit, which interacts weakly with the core proteins. Here, we report the crystal structure of the Csa5 protein 
from Sulfolobus solfataricus. Csa5 comprises a conserved α-helical domain with a small insertion consisting of a weakly 
conserved β-strand domain. In the crystal, the Csa5 monomers have multimerized into in"nite helical threads. At each 
interface is a strictly conserved intersubunit salt bridge, deletion of which disrupts multimerization. Structural analysis 
indicates a shared evolutionary history among the small subunits of the CRISPR e!ector complexes. The same α-helical 
domain is found in the C-terminal domain of Cse2 (from Type I-E Cascade), while the N-terminal domain of Cse2 is found in 
Cmr5 of the CMR (Type III-B) e!ector complex. As Cmr5 shares no match with Csa5, two possibilities present themselves: 
selective domain loss from an ancestral Cse2 to create two new subfamilies or domain fusion of two separate families 
to create a new Cse2 family. A de"nitive answer awaits structural studies of further small subunits from other CRISPR 
e!ector complexes.
Structure of the archaeal Cascade subunit Csa5
Relating the small subunits of CRISPR e!ector complexes
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Sulfolobus solfataricus
which, except type III-B, target dsDNA.11-13 Uniquely type III-B 
targets ssRNA.14,15 The type I interference complex is known as 
the CRISPR-associated complex for antiviral defense (Cascade). 
The exemplar is the type I-E complex (eCascade) from E. coli,13 
which consists of Cas5, Cas6e, Cas7, Cse1 and Cse2 in a 1:1:6:1:2 
stoichiometry with the six Cas7 subunits forming a central heli-
cal spine to which crRNA and all the other subunits bind.16 
This topology appears to be conserved in the type I-C and I-F 
systems.17,18
Significantly less is known about the effector complex of type 
I-A systems (aCascade, also known as the archaeal Cascade), 
which consists of Cas5, Cas7, Csa5 and in some systems Cas8a1 
or Cas8a2. It has not yet been possible to purify a full aCas-
cade complex; the Sulfolobus solfataricus (Sso) aCascade partly 
dissociates during purification,19 while the Thermoproteus tenax 
complex is insoluble after overexpression, with minimal soluble 
material after refolding.20 Only a stable core complex of Cas5 
and Cas7 remains after the partial dissociation of Sso aCascade. 
The Cas5/Cas7 complex forms helical oligomers reminiscent of 
the Cas7 backbone of eCascade. Interestingly this core complex 
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by the genes sso1398-1400 and sso1441-1443 
(Fig. 1A). The two Csa5 paralogs share 11% 
sequence identity. Experiments described 
here utilize the Sso1441-1443 proteins unless 
otherwise indicated. Immunoprecipitation 
of the Cas5/Cas7 core complex from S. sol-
fataricus cell lysates using affinity-purified 
antibodies raised against the recombinant 
complex co-precipitated small amounts of 
Csa5 (Fig. 1B). The reciprocal experiment 
using antibodies against Csa5 pulled down 
both Cas5 and Cas7. The small amounts 
that are co-immunoprecipitated are indica-
tive of a weak interaction between Csa5 
and Cas5/Cas7, consistent with the disso-
ciation of Csa5 from the complex during 
purification.19
Lintner et al.19 showed that cellular Cas5/
Cas7 (Sso1441-1442) bound to crRNA, raising 
the possibility that Csa5 only binds to Cas5/
Cas7 in the presence of crRNA. Fluorescently 
labeled oligonucleotides were used for fluores-
cence anisotropy experiments to determine 
interactions between Cas5/Cas7 and Csa5. 
Consistent with previous studies,19 the Cas5/
Cas7 complex bound to fluorescently labeled 
crRNA with a dissociation constant (KD) of 
1.38 ± 0.14 μM (Fig. 2A). However, Csa5 itself 
did not form a stable interaction with crRNA, 
ssDNA or a heteroduplex formed from crRNA 
and ssDNA containing a protospacer in vitro 
(Fig. 2B), nor did we observe convincing evi-
dence for binding to a pre-formed complex of 
Cas5/Cas7/crRNA (Fig. 2C).
The crystal structure of Csa5. The lim-
ited solubility of Csa5 encoded by Sso1443 
hindered its crystallization and so its paralog, 
Sso1398, was crystallized. The structure was solved using a sele-
nomethionyl variant with diffraction recorded to a resolution of 
2.7 Å (Fig. 3A and Table 1). The asymmetric unit (ASU) con-
taines nine monomers and each protein monomer is constructed 
of two domains, denoted α and β (Fig. 3B). The α-domain is an 
all α-helical arrangement consisting of α1-α4, formed by residues 
5–64 and α6 and α7 formed by residues 130–162. The β-domain is 
formed by residues 65–129 and is an insertion between α4 and α6. 
The β-domain contains a single helix (α5) and six β-strands (β1-
β6) arranged as three anti-parallel two-stranded β-sheets (Fig. 3A). 
Residues 1–4 were disordered in all monomers; the loops connect-
ing β1-β2 and β5-β6 were disordered in some monomers. The resi-
dues that are conserved across the Csa5 family are located in the 
α-domain, although the short β6 strand may show some conserva-
tion (Fig. S2). The β-domain insertions of Csa5 homologs vary in 
length from 20–67 residues and show minimal sequence conserva-
tion, even between closely related strains (Fig. S2).
Strikingly the nine monomers of the ASU are assembled in a 
continuous helical oligomer that, due to crystal symmetry, creates 
is capable of binding crRNA and a heteroduplex formed from 
crRNA and protospacer, a mimic of the R-loop structure formed 
during interference.19 Csa5 has been shown to interact with this 
complex, though its role within aCascade is unknown.19
The genome of S. solfataricus encodes three possible aCascade 
complexes as well as one CSM complex and three CMR com-
plexes.21 Here, we report the crystal structure and initial func-
tional characterization of the archaeal-specific Cascade subunit 
Csa5. Structural homology shows that Csa5 and Cse2, a subunit 
of eCascade, have one domain in common. In addition, the sec-
ond domain of Cse2 is shown to have a fold related to the small 
subunit (Cmr5) of the archaeal type III-B system. Altogether, 
these observations highlight the conservation of structural ele-
ments in diverse CRISPR effector complexes.
Results
Csa5 interacts with the Cas5/Cas7 complex. The two copies 
of S. solfataricus aCascade studied in this paper are encoded 
Figure 1. Gene organization and protein interactions of archaeal Cascade subunits. (A) 
Two of the type I-A cas loci from S. solfataricus showing the gene numbers and families. (B) 
Co-immunopreciptiation of Csa5 and Cas5/Cas7 from S. solfataricus cell extracts. Antibodies 
raised against Cas5/Cas7 pull down Csa5 from cell extracts (top two panels). Antibodies raised 
against Csa5 pull down small amounts of Cas5/Cas7 from cell extracts (middle two panels). 
Csa5 pre-immune complex did not pull down any of the proteins (bottom two panels). The 
marker lanes (m) contain recombinant proteins as size markers.
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protein. Dynamic light scattering experiments showed that the 
mutant had a smaller radius of gyration than the wild-type, sup-
porting the gel filtration data (Fig. 4B).
As both residues are conserved, we reasoned the salt bridge 
may be a conserved feature, so we examined the effect of the 
corresponding D32A mutation in Sso1443 (Csa5 itself). 
Recombinant wild-type Csa5 had a solubility limit of 1 mgml-1, 
whereas Csa5D32A exhibited a > 10-fold increase in solubility. 
Csa5D32A eluted from a gel filtration column consistent with a 
monomeric species, an observation independently supported by 
isothermal calorimetry (Fig. S4).
Structural homology to other Cas proteins. The structure 
of Sso1398 was compared with known structures and while the 
PDBeFold server23 did not find any significant matches, the 
DALI server24 detected homology for the α-domain while the 
β-domain does appear to be unique. The α-domain (excluding 
α1) matched the C-terminal domain of Cse2 from Thermus ther-
mophilus25 (PDB 2ZCA, Z score 4.5, 2.7 Å over 73 residues) and 
to a lesser extent Cse2 from Thermobifida fusca26 (PDB 4H79, 
Z-score 2.9, 2.9 Å over 73 residues). It is also similar to the 
N-terminal domain of StySJI M, a Type I HsdM subunit from a 
restriction enzyme of Bacteroides thetaiotaomicron (PDB 2OKC, 
Z score 3.3, 2.6 Å over 68 residues); the domain itself has no 
assigned function.
an infinite helical thread (Fig. 3B). The continuous helix has a 
pitch of 18 nm and a width of 8 nm. The crystal is composed of 
bundles of these infinite threads. Within the ASU, the nine mono-
mers are essentially identical, superimposing with an average Cα 
rmsd of 0.21 Å. The nine interfaces within the ASU show subtle 
differences, suggesting a level of plasticity at the interface (Fig. S3). 
Analysis of the electrostatic potential of the solvent-exposed surface 
does not reveal any regions of significant positive charge (Fig. 3C), 
consistent with the observed lack of binding to nucleic acids.
Oligomerization of Csa5 proteins. The interfacing residues 
are predominantly located in the α-domain with a few contacts 
from β1, β2 and β6. Analysis of the interfaces within the heli-
ces using the PDBe PISA server22 showed that 1100 Å2 of sur-
face area from each monomer was buried within a “dimer.” The 
interfaces are hydrophilic and are scored in PISA as unstable in 
solution. In our analysis, we noted an intersubunit salt bridge 
between two conserved residues, Asp35 and Arg55 (Figs. 3D; 
Fig. S2). Disrupting this salt bridge (Sso1398D35A) led to the 
protein eluting from a calibrated gel filtration column with a 
larger retention volume than the wild-type protein (16.4 ml and 
13.9 ml, respectively) (Fig. 4A), indicating that the mutant is 
smaller. The estimated weights of both native and mutant are 
physically unrealistic (26 and 6 kDa, respectively, where a mono-
mer is 19 kDa) and we attribute this to the unusual shape of the 
Figure 2. Analysis of the interactions of aCascade with nucleic acids using !uorescence anisotropy. (A) The average change in anisotropy upon bind-
ing of the Cas5/Cas7 complex to !uorescent crRNA. Experiments were performed in triplicate and error bars represent the standard error of the data. 
The data were "tted to a binding curve with a KD of 1.38 ± 0.14 μM (error estimated from curve "tting). (B) Csa5 does not interact with crRNA, ssDNA or 
a heteroduplex of crRNA and protospacer. (C) Csa5 does not interact with a pre-formed complex of Cas5/Cas7/crRNA.
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Cse2 forms a dimer in eCascade, which creates a positively 
charged surface for interacting with nucleic acids.16 This face is 
formed by both domains of the protein and, therefore, is only par-
tially conserved in Csa5. This surface is not significantly positively 
charged in Sso1398 or in a homology model of Csa5. Although 
Csa5 possesses a weakly positively charged face at the base of the 
α-domain (Fig. S5), the residues that form it are not well-conserved 
across the family. Cse2 itself is capable of binding both dsDNA 
and ssRNA non-specifically26 and an eCascade-crRNA complex 
lacking Cse2 shows reduced binding affinity for target plasmid 
DNA.27 It has been hypothesized that Cse2 stabilizes the R-loop 
nucleotide structure by either binding the RNA/DNA heterodu-
plex directly or indirectly by binding to non-complementary DNA 
strand. In contrast, Csa5 did not bind to any nucleic acid tested, 
including a DNA/RNA heteroduplex and ssDNA, both of which 
are present in an R-loop. Therefore, despite the structural homol-
ogy between Cse2 and Csa5, these two proteins may play different 
roles within their respective Cascade complexes.
In a recent bioinformatics study, Makarova et al. suggested that 
several small Cas proteins, which were predicted to be largely heli-
cal, could be combined into a new family (Cas11).28 The putative 
Cas11 family has been proposed to comprise Csa5 (type I-A), Cse2 
(type I-E), Csm2 (type III-A) and Cmr5 (type III-B) as well as 
the C-terminal helical domain of Cas8 (various subtypes). Crystal 
structures are now available for three of these protein families: 
Csa5 (Sso1398), Cse2 (TthCse2 and TfuCse2) and Cmr5 “T. ther-
mophilus (PDB 2ZOP)25 and Archaeoglobus fulgidus (PDB 2OEB),” 
Discussion
Our data show that the interaction of the Csa5 subunit with 
the core Cascade structure is below the detection limit of the 
biophysical techniques we employed. Pull-down experiments 
also point to the interaction being weak. Of course, we cannot 
exclude the possibility that additional factors such as Cas6 and/or 
the presence of target DNA are required for assembly. However, 
in general our data fit with an emerging picture that Csa5 easily 
dissociates from the aCascade complex.
The structure of the paralog Sso1398 shows a remarkable 
arrangement in the crystal. The continuous helical oligomers 
are reminiscent of the Cas7 helical backbone that appears to be 
a conserved feature of Cascade complexes.16-18 The S. solfataricus 
Cas7 oligomer exhibits a helical pitch of 14 nm,19 which is broadly 
compatible with the Csa5 pitch of 18 nm. The helical threads are 
stabilized by a conserved pair of residues that form an intersubunit 
salt bridge. The absolute conservation of these residues is striking, 
as only one other residue (Ala158, located in the hydrophobic core) 
is completely conserved across the Csa5 family (Fig. S2). Mutation 
of the salt bridge both in the paralog and in Csa5 itself results in a 
profound change in the biophysical properties of the proteins. In 
both proteins, the mutant is smaller and less prone to aggregation. 
Since the change is seen in both proteins and the salt bridge is 
conserved, we hypothesize that the interface (but not the infinite 
threads) has a functional significance that will be revealed when 
the structure of the aCascade complex is determined.
Figure 3. The crystal structure of Sso1398. (A) The Sso1398 monomer consists of the α-domain (yellow) and the β-domain (purple). Secondary struc-
ture elements are labeled and the N- and C-termini are shown as blue and red spheres, respectively. (B) The crystal contains chains of helical oligomers 
of Sso1398, shown here across three ASUs with the molecules of one ASU shown in colors. The helical pitch and width are indicated. (C) Electrostatic 
surface potential of a monomer of Sso1398 calculated using CCP4MG.41 (D) Close up of the box in (B). A conserved salt bridge forms at the dimer inter-
face between Asp35 (green) and Arg55 (cyan) and contributes signi!cantly to the stability of the oligomer.
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oligonucleotide sequences used for cloning and mutagenesis are 
available on request.
Expression and purification. Sso1398, Sso1443 and their 
variants were expressed in C43 (DE3) E. coli in LB medium 
using 1.0 or 0.4 mM isopropyl β-D-1-thiogalactopyranoside 
(IPTG), respectively, to induce protein expression. The cultures 
were incubated at 37°C throughout (Sso1398) or 25°C (Sso1443) 
after induction and the cells harvested after overnight incuba-
tion. The selenomethionyl derivative of Sso1398 was expressed in 
B834 (DE3) E. coli grown in M9 minimal medium supplemented 
with Selenomethionine Nutrient Mix (Molecular Dimensions) 
and 50 mgL-1 (L)-selenomethionine. The expression conditions 
were as with the native protein except the cells were harvested 
after 30 h. Sso1441 and Sso1442 were co-expressed in E. coli as 
described previously.19
All proteins were purified using previously published proto-
cols.19,29 Briefly, cell pellets were resuspended and then lysed by 
sonication (MSE Soniprep) or with a cell disruptor (Constant 
Systems Ltd.). The lysate was cleared by centrifugation and 
passed over a Ni-NTA column (Qiagen). The eluted protein was 
incubated with TEV protease and then re-applied to the col-
umn before application to a Superdex S75 gel filtration column 
(GE Healthcare) equilibrated in 20 mM Tris pH 7.5, 150 mM 
NaCl (Sso1398) or 20 mM Tris pH 7.5, 500 mM NaCl, 10% 
glycerol (Sso1443). One mM β-mercaptoethanol was added to 
all buffers during purification of the selenomethionyl deriva-
tive. All proteins were concentrated to ≥ 10 mgml−1 except 
for wild-type Sso1443, which was to 1 mgml−1 due to low 
solubility.
Pull-down interactions. For the production of antibodies, 
1 mg of purified recombinant Csa5 or Cas5/Cas7 protein was 
used to raise polyclonal antibodies in sheep (Scottish National 
Blood Transfusion Service). The antibodies were affinity purified 
using cyanogen bromide-activated-Sepharose 4B resin (Sigma). 
The target protein (Cas5/Cas7 or Csa5) and resin were incubated 
allowing an assessment of these predictions. The α-domain of 
Sso1398 is indeed homologous to the C-terminal domain of Cse2 
(Fig. 5) but neither it nor the β-domain bears any resemblance to 
either Cmr5 structure. However, the N-terminal domain of Cse2 
is homologous to four helices of Cmr5 (Cα rmsds of 3.2 Å over 50 
residues and 3.0 Å over 60 residues to AfuCmr5 and TthCmr5, 
respectively) (Fig. 5). Sequence conservation between the struc-
tures is limited to residues of the hydrophobic core; the lack of 
conservation in exposed residues would argue against a common 
function. This is supported by the different properties of Csa5 and 
Cse2 combined with the observation that Cmr5 is not essential for 
the function of the CMR complex,15 whereas loss of Cse2 signifi-
cantly impacts the activity of eCascade.27
Analysis of the structures reveals a nuanced set of relationships 
among the small subunits. Of the two domains of Cse2, one is 
found in the Cmr5 family and the other in the Csa5 family; there 
is no structural relationship between the Cmr5 and Csa5 families. 
This is consistent with either selective loss of one or other domain 
from the ancestral Cse2 (Cas11) family during the diversifica-
tion of the CRISPR/Cas systems to form the Cmr5 and Csa5 
lineages, or alternatively a fusion of the Cmr5 and Csa5 families 
to create the Cse2 lineage as the Csa5 and Cmr5 proteins have 
nothing in common beyond a potential shared ancestor in Cse2. 
To further elucidate the evolutionary relationships between the 
so-called small subunits of the interference complexes, the struc-
ture of Csm2 would be particularly helpful, as it is a key remain-
ing missing piece. The full-length structure of Cas8 is also likely 
to be useful in firmly establishing such relationships.
Materials and Methods
Cloning. sso1398 was cloned into the pDEST14 plasmid29 and 
sso1443 into pET151/D-TOPO (Invitrogen) with cleavable 
N-terminal His6-tags. Mutations were introduced using pub-
lished30 or standard QuikChange (Stratagene) protocols. The 
Figure 4. The oligomerization of Csa5. (A) Gel "ltration elution pro"les for Sso1398WT and Sso1398D35A using 2 mgml-1 protein loaded onto a 
Superose 12 10/300 column. The proteins ran aberrantly on gel "ltration and so the masses of the oligomers could not be accurately estimated. (B) 
Representative radius distributions of Sso1398WT and Sso1398D35A determined by dynamic light scattering.
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of which was 100 mM glycine pH 2.5 directly into 1 M Tris pH 
8.0. The resin was further washed with 10 mM Tris pH 8.8 and 
the antibodies then eluted with 100 mM triethylamine pH 11.5 
into 1 M Tris pH 8.0. The purified antibodies were dialyzed into 
PBS and then cross-linked to Protein G Sepharose (Sigma) by 
incubating together in TBS buffer followed by cross-linking with 
20 mM dimethyl pimelimidate in 0.2 M triethanolamine. The 
beads were washed with trithenaolamine and ethanolamine before 
overnight in 0.1 M NaHCO3 pH 8.3, 0.5 M NaCl at 4°C. The 
resin was washed with buffer, resuspended in 1 M ethanolamine 
pH 8.0 and incubated at 4°C overnight. The resin was washed 
with 0.1 M NaHCO3 pH 8.3, 0.5 M NaCl and then 10 mM Tris 
pH 4.0 for four cycles followed by incubation with the immune 
serum in 10 mM Tris pH 7.5 at 4°C overnight. The resin was 
washed with 10 mM Tris pH 7.5 and then 10 mM Tris pH 7.5, 
0.5 M NaCl. The antibodies were eluted in two stages, the first 
Figure 5. Structural homology between Csa5, Cse2 and Cmr5. (A) The structures of AfuCmr5 (PDB 2OEB, right), TthCse2 (PDB 2ZCA, middle) and Csa5 
(right). Structural features conserved between Cmr5 and Cse2 are shown in shades of blue and between Cse2 and Csa5 in shades of yellow. Non-con-
served features are shown in green (Cmr5), orange (Cse2) and purple (Csa5). (B) Connector diagrams of the three proteins highlighting the conserved 
connectivity of the structural elements. (C) Superposition of the conserved helices of AfuCmr5, TthCse2, TthCmr5 (navy) and TfuCse2 (pale blue). (D) 
Superposition of the conserved helices of TthCse2, TfuCse2 (brown) and Csa5.
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Dynamic light scattering. DLS experiments were performed 
using a Zetasizer μV system (Malvern Instruments) with a quartz 
SUPRASIL® cuvette. The experiments were performed at room 
temperature and in triplicate. The data were analyzed using the 
Zetasizer software.
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incubation with S. solfataricus P1 cell lysate prepared as described 
previously.19 After overnight incubation at 4°C, the beads were 
washed with TBS and the bound protein eluted with sodium 
citrate pH 2.5. Samples were run on NuPAGE SDS-PAGE gels 
(Invitrogen) and blotted onto iBlot stacks (Invitrogen). The sam-
ples were blocked with 5% milk powder in PBS, 0.05% TWEEN 
for 1 h and then incubated with the primary antibody of choice. 
The blots were incubated with 1:10,000 Immunopure rabbit 
anti-goat HRP (Thermo Scientific) in PBS, 0.1% TWEEN for 
1 h and then visualized with SuperSignal West Pico kit (Pierce) 
according to the manufacturer’s instructions.
Fluorescence anisotropy. Synthetic oligonucleotides were 
purchased from Integrated DNA Technologies of fluorescently 
labeled crRNA from spacer 26 of CRISPR locus A of S. solfa-
taricus P1, non-labeled complementary target ssDNA with 
PAM sequence and fluorescently labeled non-target ssDNA (see 
Table S1 for sequences). crRNA and protospacer were mixed 1:1, 
heated at 80°C for 5 min and cooled slowly to form a hetero-
duplex. Fluorescence anisotropy measurements (λex 490 nm, λem 
535 nm) were recorded using a Varian Cary Eclipse fluorescence 
spectrophotometer at room temperature. Protein solutions were 
titrated into 20 nM crRNA, 20 nM non-target ssDNA or 20 nM 
heteroduplex in 20 mM Tris pH 7.5, 150 mM NaCl, 5% glyc-
erol, 1 mM EDTA. Measurements were recorded over a range of 
protein concentrations (0.04 –11 μM). The data were analyzed 
using KaleidaGraph (Synergy Software) and, where appropriate, 
fitted to binding curves.
Crystallization of Sso1398. The selenomethionyl derivative 
of Sso1398 was crystallized at 2 mg ml-1 in vapor diffusion sit-
ting drop experiments at 20°C. The crystals grew in a condition 
of 1:1 protein-to-precipitant with a reservoir of 0.1 M sodium 
acetate pH 4.0, 0.23 M potassium chloride and 39% PEG500. 
The crystals were cryo-cooled in liquid nitrogen directly from 
the drop. A single-wavelength anomalous diffraction data set was 
collected at the Se-K absorption edge at 100 K on the microfocus 
beamline I24, Diamond Light Source. The data were processed 
with xia231 and the phases solved using Phenix AutoSolve.32 
The electron density map was further modified using Parrot33 
before chain tracing with Buccaneer,34 both as part of the CCP4 
suite.35 The chains were manually assigned followed by auto-
mated model building with Phenix AutoBuild.32 The model was 
refined by cycles of manual correction in COOT36 and refine-
ment with REFMACv5.637 using TLS constraints generated 
using the TLSMD web server.38,39 The structure was validated 
with MolProbity.40




Wavelength (Å) 0.98 Rwork/Rfree 0.20/0.22
Space group C 1 2 1 Mean B-value (Å2)
a, b, c (Å) 285.0, 53.7, 216.7 All atoms 43
α, β, γ (°) 90.0, 124.7, 90.0 Protein 43
Resolution (Å) 2.72 Water 26
I/σI 12.3 (2.3) PEG 55
Rmerge 0.109 (0.814) Rmsd
Completeness 100.0 (100.0) Bond lengths (Å) 0.01





Data are presented as averages with statistics for the highest resolution 
shell in parentheses.
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CRISPR interference: a structural perspective
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CRISPR (cluster of regularly interspaced palindromic repeats) is a
prokaryotic adaptive defence system, providing immunity against
mobile genetic elements such as viruses. Genomically encoded
crRNA (CRISPR RNA) is used by Cas (CRISPR-associated)
proteins to target and subsequently degrade nucleic acids of
invading entities in a sequence-dependent manner. The process
is known as ‘interference’. In the present review we cover recent
progress on the structural biology of the CRISPR/Cas system,
focusing on the Cas proteins and complexes that catalyse crRNA
biogenesis and interference. Structural studies have helped in
the elucidation of key mechanisms, including the recognition
and cleavage of crRNA by the Cas6 and Cas5 proteins, where
remarkable diversity at the level of both substrate recognition
and catalysis has become apparent. The RNA-binding RAMP
(repeat-associated mysterious protein) domain is present in the
Cas5, Cas6, Cas7 and Cmr3 protein families and RAMP-like
domains are found in Cas2 and Cas10. Structural analysis has
also revealed an evolutionary link between the small subunits of
the type I and type III-B interference complexes. Future studies
of the interference complexes and their constituent components
will transform our understanding of the system.
Key words: antiviral defence, cluster of regularly interspaced
palindromic repeats (CRISPR), crystallography, evolution,
protein structure, repeat-associated mysterious protein (RAMP).
INTRODUCTION
CRISPRs (cluster of regularly interspaced palindromic repeats)
are a prokaryotic defence mechanism against viral infection
and horizontal gene transfer. CRISPRs are the largest family
of prokaryotic repeats [1] and have been found in 48% of
bacterial and 84% of archaeal sequenced genomes to date [2].
A CRISPR array consists of a series of short identical repeat
sequences separated by similarly short variable sequences known
as spacers [3]. Located adjacent to the CRISPR array are clusters
of cas (CRISPR-associated) genes [4] that encode for the proteins
responsible for mediating the CRISPR response to foreign nucleic
acids. The spacers are derived from foreign nucleic acids, such
as viruses and conjugative plasmids, and provide the host with
a ‘genetic memory’ of threats previously encountered [1,5,6].
New spacers are captured in a poorly understood process known
as ‘adaptation’ and incorporated into the CRISPR locus [7].
The spacers are used to target foreign nucleic acids containing
sequences complementary to the spacer, termed protospacers, for
degradation [8]; the process is termed ‘interference’.
The first step in the interference pathway is the transcription
of the CRISPR array from a promoter located in the ‘leader’
sequence, an AT-rich region located upstream of the CRISPR
array [4,9]. The array transcript {pre-crRNA [precursor crRNA
(CRISPR RNA)]} is then processed into short crRNAs containing
a spacer and flanking repeat fragments (Figure 1) [10].
These crRNAs are subsequently bound by complexes of Cas
proteins and used to target homologous foreign dsDNA (double-
stranded DNA) or ssRNA (single-stranded RNA) for nucleolytic
degradation during CRISPR interference (Figure 1) [8,11].
The CRISPR/Cas systems are divided into three main types (I,
II and III) on the basis of the identity and organisation of genes
within a cas locus [12]. These types are further divided into a total
of ten subtypes (I-A, I-B and so on), each of which expresses a
different protein complex responsible for interference (Figures 1
and 2). The Cascade (CRISPR-associated complex for antiviral
defence) is the effector complex for type I systems [8,13–15].
This name was originally used solely for the type I-E complex
[8], which we here call eCascade, but increasingly Cascade is used
more as a general term for all type I complexes. Type II systems
use a single protein for interference (Cas9) [16], whereas the III-B
subtype uses the CMR complex [11]. The interference complex
of the III-A subtype has yet to be characterized biochemically,
but the similarity of the III-A and III-B operons suggests that
interference is indeed mediated by an effector complex rather than
a single protein. As a result the putative complex has been termed
the CSM complex [12]. Every CRISPR/Cas system apart from the
III-B subtype is thought to target dsDNA by forming an R-loop
structure, consisting of a heteroduplex between crRNA and the
complementary protospacer strand and a ssDNA (single-stranded
DNA) non-complementary strand, followed by degradation by the
interference nuclease (Figure 1) [8,17–19]. The CMR complex
targets ssRNA by forming an RNA duplex, which is subsequently
cleaved [11,20].
The mechanisms of adaptation and CRISPR interference have
been extensively reviewed (see references [21–26]). In the present
review we will focus on the structural biology of the CRISPR
system. Crystal structures are available for eight of the ‘core’ Cas
proteins (those found in multiple subtypes) as well as a number
of subtype-specific proteins (Figure 2 and Supplementary Table
Abbreviations used: BhCas5c, Bacillus halodurans Cas5c; CRISPR, cluster of regularly interspaced palindromic repeats; Cas, CRISPR-associated;
Cascade, CRISPR-associated complex for antiviral defence; crRNA, CRISPR RNA; dsDNA, double-stranded DNA; EcoCas3, Escherichia coli Cas3;
EM, electron microscopy; HD, histidine–aspartate; MjaCas3′ ′, Methanocaldococcus jannaschii Cas3′ ′; PaCas6f, Pseudomonas aeruginosa Cas6f; PAM,
protospacer adjacent motif; PfuCas, Pyrococcus furiosus Cas; pre-crRNA, precursor crRNA; RAMP, repeat-associated mysterious protein; RRM, RNA
recognition motif; ssDNA, single-stranded DNA; SsoCas, Sulfolobus solfataricus Cas; ssRNA, single-stranded RNA; SthCas3, Streptococcus thermophilus
Cas3; tracrRNA, trans-activating crRNA; TtCas, Thermus thermophilus Cas.
1 Correspondence may be addressed to either of these authors (email naismith@st-and.ac.uk or mfw2@st-and.ac.uk).
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Figure 1 Schematic representation of crRNA biogenesis and CRISPR interference
Processing events involving nucleic acids are coloured; repeats (black), spacers (red–green) and tracrRNA (magenta). For clarity, a single spacer (red) was used to illustrate the processes, although
in actual systems all spacers are processed. Targets are shown in other red shades (lighter for the complementary strand and darker for the non-complementary). The PAMs are shown in blue. The
pre-crRNA and interference nucleases are indicated along with the interference complexes.
S1 at http://www.biochemj.org/bj/453/bj4530155add.htm). The
structures of proteins involved in spacer acquisition have provided
interesting insights into their function within the CRISPR/Cas
system as well as to similarities to non-Cas proteins, such as the
parallels between Cas2 and VapD of the toxin/antitoxin system
[27], but will not be discussed further in the present review.
EM (electron microscopy) images and structures have been
determined for five interference complexes, providing invaluable
information on the function of each subunit. CRISPR systems
are remarkably diverse and subject to rapid evolutionary change.
Analysis of the key structural features of Cas proteins involved in
crRNA biogenesis and interference highlights recurring themes
and points to evolutionary relationships between apparently
distinct protein families.
PRE-crRNA PROCESSING AND crRNA BIOGENESIS
crRNA provides the CRISPR/Cas system with the sequence
specificity needed to selectively target foreign nucleic acids.
Mature crRNAs are produced from a single long transcript of the
CRISPR array (pre-crRNA), which is processed to yield spacers
with 5′ and/or 3′ repeat fragments (Figure 1) [10,28,29]. The
method and nature of pre-crRNA processing is dependent on
the CRISPR/Cas system. Type I and III systems use the Cas6
endonuclease to cleave pre-crRNA within the repeat sequence
[8,13,15], with the exception of I-C systems that instead use
a catalytic variant of Cas5 [14,30]. The crRNAs from various
type III systems are further processed to reduce or remove the
repeat sequence at the 3′ end [11,31]. The enzyme responsible
for this degradation is not yet known. The type II system uses a
very different mechanism, requiring the transcript of an anti-sense
near-perfect repeat and flanking sequences [tracrRNA (trans-
activating crRNA)] located adjacent to the CRISPR array for
processing [32]. The duplex formed by pre-crRNA and tracrRNA
is bound by Cas9 and cleaved in the repeat sequence by cellular
RNase III and then in the spacer by an unknown nuclease to leave
a spacer fragment and a 3′ repeat fragment [32].
Cas6 and the catalytic type I-C Cas5 [Cas5c, also confusingly
known as Cas5d (Dvulg subtype)] catalyse the same reaction. The
pre-crRNA is cleaved upstream of the spacer (8 nt for Cas6, 11 nt
for Cas5c) [8,13,14,33,34] generating crRNA with a 5′ repeat-
derived sequence known as the ‘5′-handle’ or ‘5′-tag’ that is
critical for interference [20,35]. CRISPR repeats can be divided
into twelve families based on sequence and secondary structure
[36]. Cas5c targets repeats containing hairpin structures, whereas
the subfamilies of Cas6 proteins, which broadly align with the
CRISPR/Cas system with which they are associated, can cleave
either unstructured or hairpin-containing repeats [14,33,37,38].
In type I systems, Cas6 can form an integral part of Cascade
or it can exhibit a more transient interaction. Cas6e and Cas6f
remain tightly bound to their cleaved products with low or sub-
nanomolar affinities, and form part of their respective Cascades
[15,37,39,40]. In fact, the type I-F complex (f Cascade) assembles
specifically around a pre-formed Cas6f/crRNA complex [41].
Cas6 interacts more transiently with the I-A archaeal Cascade
(aCascade) [13,42]. Cas6 is not part of the type III-B CMR
complex [11,20], and the associations of Cas6 with the type I-
B, I-D and III-A complexes are unclear.
The structures of Cas5c and Cas6
Cas5 and Cas6 both belong to the RAMP (repeat-associated
mysterious protein) superfamily. These proteins contain one or
more RAMP domains, which form ferredoxin-like folds similar to
that of the RRM (RNA recognition motif) domain [43], consisting
of a four-stranded antiparallel β-sheet (arranged as β4β1β3β2)
flanked on one face by two α-helices located after β1 and β3 in a
βαββαβ fold (Figure 3A). Five conserved sequence motifs have
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Figure 2 The CRISPR/Cas systems and their respective proteins
Typical gene identities are shown for CRISPR/Cas subtypes according to the recent classification by Makarova et al. [12]. The genes are ordered by function: interference (left) and adaptation (right).
The interference proteins are subdivided into the interference nuclease (left, outlined in black), proteins of the interference complex (middle, boxed in red) and pre-crRNA nucleases (right, although
some are integral subunits of the interference complexes). The genes are coloured according to conserved domain and protein folds: catalytic RAMPs are shown in blue, non-catalytic RAMPs in
light blue, HD nuclease domains in light green, Cas3 helicase domains in dark green, the large subunits in various shades of purple and the small subunits in yellow. Subtypes I-D and II-B are not
shown as there is no directly relevant structural data. EM images and structures of the interference complexes (or subcomplex for I-A) are adapted from references 1 [13], 2 [14], 3 EMD-5314, 4 [15]
and 5 [20].
been detected in the superfamily; as yet no single protein has been
found to contain all five [44].
Cas6 proteins typically contain two sequential RAMP domains
with the glycine-rich loop (motif V of the RAMP superfamily
sequence motifs) located between α2′ and β4′ of the second
(C-terminal) domain (the prime denotes a structural element
in the second domain) (Figure 3B) [45–50]. This loop often
fits the consensus sequence G#GXXXXXG#G, where # is a
hydrophobic residue, X is any residue and the variable region
contains at least one positively charged residue [51]. Other than
this motif, the Cas6 proteins exhibit minimal sequence similarity.
PaCas6f (Pseudomonas aeruginosa Cas6f) is atypical because it
contains what is possibly a severely degraded C-terminal RAMP
domain (Figure 3C) [33]. The C-terminal domain contains four
short β-strands that, although they are orientated to form a RAMP
β-sheet, are not aligned to do so (Figure 3C). The RAMP helices
are not present, but the glycine-rich loop (albeit differing from the
consensus sequence) is located between the correct β-strands. The
Cas6 homologues contain additional secondary structure elements
relative to the RAMP elements, but only one feature is fully
conserved: a β-hairpin connecting β2′ and β3′ in the C-terminal
domain (we denote this the β2′–β3′ hairpin) that extends beyond
the β-sheet. This hairpin is even conserved in the abnormal C-
terminal domain of PaCas6f.
Cas5c contains an N-terminal RAMP domain and a C-terminal
domain consisting of a three-stranded antiparallel β-sheet
(Figure 3D) [14,30,52]. The RAMP domain contains a glycine-
rich loop that does not match the Cas6 consensus sequence. It also
contains a β2–β3 hairpin that is joined by another short β-strand
to form a β-sheet. In some Cas5c homologues, two helices are
inserted into the tip of the hairpin [52]. Due to the hairpin and
the glycine-rich loop, this RAMP domain is similar to the Cas6
C-terminal domain, although it also exhibits significant similarity
to the N-terminal domain of archaeal Cas6 proteins. In Cas5c, α2
is not located behind β4; instead, the shorter β4 (in other RAMPs,
β4 is longer or is followed by an extended strand) allows α2 to run
antiparallel to β1 (compare Figure 3B with Figure 3D). This atyp-
ical arrangement could correctly position the residues of the active
site, which is located at the intersection of α1 and α2 at the top of
the β-sheet, a location different to that of Cas6 (see below). The
β-sheet of the C-terminal domain does not have a RAMP domain
arrangement of secondary structure elements. However, β1′ and
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Figure 3 The structures of catalytic RAMP proteins
(A) Topology diagram of a RAMP domain. The β-strands are shown in blue and the α-helices in cyan. The glycine-rich loop found in many RAMPs is shown in yellow and the β2–β3 hairpin observed
in some RAMPs is shown in green. The N- and C-termini are shown as blue and red spheres respectively. (B) The structure of TtCas6e (PDB code 1WJ9) highlighting the two RAMP domains that
may have arisen from a pseudo-duplication event. Secondary structural elements are labelled as described in the text. Conserved RAMP elements are coloured as in (A) and non-conserved elements
in grey. Disordered regions are shown as broken black lines. (C) The atypical C-terminal domain of PaCas6f (PDB code 2XLK) that probably diverged from the standard RAMP fold. The recognizable
features are labelled. (D) The structure of BhCas5c (PDB code 4F3M), a catalytic variant of the typically non-catalytic Cas5 family. The short β4 strand and parallel α2 helix are boxed in black. The
possible β2′–β3′ hairpin in the C-terminal domain is shown in black.
β2′ form an extended β-hairpin reminiscent of the β2′–β3′ hairpin
of Cas6, although this is the only feature that is potentially RAMP-
like. Thus it is not possible to say with certainty whether the
C-terminal domain of Cas5c is a highly divergent RAMP domain.
RNA binding and cleavage
Cas5c and Cas6 are both metal-independent ribonucleases that
form products with 5′-hydroxyls and 2′,3′-cyclic phosphates
[30,33,46,53], indicative of a general acid/base mechanism
involving nucleophilic attack by the deprotonated 2′-hydroxyl on
the scissile phosphate. The active site of Cas6 is located between
α1 and the glycine-rich loop, although the exact position of the site
varies amongst the subfamilies (Figures 4A–4D). Remarkably, the
catalytic residues also vary between the proteins and none of
the residues are conserved in all of the Cas6 subfamilies. Cas6
enzymes from Pyrococcus furiosus (PfuCas6) and Thermus
thermophilus (TtCas6) possess a catalytic triad of histidine,
tyrosine and lysine residues similar to the RNA-splicing
endonuclease [37,46,54,55]. The tyrosine residue has been
assigned as the general base and the histidine residue as the general
acid, with the lysine residue stabilizing the pentacoordinate
phosphate intermediate. PaCas6f, however, uses a catalytic dyad
of histidine and serine residues, with the histidine residue acting
as the general base and the serine residue holding the ribose ring in
the correct conformation [41]. Two active Cas6 paralogues from
Sulfolobus solfataricus contain neither a general acid nor a general
base, instead using conserved positively charged residues to
correctly orientate the substrate and stabilize the pentacoordinate
phosphate intermediate [49,50]. The presence of a catalytic
histidine residue in the N-terminal domain had previously been
highlighted as a characteristic feature of Cas6s [56], but it is now
clear that this is not necessarily the case.
The location of the Cas5c active site is different to that of
Cas6, suggesting that the active sites evolved independently of
each other. The catalytic triad of BhCas5c (Bacillus halodurans
Cas5c) consists of a tyrosine residue located in α1 and histidine
and lysine residues in α2, similar to the PfuCas6 and TtCas6e
active sites [14]. The lysine is the only residue of the triad
that is invariant across the family; the tyrosine residue can
be exchanged for histidine (as in the active Cas5c nucleases
from Mannheimia succiniciproducens and Xanthomonas oryzae
[30,52]), phenylalanine or leucine, whereas the catalytic histidine
residue can be replaced by other aromatic residues (phenylalan-
ine/tyrosine) (Supplementary Figure S1 at http://www.biochemj.
org/bj/453/bj4530155add.htm), but the roles of the residues are
not yet understood. None of these supposed catalytic residues
are conserved in other Cas5 proteins, perhaps unsurprisingly since
only Cas5c is catalytically active.
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Figure 4 RNA binding and catalysis by Cas6 and Cas5c
The structures of (A) PfuCas6 (PDB code 3PKM), (B) SsoCas6 (PDB code 4ILL), (C) TtCas6e (PDB code 2Y8W) and (D) PaCas6f (PDB code 2XLK) in complex with RNA (red). The glycine-rich loop
is shown in yellow and the catalytic residues as magenta sticks. (E) The structure of BhCas5c (PDB 4F3M) highlighting the position of the active site (magenta). The four structures are shown to the
same scale and same orientation. A three-dimensional representation of this Figure is available at http://www.biochemj.org/bj/453/0155/bj4530155add.htm.
As expected for nucleases that process RNA substrates with a
range of secondary structures, multiple modes of RNA binding
have been observed across the Cas6 family. This perhaps underlies
the variation in the position of the active site as the different
modes alter the position of the scissile bond. PfuCas6 and its
inactive homologue from Pyrococcus horikoshii (PhCas6nc) bind
unstructured RNA in a ‘wrap-around’ mechanism where the
RNA binds in the cleft between the two domains (Figure 4A)
[38,48]. These enzymes bind the 5′ end of the repeat in the cleft
between the β-sheets of the two domains and this interaction with
the first ∼10 nt appears to be the predominant determinant of
binding affinity. Although the 3′ end of the substrate, including
the scissile phosphate, is disordered in the crystal structures, it
is predicted to follow the positively charged cleft into the active
site [38]. TtCas6e, PaCaf6f and a homologue from S. solfataricus
(SsoCas6) bind hairpin RNA with the majority of the contacts
formed by the C-terminal domain (Figures 4B–4D). TtCas6e and
SsoCas6 bind the hairpin across the helical face of the protein
using a series of basic residues to bind the phosphate backbone
of the 3′ strand of the hairpin [37,49,55]. The RNA hairpin of
SsoCas6 is shorter than that of TtCas6e by 3 bp and is predicted
to be unstable in solution [36], meaning that SsoCas6 specifically
stabilizes the hairpin conformation. PaCas6f, which shares few C-
terminal secondary structure elements with other Cas6 proteins,
binds the RNA hairpin between the RAMP β-strands and a helix–
loop–helix motif, using the first helix to bind the major groove of
the RNA [33]. In all three of these proteins, the β2′–β3′ hairpin
is inserted into the base of the RNA hairpin, serving to position
the scissile phosphate within the active site and, in the case of
PaCas6f and SsoCas6, provides key catalytic residues. It seems
likely that the β2′–β3′ hairpin plays a conserved role across the
Cas6 family.
The method of substrate binding in Cas5c must be significantly
different to that observed in Cas6 proteins, because the active
sites of the two families are in different locations (Figure 4). In
Cas5c, RNA is expected to bind to the helical face of the protein,
which in all structures is positively charged, particularly adjacent
to the active site [14,30]. Both domains of Cas5c are implicated
in binding the substrate, including the β-sheet encompassing the
putative β2′–β3′ hairpin [14,30]. However, neither the β2–β3 nor
theβ2′–β3′ hairpin can function by inserting at the base of the RNA
hairpin, as this would place the scissile phosphate too far away
from the active site. A complex structure of Cas5c and substrate
is required to determine the exact mode of binding.
The method of RNA binding for Cas5c and Cas6 differs from
typical RRMs, which contain the same ferredoxin-like fold as
RAMPs. Typical RRMs possess two conserved sequence motifs
located in β1 and β3 (termed RNP2 and RNP1 respectively)
that are not present in RAMPs (Supplementary Figure S2
at http://www.biochemj.org/bj/453/bj4530155add.htm) [57,58].
These motifs allow RRMs to bind ssRNA or ssDNA across
the face of the β-sheet [59,60], although not hairpin or dsRNA
(double-stranded RNA), whereas RAMPs bind ssRNA or hairpin
RNA through diverse modes of binding.
The active sites appear to have evolved independently for Cas6
and Cas5c, and even within the Cas6 family there is no universally
conserved catalytic mechanism. Given that the catalytic rate
constants of these enzymes, at 1–5 min− 1 [37,40], are of the same
order as those observed for catalytic RNA [61], these enzymes
may be more constrained by the need to recognize pre-crRNA
specifically than by a requirement to turn over rapidly.
THE PROTEINS OF THE INTERFERENCE COMPLEXES
Atomic level detail structures are now available for a number of
individual proteins that are involved in interference. In addition,
EM structures have been solved for a number of the interference
complexes (Figure 2). The highest resolution structures available
are those of the Escherichia coli eCascade in complex with crRNA
and with a crRNA/protospacer RNA duplex at resolutions of 8 and
9 Å (1 Å= 0.1 nm) respectively [39]. Lower resolution images
and structures are also available for the B. halodurans cCascade
[14], Ps. aeruginosa f Cascade [15] and S. solfataricus CMR
complex [20] as well as the core complex of S. solfataricus
aCascade [13]. Although the overall complex topologies can be
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Figure 5 The structure of Cas7, the core subunit of Cascade
(A) The structure of SsoCas7 (PDB code 3PS0) where the central RAMP domain is extended by an αβα motif (orange) and flanked by two unique domains (grey). The proposed crRNA-binding cleft
located across the face of the β-sheet is indicated. (B) Topology diagram of SsoCas7 showing the connectivity of the RAMP fold relative to the other domains.
discerned, the resolution of these structures has precluded reliable
placement of individual proteins within the complex.
Cas7, the backbone of the type I complex
The structural backbone of Cascade is composed of multiple
monomers of Cas7 [13,14,39]. In eCascade, Cas7 assembles into
a helical hexameric structure with crRNA binding in a groove
formed along the outer face of the oligomer [39]. This helical
arrangement is conserved in the core complex of the S. solfataricus
aCascade, although this complex of Cas5 and Cas7 forms oli-
gomers of variable length [13]. It is possible that further factors
are needed to produce a complex of defined length or perhaps
aCascade exhibits greater structural plasticity than eCascade. A
similar helical arrangement to eCascade was observed in EM
images of cCascade [14], and, although it was not possible to
unambiguously define the quaternary structure of the complex,
it is probable that the six Cas7 subunits of the complex form
the same backbone. f Cascade contains six Csy3 subunits with
a similar twisted topology to both cCascade and eCascade [15].
This, combined with secondary structure predictions and MS frag-
mentation analysis, has recently led to the hypothesis that Csy3
actually belongs in an expanded Cas7 family [56,62]. Similar
structure predictions place Csc2 of dCascade in the Cas7 family
[56], suggesting that the Cas7 helical backbone is a conserved
and perhaps characteristic feature of all Cascade complexes.
The structure of Cas7 from one of the S. solfataricus aCascade
complexes [13] (termed SsoCas7) contains a central RAMP fold
modified with an additional αβα motif located immediately after
β4 (Figure 5A). This motif adds a fifth strand to the β-sheet
(β5β4β1β3β2) with the two helices on either side of β5. The loop
between α2 and β4 is disordered in the structure and is not glycine-
rich, a conserved feature of the Cas7 family [56]. Significant
insertions are located between each of the four β-strands; these
form two distinct regions above and below the β-sheet to form
a crescent-shaped molecule (Figure 5B). Residues located in the
cleft of SsoCas7 have been implicated in binding crRNA [13].
The structure of eCascade shows that the E. coli Cas7 adopts a
similar topology to SsoCas7 and that the cleft forms the extended
groove along the helical assembly of Cas7 [39]. Given the likely
ubiquitous nature of the Cas7 backbone, it is probable that all
Cascade complexes bind crRNA in the same manner.
Non-catalytic variants of Cas5
Although Cas5c possesses catalytic activity, the other members
of the Cas5 family are non-catalytic and are limited to structural
roles. In both aCascade and eCascade, Cas5 interacts stably with
Cas7 [13,39]. Cas5e also interacts with Cse1 and Cse2 in eCascade
and appears to help stabilize the protospacer-bound conformation
of the complex [39]. cCascade contains two copies of Cas5c,
which appear to occupy the positions of Cas5 and Cas6e in
eCascade [14,39]. Cas5c from Streptococcus pyogenes and X.
oryzae bind dsDNA, which could be mimicking target dsDNA or
the heteroduplex of the interference R-loop [52]. Therefore Cas5c
seems to be able to function as both a catalytic Cas6 equivalent
and a structural Cas5 equivalent.
Of the Cascade complexes, only dCascade and f Cascade do not
contain Cas5 [12]. On the basis of secondary structure predictions,
Makarova et al. [56] predicted that Csc1 (I-D) and Csy2 (I-
F) belong to the Cas5 family. EM images and the small-angle
X-ray scattering (SAXS) structure of f Cascade place Csy2 in a
similar position to the structural Cas5s of cCascade and eCascade
[14,15,39]. However, the fragmentation patterns of eCascade and
f Cascade suggest that Csy2 does not interact with Csy3 (probable
Cas7 equivalent) in the same manner as Cas5 and Cas7 from
eCascade, leading van Duijn et al. [62] to conclude that f Cascade
does not contain a Cas5 equivalent. Further data are required to
settle the relationships between the complexes.
The small subunits of the interference complexes
Several of the interference complexes contain so-called ‘small’
subunits, which are typically <200 residues. These proteins are
Csa5 (I-A), Cse2 (I-E), Csm2 (III-A) and Cmr5 (III-B) and it
has been hypothesized that these proteins belong to a single
family (Cas11) [56]. Analysis of the structures of Csa5 [63], Cse2
[64,65] and Cmr5 [66] (PDB codes 2OEB and 4GKF) shows that,
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Figure 6 The small subunits of interference complexes
Comparison of T. thermophilus Cmr5 (PDB code 2ZOP, left), T. thermophilus Cse2 (PDB code 2ZCA, middle) and S. solfataricus Csa5 (PDB code 3ZC4, right). The N-terminal domain of Cse2 (light
orange) is superimposed on Cmr5 (blue) and the C-terminal domain of Cse2 (yellow) is superimposed on Csa5 (green).
although structural homology can be detected, the evolutionary
links between the proteins are complex. Cse2 contains N- and
C-terminal domains that consist of four and five α-helices
respectively. The N-terminal domain is homologous with the core
structure of Cmr5, whereas the C-terminal domain is homologous
with one of the domains of Csa5 (Figure 6). Csa5 consists of an
α-helical domain (homologous with the Cse2 C-terminal domain)
and a β-sheet domain that is not homologous with Cse2 or Cmr5.
In fact, this domain is very poorly conserved across the Csa5
family and is likely to vary significantly between homologues.
Possible evolutionary scenarios for the homology include
fusion of csa5 and cmr5 genes to form cse2 or the evolution
of the three proteins from a single cse2-like gene with domain
loss to form Csa5 and Cmr5 [63]. Csm2, the remaining small
subunit for which there is no structure available, may be critical for
determining the likely scenario, although it is certainly possible
that Csm2 may not possess any homology with the other small
subunits. Makarova et al. [56] suggested that the Cas8 C-terminal
domain, which is predicted to be helical, might be homologous
with the small subunits, although no experimental structure exists
to confirm this.
The Cse2 dimer is an integral part of eCascade [39] and is
responsible for stabilizing the R-loop, increasing the affinity of
eCascade for dsDNA approximately 10-fold [67]. Cse2 alone
binds non-specifically to dsDNA and ssRNA [65]. Conversely,
the S. solfataricus Csa5 does not stably interact with Cas5/Cas7 in
the presence of crRNA or with nucleic acids alone [63]. Cmr5,
in contrast with both Csa5 and Cse2, appears to be non-essential
to the function of the CMR complex [11]. Thus we conclude
that the similarity of the small subunits is structural rather than
functional.
The large subunits of the interference complexes
Similarly to the small subunits, each of the type I and
III interference complexes contains a ‘large’ (>500 residues)
subunit: Cas8 (I-A, I-B, I-C), Cse1 (I-E), Csy1 (I-F) and Cas10
(I-D, III-A and III-B). Cas10 was originally predicted to be a
polymerase (hence the name polymerase cassette for the III-B
subtype) on the basis of sequence features typical of a palm
domain commonly found in polymerases and cyclases [44].
Subsequently it was proposed that all of the large subunits were
homologous and part of a Cas10 superfamily [56]. However,
recent structures of a type III-B Cas10 [68,69], denoted Cas10b,
show that, although the prediction of the palm domain was correct
(albeit more akin to cyclases), no significant structural homology
exists with Cse1 [70,71] (PDB codes 4H3T and 4EJ3). This argues
against a single common ancestor for all of the large subunits.
Cas10, the large subunit of type III systems
Cas10 is the defining protein of the type III system and consists
of an N-terminal HD (histidine–aspartate) phosphohydrolase
domain (for which there is no structure) and a C-terminal
region (Cas10dHD) that contains the palm domain [56]. Cas10bdHD
from P. furiosus consists of two adenylate cyclase-like domains
(denoted D1 and D3) and two α-helical domains (D2 and D4)
(Figures 7A and 7B) [68,69]. D2 is not significantly homologous
with known structures, but D4 is structurally homologous with
Cmr5 and the N-terminal domain of Cse2, although sequence
conservation is minimal and the biological implications of the
homology are unclear. A typical adenylate cyclase domain
consists of a ferredoxin-like fold with a C-terminal α3β5α4β6β7
modification, which creates a seven-stranded β-sheet with the
two additional helices located on either side of the sheet [72].
D1 and D3 lack some of these key structural elements: D3 lacks
α4 and β6, whereas D1 lacks every additional element bar α3.
Individually, D1 and D3 are most similar to the type III adenylate
cyclase from Mycobacterium tuberculosis [72]. However, these
bacterial cyclases are typically homodimers, whereas D1 and
D3 of Cas10bdHD exist as a pseudoheterodimer more similar to
the arrangement of mammalian cyclases [73]. The orientation
between D1 and D3 is markedly different to that of typical cyclases
which, combined with the loss of key structural and sequence
features, is consistent with PfuCas10bdHD lacking a cyclase-like
catalytic activity, although D3 retains the ability to bind ADP
[68].
In the CMR complex Cas10b interacts with Cmr3, an
interaction observed in both S. solfataricus and P. furiosus [20,74].
The structure of the P. furiosus Cas10bdHD–Cmr3 complex shows
that the two proteins form a heterodimer with the interface formed
by D1 of Cas10bdHD and one face of Cmr3 (see below) [74]. At the
interface between the two proteins is a highly positively charged
cleft ∼50 Å in length, which is suggestive of a role in crRNA
binding. The nucleotide bound by D3 in both the Cas10bdHD and
Cas10bdHD–Cmr3 structures lies at the centre of this cleft and so
could be mimicking crRNA binding by the complex rather than
substrate binding by the ‘cyclase’ domains of Cas10bdHD. This is
consistent with the nucleotide binding in a different orientation to
that observed in cyclases.
If the Cas10b–Cmr3 complex does bind to part of the crRNA,
the remainder of the crRNA must be bound by other subunits of the
CMR complex. Three subunits of the complex (Cmr1, Cmr4 and
Cmr6) are RAMPs and thus are plausible candidates. Makarova et
al. [56] have predicted Cmr4 and Cmr6 to be Cas7 homologues.
However, EM structures of the CMR complex (which targets
ssRNA and not dsDNA) show that it is more compact than Cascade
and lacks a central helical structure [20].
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Figure 7 The large subunits of interference complexes
(A) The structure of PfuCas10bdHD (PDB code 3UNG) in complex with ADP (red sticks). The ferredoxin-like folds are coloured as for RAMPs and the additional adenylate cyclase elements are shown
in orange. D4 is shown in yellow to highlight its homology with the small subunits. The three metal ions are shown as grey spheres. Inset: schematic diagram showing the relative positions of the
four domains (D1–D4) with the cyclase-like domains in blue and the small subunit-like domain in yellow. (B) The structure of the Cas10bdHD–Cmr3 complex (PDB code 4H4K) with Cmr3 shown in
navy blue and Cas10bdHD as in (A). The putative crRNA-binding cleft is indicated with a solid black line. (C) The structure of Cse1 from T. thermophilus (PDB code 4AN8) with the disordered loop
L1 indicated.
Cse1, the PAM (protospacer adjacent motif) sensor of eCascade
The structures of Cse1 from T. thermophilus [70,71] (PDB
code 4EJ3) and Acidimicrobium ferrooxidans (PDB code 4H3T)
consist of an N-terminal mixed α/β domain with a novel fold
and a C-terminal four-helix bundle (Figure 7C). In eCascade,
Cse1 is responsible for recognition of the PAM, a short (2–5 nt)
conserved sequence located immediately next to the protospacer
that is required for interference [75]. Cascade recognizes a PAM
located 5′ to the protospacer [75] and, at least for eCascade,
PAM recognition uses the complementary strand [76]. Target
dsDNA lacking a PAM is bound weakly by eCascade [76,77]
and is resistant to cleavage [78], consistent with the observation
that mutations in the PAM can prevent interference [15,79].
The N-terminal domain of Cse1 contains a loop (L1, Figure 7C)
that is disordered in all of the available crystal structures, but is
critical for PAM recognition [70,71]. Analysis of the eCascade
structures led Mulepati et al. [70] and Sashital et al. [71] to suggest
that L1 binds to the crRNA 5′-handle and PAM in the absence and
presence of target DNA respectively. Cse1 is also critical for
binding to negatively supercoiled dsDNA, both specifically to a
protospacer and also non-specifically, a function that is dependent
on the L1 loop [53,70,71]. Sashital et al. [71] have proposed
that Cse1 scans dsDNA for PAM sequences and once in contact
destabilizes the duplex to allow for target recognition, first through
a 5′ seed sequence and then along the remainder of the target.
Other Cascade complexes lack Cse1 and must use a different
protein for PAM sensing, although their identities have not been
established. Cas8 and Csy1 are candidates as they dissociate easily
from their respective complexes (similar to Cse1 and eCascade)
and EM images suggest that they are located in a similar position
to Cse1 within their complexes [14,39,62].
Cmr3, a type III-B Cas6-like protein
Cmr3 is a RAMP protein of the CMR complex and the structure
of PfuCmr3, available only in complex with Cas10bdHD, shows
that it contains two RAMP domains arranged in a similar
manner to Cas6 (compare Figure 8 with Figure 3B) [74]. The
C-terminal domain contains two of the conserved features of
Cas6: the β2′–β3′ hairpin and the glycine-rich loop, both of
which adopt similar conformations to those seen in Cas6 proteins.
The Cmr3 glycine-rich loop also exhibits a similar consensus
sequence to that of Cas6 (XXXXXGϕG, where ϕ is an aromatic
residue, X is any residue and the variable region contains at
least one positively charged residue) (Supplementary Figure S3
at http://www.biochemj.org/bj/453/bj4530155add.htm). In the N-
terminal domain, a β-strand located after α2 forms a β-hairpin
with β4, as is also seen in the Pyrococcus and Sulfolobus Cas6
homologues [46–50], with the turn of the hairpin containing the
two conserved glycine residues identified by Makarova et al.
[56] as an N-terminal glycine-rich loop. The tip of this loop is
disordered, but since it is only three residues in length it acts more
as a turn rather than the extended loop seen in many RAMPs.
Cmr3 exhibits two significant deviations from Cas6. α2′ is
replaced by a short β-strand located immediately prior to the C-
terminal glycine-rich loop, similar to the β-strand located before
the N-terminal glycine-rich loop. The second difference is the
presence of a significant structural insertion located between β2
and β3 of the N-terminal domain. This insertion consists of two
short helices and seven β-strands and packs against the C-terminal
β-sheet. The insertion and the β2′–β3′ hairpin together form the
interface with Cas10bdHD and line the putative crRNA-binding
cleft.
THE INTERFERENCE NUCLEASES
During interference, invading nucleic acids detected by base
pairing with crRNA are targeted for degradation by an
interference nuclease. In type I systems this is the HD metal-
dependent nuclease domain of Cas3, which is recruited to Cascade
rather than being an integral component [76]. Type II systems use
Cas9 as the sole interference protein with the HNH-like and RuvC-
like nuclease domains cleaving the complementary and non-
complementary strands of the R-loop respectively [16,80]. The
interference nucleases of the type III systems are unknown.
The nuclease is within the CMR complex, but Cas10b and Cmr5
have been discounted, as has the Sulfolobales-specific protein
Cmr7 [11,20,68].
Cas3, the interference nuclease of type I systems
Cas3 is the defining protein of the type I system and consists of
an N-terminal HD nuclease domain and a C-terminal superfamily
II DExD/H-box helicase domain [12,44,81]. In some systems the
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Figure 8 The structure of Cmr3
(A) The structure of PfuCmr3 (PDB code 4H4K) showing the RAMP elements and the structural insertion in the N-terminal domain (orange). (B) Topology diagram of PfuCmr3 highlighting the
conserved RAMP features and the connectivity of the insertion domain.
Figure 9 The structures of Cas protein HD domains
(A) The structure of TtCas3HD (PDB code 3SKD) with the conserved HD superfamily helices in green and numbered. The Ni2+ ion is shown as a dark grey sphere. Residues 222–260 are not shown
as they are predicted to belong to the helicase domain. (B) A homology model of the HD domain of Cas10a from S. thermophilus created using PHYRE2 and consisting of residues 4–79. The four
HD domain helices are coloured in green and labelled. (C–E) Views of the active sites of (C) TtCas3HD, (D) MjaCas3′ ′ (PDB code 3S4L) and (E) SthCas10aHD. The HD superfamily motifs are shown
as sticks with motif numbers in parentheses and the metal ions as grey spheres with site numbers in white.
two domains are expressed as separate proteins (Cas3′ ′ and Cas3′
respectively); other variations are also known, such as domain
fusion to other Cas proteins (for example, Cas3–Cas2 in the I-
F subtype and Cas3–Cse1 in some I-E systems) and inversion
of the domain order (Figure 2) [12,44,76]. Cas3 is recruited by
Cascade after R-loop formation where it catalyses the unwinding
and degradation of the invading DNA [76,78].
Cas3 proteins contain all five HD superfamily sequence motifs
(H-HD-H-H-D) and the structures of TtCas3HD (HD domain of
TtCas3) and MjaCas3′ ′ (Methanocaldococcus jannaschii Cas3′ ′)
revealed eight conserved helices, five of which are characteristic
of the HD superfamily (Figure 9A) [82,83]. In the TtCas3HD
structure a single Ni2+ ion is bound by motifs I, II and V (site
1), whereas site 2 (a binding site formed by motifs II, III and
IV) remains unoccupied (Figure 9C). Metal binding at site 2 has
been observed in a number of HD domains (for example, see PDB
codes 2OGI, 2O08, 2PQ7, 3CCG and 3HC1) and its absence in the
TtCas3HD structure is likely to be a crystal artefact. The MjaCas3′ ′
structure shows a Ca2+ ion bound at site 2 as well as a second ion
bound by the histidine of motif II (site 3) (Figure 9D). However,
the binding at site 3 and the lack of binding at site 1 are likely
to be artefacts resulting from the protein engineering required for
crystallization.
Characterization of type I-E Cas3 nuclease domains from T.
thermophilus, Streptococcus thermophilus, and E. coli and the
type I-A Cas3′ ′ proteins from M. jannaschii and P. furiosus
showed that they are all metal-dependent nucleases specific for
ssDNA, although the Cas3′ ′ proteins also cleave ssRNA in vitro
[82–84]. These proteins are both endo- and exo-nucleases, with
the latter activity proceeding in the 3′→5′ direction. MjaCas3′ ′,
SthCas3 (Streptococcus thermophilus Cas3) and EcoCas3 (E.
coli Cas3) cleave R-loops, the biological substrate of Cas3 and
MjaCas3′ ′ and SthCas3 have been shown to target the non-
complementary ssDNA strand specifically [76,78,82]. Structural
data is not available for the helicase domain of Cas3, but the type I-
E helicase domains of SthCas3 and EcoCas3 catalyse the 3′→5′
Mg2+ - and ATP-dependent unwinding of dsDNA and DNA/RNA
duplexes [84,85]. Nicking of the non-complementary strand by the
HD domain followed by the unwinding of the DNA duplex by
the helicase domain would allow for progressive degradation
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of the non-complementary strand (Supplementary Figure S4 at
http://www.biochemj.org/bj/453/bj4530155add.htm). The com-
plementary strand is also targeted by Cas3 [78] and would occur
after dissociation of DNA from the R-loop.
The HD domains of Cas10 proteins
Cas10 proteins contain N-terminal HD domains that are highly
divergent from typical HD domains, being both shorter than clas-
sical HD proteins and lacking characteristic motifs (Supplement-
ary Figure S5 at http://www.biochemj.org/bj/453/bj4530155add.
htm) [86]. A homology model of Cas10a from S. thermophilus
built using PHYRE2 [87] shows that motifs II, III and IV could
co-ordinate a metal ion in a similar way to that of site 2 of
Cas3 (Figures 9B and 9E). Therefore this domain could also be
catalytically active and might potentially act as the interference
nuclease of the CSM complex, although so far experimental
confirmation is lacking. In contrast, Cas10b only contains motif
II and so is unlikely to be an active nuclease, consistent with
the observation that the Cas10b HD domain is not necessary
for interference by the CMR complex [68], perhaps unsurprising
since this complex targets RNA.
CONCLUDING REMARKS
The structural biology of the CRISPR system provides a wealth
of information on the evolution and mechanisms of the proteins
involved. It has revealed the underlying relationships between
highly divergent proteins that are difficult or impossible to detect
using bioinformatic approaches (however heroic) alone. The
RAMP (or RAMP-like) domains, present in the Cas2, Cas5,
Cas6, Cas7, Cas10 and Cmr3 families, are the leitmotif of the
system, providing RNA-binding and -cleavage functionalities that
are central to the process. The backbone of all type I complexes
is likely to be a helical arrangement of Cas7, and a similar
arrangement of Cas7-like RAMP subunits may be found in the
CSM complex, given that it, too, targets dsDNA. Key challenges
for crystallography include the structure of the Cas9 protein of
type II systems, which has so far evaded attempts to place it in
a wider context. Structures of the large and small subunits of the
various type I and type III-A complexes are expected to clarify
the relationships between the different families, and we can look
forward to some simplification of the overall picture as these
relationships become apparent. Finally, atomic level structural
information on the ∼400 kDa CRISPR interference complexes
remains a grand challenge in molecular biology, one that has been
taken up enthusiastically by the structural biology community.
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